Vous êtes sur la page 1sur 89

PNdex .

indd 5

24/3/2553 18:13:05

4th Edition

2553

PNDEX THAILAND 2010


(Psychotropics & Narcotics Index 2010)

ISBN

974-244-092-1

/ 0 2590 7346
: narcotic@fda.moph.go.th

()
58-60 62 10260
0 2741 5354 0 2741 5360

All rights reserved.

AW_PNdex front 20100402.indd 1

2/4/2553 13:57:04

OBJECTIVES

1.
(Identication)

2.
(Identication)

3.

.
.
.
.

AW_PNdex front 20100402.indd 2











2/4/2553 13:57:04

CONTENTS

OBJECTIVES :

HOW TO USE :

PRODUCT IDENTIFICATION SEQUENCE


PRODUCT IDENTIFICATION CHART
















/





/

10
14
15
16
16
19
19
21
23
23
23

PINK PAGES

10-39

40-61

CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICS




40
NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS)

42





IMPORTANT DRUG NOTES


48

P2 2
48

P3 3
53

P4 4
54

N2 2
58

N3 3
60

AW_PNdex front 20100402.indd 3

2/4/2553 13:57:04

INDEX







CONTROLLED SUBSTANCE CLASS


A-Z

P2 2

P3 3

P4 4

N2 2

N3 3

62-86
62
62
63
64
65

62-65

MANUFACTURERS INDEX

66-70

GENERIC AND BRAND NAME INDEX


A-Z

71-86

87-88

AW_PNdex front 20100402.indd 4

5/4/2553 17:45:15

HOW TO USE5

PRODUCT IDENTIFICATION SEQUENCE


... 9

PRODUCT IDENTIFICATION CHART


... 10-39

(Manufacturers name)
(Trade name)
(Generic name)


AW_PNdex front 20100402.indd 5

2/4/2553 13:57:05

GENERIC AND BRAND NAME INDEX


... 71-86

PRODUCT IDENTIFICATION CHART


... 10-39

NATIONAL LIST OF ESSENTIAL MEDICINE


... 42-47
()
A-Z

AW_PNdex front 20100402.indd 6

2/4/2553 13:57:06

CONTENTS
... 3-4

CLASSIFICATION OF
PSYCHOTROPICS & NARCOTICS
... 40-41

()
/

CONTROLLED SUBSTANCE CLASS INDEX


/... 62-65
A-Z

AW_PNdex front 20100402.indd 7

IMPORTANT DRUG NOTES


... 48-61
A-Z

2/4/2553 13:57:07

MANUFACTURES INDEX
... 66-70

PRODUCT IDENTIFICATION CHART


... 10-39

PNdex

(powered by MIMS.com)


1
2 ()

()

()
()

()

AW_PNdex front 20100402.indd 8

ENTER

7/4/2553 9:45:42

PRODUCT IDENTIFICATION SEQUENCE

AW_PNdex front 20100402.indd 9

2/4/2553 13:57:09

10

PN DEX 2010

PRODUCT IDENTIFICATION CHART


WHITE
Tablet

DILOMIL

Diphenoxylate HCl 2.5 mg


XN3

PHENOBARBITAL ATLANTIC

Lorazepam 1 mg

Phenobarbital Na 32.5 mg
P4
[86 mg]

P4
[100 mg]
022

011

PHENOBARBITAL ATLANTIC

LIZAVAN
Lorazepam 1 mg

Phenobarbital Na 65 mg

XP4
[100.4 mg]

P4
[95 mg]

023

P2
[50 mg]

012

KEMORA

002

LORAZENE

001

BUPRINE

Buprenorphine HCl 0.2 mg

LORAZEP

Lorazepam 1 mg

013

003

ZEDA

LORAMED
Lorazepam 1 mg

XP4

Lorazepam 0.5 mg

Codeine Phosphate (Analgesic) 15 mg

P4
[90 mg]

N2
[73 mg]

014

025

DIANO

LORAPAM

Lorazepam 1 mg
XP4

Diazepam 2 mg

004

PHENOBARBITONE
NEW LIFE PHARMA
Phenobarbital Na 30 mg
XP4

P4
[80 mg]
026
015

LORA-P

Lorazepam 1 mg
005

XP4
[113.37 mg]

LOMOTIL

016

Diphenoxylate HCl 2.5 mg


N3
[63 mg]

DIAZEPAM T P DRUG

006
017

P2
[59.98 mg]

Codeine Phosphate (Analgesic) 30 mg

CODEINE GPO
N2
[113 mg]

007
018

XN3

Lorazepam 1 mg

LONZA
P4
[85 mg]

Diphenoxylate HCl 2.5 mg


N3
[79.97 mg]

Lorazepam 1 mg
P4
[100 mg]
020

009

DIAPINE

ANTA

Diazepam 2 mg

XP4

PHENOBARBITAL ACDHON
Phenobarbital Na 60 mg

MEILAX

XP4

ORA

Lorazepam 1 mg
P4
[100 mg]

VALAX

Diazepam 2 mg
XP4

031

Ethyl Loflazepate 1 mg

RAZEPAM
Lorazepam 1 mg

P4
[100 mg]

XP4

XP4

010

021

032

Indicates brands that contain more than 1 ingredient

030

019

Lorazepam 1 mg

029

DITROPINE

SPASIL

ATIVAN

028

TEMGESIC

008

Lorazepam 1 mg
P4
[100 mg]

XP4

Diphenoxylate HCl 2.5 mg

LORAVAN

027

Diazepam 2 mg

Buprenorphine HCl 0.2 mg

P4
[100 mg]
024

P4
[65 mg]

CODEINE GPO

Lorazepam 1 mg

XP4

Lorazepam 1 mg

ANXIRA

PN DEX 2010

PRODUCT IDENTIFICATION CHART 11

LORAZEPAM ACDHON

LORAZIN

PRENARPIL

XP4

P4
[103.02 mg]

P4
[148.76 mg]

Lorazepam 1 mg

033

Lorazepam 1 mg

Clonazepam 2 mg

044

TRANAVAN

Lorazepam 1 mg
P4
[100 mg]

054

PSEUDOEPHEDRINE MILANO

RIVOTRIL

P2
[130 mg]

P4
[170 mg]

034

LORAPINE
Lorazepam 1 mg
XP4

055

045

PHENOBARB

SIPAM

LORA

Diazepam 2 mg

Phenobarbital Na 60 mg
035

P4
[164 mg]

XP4
[130 mg]

Lorazepam 1 mg

056
046

P4
[130 mg]

PSEUDOEPHEDRINE
ASIAN PHARM

036

FRISIUM
Clobazam 10 mg

Clonazepam 2 mg

Pseudoephedrine HCl 60 mg

Pseudoephedrine HCl 60 mg

ALPRAX

Alprazolam 1 mg
XP4
[190 mg]

P2
[155 mg]

XP4

057

TAZCINE

047

037

RUBIFEN

Methylphenidate HCl 10 mg
P2
[190 mg]

ZOPAM
Diazepam 2 mg

XP3
[149 mg]

P4
[160 mg]
058
048

038

MED-ZEPAM
Diazepam 2 mg
XP4

DIVOPAN

VOMED

Diazepam 2 mg
XP4

Diazepam 2 mg
P4
[180 mg]

059

049
039

DIPAM
Diazepam 2 mg

Pentazocine HCl 25 mg

DONNATAL

DIAZEPAM BJ BENJAOSOTH

Phenobarbital Na 16.2 mg

XP4

Diazepam 2 mg

XP4

P4
[158.25 mg]

040

050

RITALIN

GRANDAXIN

P2
[140 mg]

P4
[180 mg]

XP4
[180 mg]

051

061

DIAZEPAM GPO

NITRADOS

P4
[182 mg]

P2

042

052

062

FRISIUM

MED-ZEPOXIDE

Chlordiazepoxide HCl 10 mg

Diazepam 2 mg

P4
[120 mg]

XP4
[198.8 mg]

XP4

043

053

Methylphenidate HCl 10 mg

041

ALPRALAN
Alprazolam 0.25 mg
P4
[154.7 mg]

Clobazam 5 mg

060

DIAZ

Diazepam 2 mg

Tofisopam 50 mg

Nitrazepam 5 mg

Diazepam 2 mg

WINOPAM

063

Indicates brands that contain more than 1 ingredient

12

PN DEX 2010

PRODUCT IDENTIFICATION CHART

VORAPAM

PARADEINE

Diazepam 2 mg

Codeine Phosphate (Analgesic) 15 mg

P4
[180 mg]

N3
[470 mg]

REINBAMATE
Meprobamate 400 mg
XP3
[525 mg]

064

VALENIUM
Diazepam 2 mg

074

XP4

TYLENOL WITH CODEINE

082

Codeine Phosphate (Analgesic) 15 mg


N3
[432.5 mg]

065

DIAZEPAM LERD SINGH


Diazepam 2 mg

Codeine Phosphate (Analgesic) 8 mg


XN3

P4
[180 mg]

075

TYLENOL WITH CODEINE

066

POVANIL

PARADYL

Codeine Phosphate (Analgesic) 30 mg

Clonazepam 2 mg

083

DIETIL RETARD
Diethylpropion HCl 75 mg

N3
[478.72 mg]

P2
[755 mg]

P4
[150 mg]
067

076

DIMED

PARCOD

Diazepam 2 mg

Codeine Phosphate (Analgesic) 15 mg

XP4

XN3
[600 mg]

084

ANAX

Alprazolam 0.25 mg
P4
[130 mg]

068

XANAX XR

085

Alprazolam 1 mg

077

P4
[347.19 mg]

ALODORM

ANZION
Alprazolam 0.25 mg
XP4
[132.25 mg]

Nitrazepam 5 mg
P2
[556 mg]

069

LEXOTAN

086

ALNAX

Bromazepam 1.5 mg

Alprazolam 0.25 mg

P4
[200 mg]

XP4
[130 mg]

078

PARCONO

Codeine Phosphate (Analgesic) 8 mg


070

N3
[600 mg]

COCET

ANPRESS
P4
[131.2 mg]

XN3

088

079

NASA WITH CODEINE

Codeine Phosphate (Analgesic) 15 mg

CEMOL - CODEINE

Codeine Phosphate (Analgesic) 15 mg

Alprazolam 0.25 mg

Codeine Phosphate (Analgesic) 15 mg

071

087

N3
[600 mg]

DIZOLAM
Alprazolam 0.25 mg
P4
[130 mg]
089

XN3

MARZOLAM
Alprazolam 0.25 mg
080
072

COTENOL

Codeine Phosphate (Analgesic) 15 mg

MOGADON
Nitrazepam 5 mg
P2

XN3

P4
[129.75 mg]
090

XANACINE
Alprazolam 0.25 mg
P4
[110 mg]

073

081

Indicates brands that contain more than 1 ingredient

091

PN DEX 2010

PRODUCT IDENTIFICATION CHART 13

FARZOLAM

ALLAM

Alprazolam 0.25 mg

Alprazolam 0.25 mg

Codeine Phosphate (Analgesic) 15 mg

XP4

P4
[130 mg]

XN3
[478.77 mg]

092

103

ZOLAM

INZOLAM
Alprazolam 0.25 mg

113

P4
[131.55 mg]

P4
[132 mg]

CONCERTA

093

104

Alprazolam 0.25 mg

PARAGEN CO

Methylphenidate HCl 36 mg

MOXINAX

Alprazolam 0.25 mg
P4
[130 mg]

P2
[515 mg]

ALPRAMED
Alprazolam 0.5 mg
P4
[130 mg]

094

XALAM
Alprazolam 0.25 mg
XP4

114

REGENON RETARD

105

Diethylpropion HCl 75 mg
P2
[755 mg]

MITRANAX
Alprazolam 0.25 mg
P4
[130 mg]

095

XANAX

106

Alprazolam 0.25 mg

SUNAX

P4
[128.25 mg]

Alprazolam 0.25 mg

115

XP4
[130.03 mg]

PARDEX

Dextropropoxyphene Napsylate 32.5 mg

096

XN3

ALCELAM

Alprazolam 0.25 mg
P4
[130 mg]

107

XIEMED

Alprazolam 0.25 mg
P4
[130.01 mg]

097

116

METHYLPHENIDATE HEXAL
108

P4
[125 mg]

ALPRAZOLAM FRX

P2
[174.98 mg]

098

XP4
[130 mg]

SIAMPRAXOL

Alprazolam 0.25 mg

MANEX

Methylphenidate HCl 10 mg

Alprazolam 0.25 mg

117

Alprazolam 0.25 mg

109

P4
[130 mg]

STILNOX

Capsule
ZEPOXIN

Zolpidem Tartrate 10 mg

Chlordiazepoxide HCl 10 mg

P2
[126 mg]

099

XP4
[100 mg]

ALPAZAM
Alprazolam 0.25 mg
XP4

118

110

POPAM

KAPANOL

Morphine Sulfate 20 mg

Diazepam 2 mg
100

N2
[142.8 mg]

XP4

PHARNAX

Alprazolam 0.25 mg
P4
[131.65 mg]

111

101

Codeine Phosphate (Analgesic) 15 mg

LORAMET

119

CODIGESIC
N3
[550 mg]

KAPANOL
Morphine Sulfate 50 mg
N2
[323.3 mg]

Lormetazepam 1 mg
P2

102

112

120

Indicates brands that contain more than 1 ingredient

14

PN DEX 2010

PRODUCT IDENTIFICATION CHART

KAPANOL

RAZEPAM

DIAZEPAM SAMAKEEPHAESAJ

N2
[620.5 mg]

XP4

Diazepam 5 mg

Morphine Sulfate 100 mg

Lorazepam 2 mg

XP4

131

VALAX

142

Diazepam 5 mg

PSEUDOEPHEDRINE
ASIAN PHARM

XP4
121

Pseudoephedrine HCl 30 mg

132

YELLOW

Phenobarbital Na 30 mg
XP4

XP4
[153 mg]

143

133

Amobarbital 50 mg

AMA

DIAZEPAM VESCO

P3
[208.7 mg]

P4
[109 mg]

144

134

ZOPAM

Diazepam 5 mg

122

LORA-P

Lorazepam 2 mg
XP4
[113.43 mg]

PSEUDOEPHEDRINE
BJ BENJAOSOTH

123

BELLOID

Butobarbital 30 mg

Diazepam 5 mg
P4
[160 mg]

P2
[158.22 mg]

145

DIVOPAN

124

Lorazepam 2 mg
P4
[100 mg]
125

METHADONE GPO

Methadone HCl 5 mg

Diazepam 5 mg

PSEUDOEPHEDRINE MILANO

P4
[209 mg]

Pseudoephedrine HCl 30 mg
P2
[110 mg]

146

136

Diazepam 5 mg

VOMED

DIPAM
XP4

XP4

147

126

COZEP

LORAZENE

Chlordiazepoxide HCl 10 mg

P4
[179.55 mg]

DIAZEPAM GENERAL DRUGS


HOUSE
Diazepam 5 mg
P4
[160 mg]

148

138

127

PORA

LORAPAM

Lorazepam 1 mg

Lorazepam 2 mg

Diazepam 5 mg

137

XP4

135

N2
[110 mg]

Lorazepam 2 mg

Pseudoephedrine HCl 60 mg

XP4

ANTA

P2
[145 mg]

Clorazepate Dipotassium 5 mg

Tablet
PHENOBARBITAL ACDHON

DOPAM

XP4

DIAZEPAM GPO
Diazepam 5 mg
P4
[182 mg]

XP4
139

149

128

DIANO

ATIVAN

Diazepam 5 mg

Lorazepam 2 mg

P4
[110.2 mg]

VALENIUM
Diazepam 5 mg
XP4

XP4
140
129

TRANOLAN
Diazepam 2 mg
P4
[150.62 mg]
130

PHENYLPROPANOLAMINE
PHARMASANT

150

DIZEPAM

Phenylpropanolamine HCl 25 mg

Diazepam 5 mg

XP2

P4
[170 mg]

141

151

Indicates brands that contain more than 1 ingredient

PN DEX 2010
VALIUM

PRODUCT IDENTIFICATION CHART 15

DIAZEPAM PONDS CHEMICAL

Diazepam 5 mg
XP4

Capsule

Diazepam 5 mg

POSENE

XP4

Clorazepate Dipotassium 5 mg
XP4
[140 mg]

152

DIAZA

162

Diazepam 5 mg

DIAZEPAM T MAN

XP4
[172 mg]

Diazepam 5 mg

172

XP4

TRANCAP

Clorazepate Dipotassium 10 mg
153

XP4

SIPAM

163

DIMED

Diazepam 5 mg

Diazepam 5 mg

P4
[164 mg]

173

XP4

PREFAMONE

Diethylpropion HCl 75 mg

154

DIAZEPAM T P DRUG
Diazepam 5 mg

P2

164

CO-COF

Codeine Phosphate (Antitussive) 10 mg

XP4

N3
[294.9 mg]
155

ALPRAX

174

165

Alprazolam 0.25 mg

DIAPINE

P4
[189.74 mg]

POZAPAM

Prazepam 10 mg

Diazepam 5 mg

P4
[336.5 mg]

P4
[280 mg]

156

DIAZ

166

Diazepam 5 mg

MILA-TERCON

XP4
[180 mg]

Codeine Phosphate (Antitussive) 8 mg

175

N3
[410.05 mg]

ORANGE

157

ROPAM

Tablet

Diazepam 5 mg

167

XP4
[170 mg]

TRIALAM

MEILAX

Ethyl Loflazepate 2 mg
XP4

Triazolam 0.25 mg
P2
[100 mg]

158

VORAPAM

176

Diazepam 5 mg

168

P4
[183 mg]

CONCERTA

TRANOLAN
Diazepam 5 mg

Methylphenidate HCl 18 mg

P4
[150.85 mg]

P2
[268 mg]

159

DIAZEPAM H K PHARM

177

169

Diazepam 5 mg

POPAM

P4
[160 mg]

Diazepam 5 mg

DILIUM

Diazepam 2 mg
XP4

XP4

160

DIAZEPAM LERD SINGH


Diazepam 5 mg

178

170

DIZEP

ZORA

P4
[175 mg]

Diazepam 2 mg

161

171

Lorazepam 2 mg
P4
[130 mg]

P4
[115.05 mg]

179

Indicates brands that contain more than 1 ingredient

16

PN DEX 2010

PRODUCT IDENTIFICATION CHART

PHENOBARBITONE
NEW LIFE PHARMA
Phenobarbital Na 60 mg
XP4

DIZEP

Capsule

Diazepam 5 mg
P4
[115.05 mg]

CORYNIL

Codeine Phosphate (Antitussive) 10 mg


XN3
[430 mg]

190
180

COZEP

Chlordiazepoxide HCl 25 mg
P4
[206.23 mg]

Capsule
DIAZEPION
Diazepam 10 mg

191

Ethyl Loflazepate 2 mg

201

XP4

RED
Tablet

MST CONTINUS
Morphine Sulfate 60 mg
N2
[154 mg]

PONDNEBIUM
XP4
[74.82 mg]

EPOXIDE
XP4
[205.49 mg]

P2
[144.7 mg]

193

BENPINE

Codeine Phosphate (Antitussive) 10 mg

Phenobarbital Na 60 mg
XP4
[120 mg]

ROTUSS

P4
[165.2 mg]
194

CHLORDIXIDE
185

Chlordiazepoxide HCl 10 mg

POVANIL

P4
[237 mg]

N3
[456.5 mg]

204

ZEPOXIN

Chlordiazepoxide HCl 5 mg

195

CLINOPECT

205

Codeine Phosphate (Antitussive) 10 mg

186

EPOXIDE

Codeine Phosphate (Antitussive) 10 mg

XP4
[100 mg]

Clonazepam 0.5 mg
P4
[150 mg]

N3
[430 mg]

203

Chlordiazepoxide HCl 25 mg

N3
[430 mg]

ROLAR

Chlordiazepoxide HCl 25 mg

Pseudoephedrine HCl 60 mg

MENOBARB

Codeine Phosphate (Antitussive) 10 mg

202

192

184

CODEPECT

Chlordiazepoxide HCl 10 mg

183

PSEUDOEPHEDRINE MEDICINE
PRODUCTS

N3
[558.5 mg]

181

182

ROPECT

Codeine Phosphate (Antitussive) 10 mg

XP4
[100 mg]

VICTAN

200

Chlordiazepoxide HCl 10 mg
XP4
[284.17 mg]

PINK

XN3
[217 mg]

Tablet
196

PAM-5

ZORITUSS

Diazepam 5 mg

Codeine Phosphate (Antitussive) 10 mg

XP4

XN3
187

NEOCOF

206

Codeine Phosphate (Antitussive) 10 mg

197

XN3

NEO-COPHEN

Codeine Phosphate (Antitussive) 10 mg

BELLERGAL
Phenobarbital Na 20 mg
XP4

XN3
188
198

XN3
[580 mg]

Codeine Phosphate (Antitussive) 10 mg

Codeine Phosphate (Analgesic) 8 mg

189

207

PACOGESIC

NEOPECT

PHENOBARBITAL ATLANTIC

Phenobarbital Na 16.25 mg

N3
[399.73 mg]

XP4
[84.99 mg]

199

208

Indicates brands that contain more than 1 ingredient

PN DEX 2010
PHENOBARB

PRODUCT IDENTIFICATION CHART 17


S.CO ZEPAM

Phenobarbital Na 30 mg

Diazepam 5 mg

XP4
[90 mg]

XP4

ANAX
P4
[130 mg]

209

LORAMED
Lorazepam 2 mg
P4
[100 mg]

230

220

BELLADONNA ALKALOIDS WITH


PHENOBARBITAL
Phenobarbital Na 16.2 mg
XP4
[160 mg]

210

Alprazolam 0.5 mg

ANZION
Alprazolam 0.5 mg
XP4
[132.5 mg]
231

DIAZEPAM T MAN
Diazepam 5 mg

ALNAX

221

DIAZEPAM BJ BENJAOSOTH

211

Diazepam 10 mg

ORA

XP4
[130 mg]

Alprazolam 0.5 mg

P4
[62.46 mg]

232

P4
[233 mg]

DIZOLAM

Lorazepam 2 mg

Alprazolam 0.5 mg

XP4
222
212

P4
[130 mg]

KENSPA

Chlordiazepoxide HCl 5 mg

VISPAM
Diazepam 5 mg

233

P4
[246 mg]

PRAZOL

Alprazolam 0.5 mg

XP4
[70.02 mg]

P4
[216.36 mg]

223

DIZEPAM

213

ALPRALAN
Alprazolam 0.5 mg

Diazepam 2 mg

234

P4
[170 mg]

MARZOLAM

P4
[157.28 mg]

Alprazolam 0.5 mg
P4
[130 mg]

224
214

PORA

Lorazepam 2 mg
XP4

CENTRODINE CD

Codeine Phosphate (Antitussive) 10 mg

235

N3
[205.2 mg]

XANACINE
P4
[110 mg]

225

215

DIAZEPAM PONDS CHEMICAL

Diazepam 5 mg

TAZCINE

236

Pentazocine HCl 50 mg

ZOLAM

XP3

Alprazolam 0.5 mg

P4
[145.6 mg]

P4
[133.8 mg]

226
216

LORA
Lorazepam 2 mg
P4
[200 mg]

Alprazolam 0.5 mg

LORAZIN

237

Lorazepam 2 mg

MOXINAX

P4
[200 mg]

Alprazolam 0.5 mg
P4
[130 mg]

227

217

DIAZEPAM H K PHARM


Diazepam 2 mg

LEXOTAN

238

Bromazepam 3 mg

XALAM

P4
[200 mg]

Alprazolam 0.5 mg
XP4

P4
[130 mg]
228
218

AZEPAM

Diazepam 2 mg

PHENOCON

239

Phenobarbital Na 60 mg

XANAX

XP4

219

Alprazolam 0.5 mg

XP4
[100 mg]

P4
[128.56 mg]
229

240

Indicates brands that contain more than 1 ingredient

18

PN DEX 2010

PRODUCT IDENTIFICATION CHART


ALPRAMED

ANXENE

Alprazolam 0.25 mg

Clorazepate Dipotassium 10 mg

P4
[130 mg]

P4
[130 mg]

XP4

241

252

FARZOLAM

MITRANAX

XP4

P4
[130 mg]

ALCELAM

Alprazolam 0.5 mg

Alprazolam 0.5 mg

242

262

MANOTRAN

Alprazolam 0.5 mg

Clorazepate Dipotassium 10 mg
XP4
[150 mg]

253

SIAMPRAXOL

SUNAX

Alprazolam 0.5 mg

Alprazolam 0.5 mg

263

P4
[125.75 mg]

XP4
[129.95 mg]

CLORAMED

243

254

Clorazepate Dipotassium 10 mg
XP4

MANEX

CODICET PINK

Alprazolam 0.5 mg

Codeine Phosphate (Analgesic) 15 mg

P4
[130 mg]

XN3

264

DEDA

Clorazepate Dipotassium 10 mg
244

P4
[130 mg]

255

ALPAZAM
Alprazolam 0.5 mg
XP4

245

ALPAZAM
Alprazolam 1 mg
XP4

ALPRAZOLAM FRX
Alprazolam 0.5 mg
P4
[130 mg]

265

256

CLORAZE

TRANSPON FORTE

XP4
[120 mg]

Clorazepate Dipotassium 10 mg

Clorazepate Dipotassium 10 mg

XP4
[190 mg]

246

266

257

PHARNAX

P4
[131.9 mg]

UPTRAN

Capsule

Alprazolam 0.5 mg

Clorazepate Dipotassium 10 mg

SANOR

XP4

Clorazepate Dipotassium 10 mg
XP4

247

ANPRESS

267

POLIZEP

Alprazolam 0.5 mg

258

P4
[130 mg]

SERENE MASA LAB


Clorazepate Dipotassium

10 mg

XP4
[234 mg]

XP4
[173.5 mg]

248

XIEMED

Alprazolam 0.5 mg
P4
[130.25 mg]

268
259

DIPOSEF

249

ALLAM

Clorazepate Dipotassium 10 mg

Clorazepate Dipotassium 10 mg

Alprazolam 0.5 mg

XP4
[140 mg]

TENMED

Clorazepate Dipotassium 10 mg
P4
[234 mg]

P4
[130 mg]
250

INZOLAM
Alprazolam 0.5 mg
P4
[132.81 mg]
251

260

269

TRANMED

POLYDINE CD

Clorazepate Dipotassium 10 mg
XP4
[163.13 mg]

261

Indicates brands that contain more than 1 ingredient

Codeine Phosphate (Antitussive) 10 mg


XN3

270

PN DEX 2010

PRODUCT IDENTIFICATION CHART 19

TRANXENE

ANZION

MANEX

Alprazolam 1 mg

Alprazolam 1 mg

XP4

XP4
[133.12 mg]

P4
[130 mg]

280

291

Clorazepate Dipotassium 10 mg

271

TRANCLOR

Clorazepate Dipotassium 10 mg
XP4

ALNAX

PHARNAX

Alprazolam 1 mg

Alprazolam 1 mg

XP4
[100 mg]

P4
[132.41 mg]

281
272

292

ANPRESS

ALLAM

Alprazolam 1 mg

Alprazolam 1 mg

P4
[131.2 mg]

P4
[130 mg]

282

293

273

MARZOLAM

INZOLAM

FLULIUM

P4
[130 mg]

P4
[134.39 mg]

CEXENE

Clorazepate Dipotassium 10 mg
XP4

Alprazolam 1 mg

Clorazepate Dipotassium 10 mg

Alprazolam 1 mg

XP4
283

294

XANACINE

MITRANAX

Alprazolam 1 mg
274

DAVOL

Dextropropoxyphene HCl 32.5 mg


XN3
[377.5 mg]

Alprazolam 1 mg

P4
[110 mg]

P4
[130 mg]

284

295

ZOLAM

XIEMED

Alprazolam 1 mg

Alprazolam 1 mg

P4
[136.67 mg]

P4
[130 mg]

285

296

XALAM

275

DIZOLAM

Alprazolam 1 mg

PURPLE
Tablet
CALMIPAM
Diazepam 5 mg
XP4

Alprazolam 1 mg

XP4

P4
[130 mg]

286

XANAX

297

Alprazolam 1 mg

BRONPECT

P4
[129.12 mg]

Codeine Phosphate (Antitussive) 10 mg


N3
[573.5 mg]

276
287

PHENOBARBITAL ATLANTIC

ALCELAM

P4
[128.97 mg]

P4
[130.2 mg]

277

288

MST CONTINUS

FARZOLAM

N2
[154 mg]

XP4

278

289

ZEPOXIDE

SIAMPRAXOL

ANXIRA

Alprazolam 1 mg

Lorazepam 0.5 mg

P4
[91.2 mg]

XP4

P4
[50 mg]

279

290

Phenobarbital Na 100 mg

298

Alprazolam 1 mg

AZEPAM

Diazepam 5 mg
XP4

Morphine Sulfate 30 mg

299

Alprazolam 1 mg

BLUE

Chlordiazepoxide HCl 10 mg

Tablet

300

Indicates brands that contain more than 1 ingredient

20

PN DEX 2010

PRODUCT IDENTIFICATION CHART

LORAZENE
Lorazepam 0.5 mg

PHENOBARBITAL
CHEW BROTHERS

XP4

Phenobarbital Na 30 mg

XP4
[70 mg]

VISPAM
Diazepam 10 mg
P4
[102.26 mg]
323

301

LORAVAN

Lorazepam 0.5 mg

312

LONZA

P4
[50 mg]

Lorazepam 0.5 mg

302

313

LOZEPAM

LORAPINE

P4
[50 mg]

LORAZIN
Lorazepam 0.5 mg
P4
[103.03 mg]
324

Lorazepam 0.5 mg
XP4

Lorazepam 0.5 mg
XP4

ANTA

Lorazepam 0.5 mg

RAZEPAM
Lorazepam 0.5 mg
XP4

P4
[49.6 mg]

LIZAVAN
Lorazepam 0.5 mg
XP4
[50.22 mg]
305

LORAMED
Lorazepam 0.5 mg
XP4

306

TRANAVAN

VEMED

Lorazepam 0.5 mg

Lorazepam 0.5 mg
P4
[50 mg]

ZORA

Lorazepam 0.5 mg

Lorazepam 0.5 mg

XP4
[50 mg]

P4
[130 mg]

317

328

DIAZEPAM GENERAL DRUGS


HOUSE

DIAPAM
Diazepam 5 mg
P4
[152 mg]
329

LORA-P

Lorazepam 0.5 mg
XP4
[105.2 mg]

DIPAM
Diazepam 10 mg
XP4

330

319

LORAZEP

Diazepam 10 mg

327

318

308

DIAZEPAM T MAN

LORAZEPAM ACDHON

P4
[50 mg]

XP4

XP4

316

P4
[139.83 mg]

Lorazepam 0.5 mg

Diazepam 5 mg

XP4

Diazepam 2 mg

ATIVAN

DILIUM

XP4

Lorazepam 0.5 mg

307

P4
[110 mg]

326

315

304

Diazepam 2 mg

325

314

303

DIAZEPAM VESCO

DIAZEPAM SOMMAI BHAESAJ

ZOPAM

Diazepam 5 mg

P4
[180 mg]

Diazepam 10 mg

XP4
331

309

ORA

BLUCON

320

Lorazepam 0.5 mg
P4
[50.02 mg]

HAWKCOPAX

Lorazepam 0.5 mg
P4
[100 mg]

Codeine Phosphate (Antitussive) 10 mg


XN3
[175.2 mg]

332

310

321

LORAPAM

VALAX

Lorazepam 0.5 mg

Diazepam 10 mg

XP4
[43.67 mg]

XP4

XP4

311

322

333

Indicates brands that contain more than 1 ingredient

DIAZEPAM CHAROEN BHAESAJ

Diazepam 2 mg

PN DEX 2010
DIAZEPAM GPO
Diazepam 10 mg

PRODUCT IDENTIFICATION CHART 21


XANAX XR

Capsule

Alprazolam 0.5 mg

ZEPAM

P4
[182 mg]

P4
[346.11 mg]

334

344

MANODIAZO

NEOCOD

Diazepam 5 mg
XP4

Diazepam 10 mg
P4
[160 mg]

354

Codeine Phosphate (Antitussive) 10 mg

BLUCO

XN3
[497.3 mg]

Codeine Phosphate (Antitussive) 10 mg


N3
[249.7 mg]

335
345

MED-ZEPAM

NEO-CODEIN

Diazepam 5 mg

Codeine Phosphate (Antitussive) 10 mg

XP4

355

XN3
[503 mg]

GREEN
Tablet

336

PRENARPIL

346

PHENOBARBITAL ACDHON
Phenobarbital Na 15 mg

P4
[147.79 mg]

PARA-CO

Codeine Phosphate (Analgesic) 15 mg

Clonazepam 1 mg

N3
[390.09 mg]

XP4

356

337

LORAZEP

DIAZA

Lorazepam 2 mg

Diazepam 2 mg

P4
[65 mg]

347

XP4
[172 mg]

TRYCAM
Triazolam 0.25 mg

357

P2

CHLORDIXIDE

338

SIPAM

Chlordiazepoxide HCl 5 mg

P4
[232 mg]

348

Diazepam 10 mg

DIADON

P4
[160 mg]

Diazepam 5 mg

358

XP4

CHLORZEP

339

Chlordiazepoxide HCl 5 mg

DIAZEPAM T P DRUG
Diazepam 10 mg

XP4

349

XP4

HALCION
Triazolam 0.25 mg

359

P2
[97.408 mg]

ZEDA

Lorazepam 1 mg
340

350

DIAZ

DORMICUM
Midazolam 15 mg

360

XP4
[180 mg]

P2
[208 mg]

CALMIPAM

341

351

Diazepam 10 mg

P4
[90 mg]

Diazepam 2 mg
XP4

CLONARIL

CODICET BLUE

P4
[150 mg]

Clonazepam 1 mg

361

Codeine Phosphate (Analgesic) 15 mg

COMOBEN

N3
[365 mg]

Chlordiazepoxide HCl 5 mg

P4
[125.82 mg]

342

DIAZEPAM H K PHARM

362

352

XANAX XR

Diazepam 10 mg

Alprazolam 2 mg

P4
[166.62 mg]

P4
[345.69 mg]

343

353

DIAZEPAM SAMAKEEPHAESAJ

Diazepam 2 mg
XP4

363

Indicates brands that contain more than 1 ingredient

22

PN DEX 2010

PRODUCT IDENTIFICATION CHART

DIAZEPAM T MAN
Diazepam 2 mg

P4
[115 mg]

WINOPAM

DIRAX

XP4

P4
[200 mg]

Diazepam 5 mg

Chlordiazepoxide HCl 5 mg

364

HAWKCOPAX

375

385

Lorazepam 1 mg

POBRAX

XP4

Chlordiazepoxide HCl 5 mg
XP4

Diazepam 2 mg

376

386

MODURAX

XP4
[140 mg]

Chlordiazepoxide HCl 5 mg
P4
[250 mg]

366

Diazepam 10 mg
P4
[320 mg]

365

VISPAM

DIAPINE

TERCO-C

Codeine Phosphate (Antitussive) 10 mg


N3
[591.1 mg]

DIAZEPAM PONDS CHEMICAL

377

Diazepam 2 mg

CLINOPRONT

P4
[122 mg]

Codeine Phosphate (Antitussive) 10 mg

CODEE-C

Codeine Phosphate (Antitussive) 10 mg

N3
[283.31 mg]

367

387

N3
[345.02 mg]

LORA

Lorazepam 0.5 mg

378

P4
[100 mg]

LICON

388

Chlordiazepoxide HCl 5 mg

SECO

XP4

Codeine Phosphate (Antitussive) 10 mg

368

DIAPAM
Diazepam 2 mg
P4
[142 mg]

379

CEBARAX

369

PORA

N3
[331.56 mg]

Chlordiazepoxide HCl 5 mg

Lorazepam 0.5 mg

P4
[250 mg]

389

TOCODYL

Codeine Phosphate (Antitussive) 10 mg


XN3
[325.82 mg]

XP4
380
370

PONDNEBIUM

LIBRAX

Chlordiazepoxide HCl 5 mg
P4
[200 mg]

Chlordiazepoxide HCl 5 mg
P4
[299 mg]

CODESIA

Codeine Phosphate (Antitussive) 10 mg


N3
[350 mg]

371

381

LORAZEPAM MACROPHAR

CHLORDIBRAX

391

XP4

RADIBRAX

Lorazepam 1 mg

Chlordiazepoxide HCl 5 mg

XP4

372

382

CHLORDIAZEPOXIDE T MAN

UTORAX

Chlordiazepoxide HCl 10 mg

Chlordiazepoxide HCl 5 mg

XP4
[120 mg]

Chlordiazepoxide HCl 5 mg
XP4

392

ALPRAMED
Alprazolam 1 mg

P4
[168.8 mg]

P4
[259 mg]

373

383

ZEPOBRAX

393

DIAZEPAM BJ BENJAOSOTH

Chlordiazepoxide HCl 5 mg

ROHYPNOL

XP4

Flunitrazepam 1 mg

Diazepam 5 mg

374

P2
[175 mg]

P4
[190.2 mg]

390

384

Indicates brands that contain more than 1 ingredient

394

PN DEX 2010

PRODUCT IDENTIFICATION CHART 23

PARAMED-CO

BENERA

Codeine Phosphate (Analgesic) 15 mg

Phenobarbital Na 20 mg

XN3
[601.1 mg]

XP4
[135.5 mg]

MIXED COLORS
Tablet
CODICET

404

Codeine Phosphate (Analgesic) 15 mg

LOZEPAM

N3
[565 mg]

Lorazepam 1 mg

395

XP4

VASON

Diazepam 2 mg

405

P4
[110 mg]

414

MST CONTINUS
Morphine Sulfate 10 mg

396

CELIUM

Capsule

N2
[154 mg]

FREXENE

Clorazepate Dipotassium 5 mg

Medazepam 5 mg

XP4

406

P4
[110 mg]

PRENARPIL

397

Clonazepam 0.5 mg

415

P4
[147.22 mg]

TRANPATE

Capsule
EUHYPNOS 20

Temazepam 20 mg
P2
[868.96 mg]

Clorazepate Dipotassium 5 mg
P4
[146 mg]

407

RIVOTRIL

Clonazepam 0.5 mg

416

P4
[150 mg]

DIZAN
Diazepam 5 mg
XP4
[175 mg]

408

398

ZEPAM

Diazepam 2 mg

ALPRAX

Alprazolam 0.5 mg

XP4

XP4
[189.98 mg]

399

409

TUMAX

MASAPARA WITH CODEINE

P4
[180 mg]

N3
[500 mg]

417

DITRAN

Chlordiazepoxide HCl 5 mg

Diazepam 2 mg
P4
[163 mg]

Codeine Phosphate (Analgesic) 15 mg

418

FREXENE

Clorazepate Dipotassium 10 mg

400

XP4

STESOLID

410

Diazepam 2 mg

419

BLACK

XP4

CONZEP

Tablet
401

POSENE

Clorazepate Dipotassium 10 mg
XP4

KEMORA

XP4

P4
[50 mg]

420

Lorazepam 0.5 mg

CLOZENE

411

BENPINE

402

Tablet
NEURAMIZONE

XP4
[165 mg]

P4
[136.82 mg]
421
412

ZEPOXIDE

TRANCON

Phenobarbital Na 20 mg

Chlordiazepoxide HCl 5 mg

P4
[30.3 mg]

XP4

403

413

Clorazepate Dipotassium 5 mg

Chlordiazepoxide HCl 5 mg

BROWN

Clorazepate Dipotassium 10 mg

Clorazepate Dipotassium 10 mg
XP4
[140 mg]

422

Indicates brands that contain more than 1 ingredient

24

PN DEX 2010

PRODUCT IDENTIFICATION CHART

POMADOM

DIPOT

TRANPON

P4
[140 mg]

P4
[145 mg]

XP4
[173 mg]

423

432

441

PHENTERMINE TRENKER

CLORAZE

CLOZEPATE

P4
[120 mg]

XP4

Clorazepate Dipotassium 10 mg

Clorazepate Dipotassium 5 mg

Clorazepate Dipotassium 5 mg

Phentermine Resinate 30 mg
P2
[180 mg]

TRANZEP

Clorazepate Dipotassium 5 mg

PANBESY

Clorazepate Dipotassium 5 mg

442

433

424

Clorazepate Dipotassium 5 mg

FLULIUM

Clorazepate Dipotassium 5 mg

XP4

XP4
[160 mg]

434

443

MANOTRAN

POLIZEP

XP4
[150 mg]

P4
[234 mg]

Phentermine HCl 15 mg
P2
[310 mg]

Clorazepate Dipotassium 5 mg
425

SANOR

Clorazepate Dipotassium 5 mg

Clorazepate Dipotassium 5 mg
XP4
[149.55 mg]

435

444

CLORAXENE 5

Clorazepate Dipotassium 5 mg
P4
[121.8 mg]

426

DIPOSEF

TAMYLAB-S

Clorazepate Dipotassium 5 mg
XP4
[220 mg]

Clorazepate Dipotassium 5 mg
XP4
[140 mg]

436

DEDA

445

Clorazepate Dipotassium 5 mg
P4
[160 mg]

427

T-FIVE

Clorazepate Dipotassium 5 mg
XP4

TRANMED

Clorazepate Dipotassium 5 mg
P4
[163.1 mg]

437

TRANXENE

446

Clorazepate Dipotassium 5 mg
P4
[145 mg]

428

CLORAMED

TRANADON-S

Clorazepate Dipotassium 5 mg
XP4
[220 mg]

Clorazepate Dipotassium 5 mg
XP4
438

TRANCLOR

429

ANXENE

Clorazepate Dipotassium 5 mg

XP4

447

GAXENE

Clorazepate Dipotassium 5 mg
XP4

Clorazepate Dipotassium 5 mg
XP4

430

SERENE V S PHARMA

Clorazepate Dipotassium 5 mg
XP4
[163.1 mg]

431

439

448

TENMED

ZETRAN

P4
[234 mg]

XP4
[166 mg]

440

449

Clorazepate Dipotassium 5 mg

Indicates brands that contain more than 1 ingredient

Clorazepate Dipotassium 5 mg

PN DEX 2010
CEXENE

PRODUCT IDENTIFICATION CHART 25


ANXIELAX

Clorazepate Dipotassium 5 mg

Clorazepate Dipotassium 5 mg

XP4

XP4
[248 mg]

MED-ZEPOXIDE
Chlordiazepoxide HCl 5 mg
XP4

468

450

MANODIAZO

PHENTERMINE OSMOPHARM

460

Phentermine HCl 15 mg

PANBESY

P2
[130.01 mg]

Phentermine HCl 30 mg

Diazepam 2 mg

P4
[165 mg]

P2
[320 mg]
469

TRANCAP

Clorazepate Dipotassium 5 mg

451

CLOZENE

P4
[160 mg]

461

Clorazepate Dipotassium 10 mg

ZEPAXID

XP4
[165 mg]

P4

Diazepam 5 mg

470

DZP2
452

A-ZERAX
Diazepam 2 mg
P4
[145 mg]

Diazepam 2 mg

462

XP4

A-ZERAX
Diazepam 5 mg

471

P4
[145 mg]

DIAZEPAM ACDHON
Diazepam 2 mg

453

XP4

CONZEP

Clorazepate Dipotassium 5 mg
XP4

463

DOMAR

472

Pinazepam 5 mg
P4
[101 mg]

454

DIAPINE
P4
[146 mg]

POMADOM

Clorazepate Dipotassium 5 mg
XP4

464

V DAY ZEPAM
Diazepam 5 mg

455

TRANCON

473

DIAZEPION

P4
[200 mg]

Diazepam 5 mg

Clorazepate Dipotassium 5 mg
P4
[140 mg]

Diazepam 2 mg

XP4
[100 mg]
465
474

PHENTERMINE TRENKER

V DAY ZEPAM

456

DIZAN
Diazepam 2 mg
XP4
[175 mg]

Diazepam 2 mg

Phentermine Resinate 15 mg

P4
[200 mg]

P2
[160 mg]

475
457

DITRAN

PRASEPINE

Prazepam 5 mg
XP4

CHLORDIAZEPOXIDE
MARCH PHARMA
Chlordiazepoxide HCl 25 mg

458

POZAPAM

P4
[165 mg]

476

P4
[346 mg]

MINOXIDE

Chlordiazepoxide HCl 10 mg

Prazepam 5 mg

P4
[149.5 mg]

P4
[170 mg]

459

Diazepam 5 mg
466

477

467

Indicates brands that contain more than 1 ingredient

26

PN DEX 2010

PRODUCT IDENTIFICATION CHART

DALMADORM

DUROMINE

Flurazepam 15 mg

Phentermine Resinate 30 mg

Chlordiazepoxide HCl 10 mg

P2

P2
[291 mg]

P4
[130 mg]

BENPINE

478

STESOLID

488

Diazepam 10 mg

EXAN

XP4

Clorazepate Dipotassium 5 mg

498

XP4

489

Diazepam 2 mg

UPZENE

XP4
[100 mg]

Clorazepate Dipotassium 5 mg
XP4

499

CHLORDIAZEPOXIDE
CHAROEN BHAESAJ

480

METAXIDE

Phentermine Resinate 15 mg
P2
[291.03 mg]

479

DIAZEPION

DUROMINE

490

Chlordiazepoxide HCl 10 mg

Chlordiazepoxide HCl 10 mg

COMOBEN

P4
[120 mg]

Chlordiazepoxide HCl 10 mg
P4
[211.36 mg]

XP4

500

CHLORDIAZEPOXIDE ACDHON

481

DIAMED

491

Chlordiazepoxide HCl 10 mg

Diazepam 5 mg

EXAN

P4
[168.5 mg]

Clorazepate Dipotassium 10 mg

XP4

XP4
501
492

482

MEDAZINE
Medazepam 10 mg
P4
[165 mg]

Codeine Resinate 30 mg
XN3
[234 mg]

Diazepam 5 mg
P4
[147 mg]

484

STESOLID
Diazepam 5 mg
XP4

MANODIAZO
Diazepam 5 mg
P4
[165 mg]

502

493

483

DIAPINE

CODIPRONT

CODIPRONT

Codeine Resinate 30 mg
N3
[298.6 mg]

DIAMED
Diazepam 2 mg
P4
[165.53 mg]

503

494

CLINEPECT

Codeine Phosphate (Antitussive) 10 mg


XN3
[270 mg]

MIRAPRONT N

D-norpseudoephedrine HCl 20 mg
P2

504

485

REGENON RETARD

495

Diethylpropion HCl 75 mg

MONOZIDE

P2
[480 mg]

Diazepam 2 mg

XP4

D-NORPSEUDOEPHEDRINE SR
OSMOPHARM

D-norpseudoephedrine Resinate 20 mg
P2
[173.28 mg]

496
486

MEDAZINE
Medazepam 5 mg

ATRACTIL

Diethylpropion Resinate 75 mg

505

P2
[402.64 mg]

ZEPAXID

487

Diazepam 2 mg

P4
[165 mg]

P4

497

Indicates brands that contain more than 1 ingredient

506

PN DEX 2010
*COMODINE COUGH

PRODUCT IDENTIFICATION CHART 27


*PHENOBARBITAL ELIXIR
ACDHON

Codeine Phosphate (Antitussive) 60 mL

Phenobarbital Na 20 mg/5 mL x 240 mL

XN3

XP4

*BROMTUSSIA DC
Codeine Phosphate (Antitussive) 60 mL

XN3

507

511

515

*PHENOBARBITAL ELIXIR
ACDHON

*PHENOBARBITAL ELIXIR
ACDHON

*CODESIA

Phenobarbital Na 20 mg/5 mL x 30 mL

XP4

Phenobarbital Na 20 mg/5 mL x 450 mL

Codeine Phosphate (Antitussive)


10 mg/5 mL x 60 mL

XP4

N3

508

512

516

*PHENOBARBITAL ELIXIR
ACDHON

*PHENOBARBITAL ELIXIR
ACDHON

*PHENOTAL ELIXIR

Phenobarbital Na 20 mg/5 mL x 60 mL

Phenobarbital Na 20 mg/5 mL x 500 mL

XP4

Phenobarbital Na 20 mg/5 mL x 60 mL

P4

XP4

509

513

517

*PHENOBARBITAL ELIXIR
ACDHON

*PHENOBARBITAL ELIXIR
ACDHON

*PSEUDOEPHEDRINE SYRUP
ASIAN PHARM

Phenobarbital Na 20 mg/5 mL x 120 mL

Phenobarbital Na 20 mg/5 mL x 1000 mL

XP4

510

XP4

514

Pseudoephedrine HCl 30 mg/5 mL x 60 mL

P2

518

*Shown smaller than actual size

28

PN DEX 2010

PRODUCT IDENTIFICATION CHART

*TENADRIN-C

Codeine Phosphate (Antitussive) 60 mL


XN3

*PSEUDOEPHEDRINE SYRUP
BJ BENJAOSOTH

Pseudoephedrine HCl 30 mg/5 mL x 60 mL

P2

*BROWN MIXTURE GPO

Camphorated Opium Tinct


0.6 mL/5 mL x 180 mL
N3

519

*TERADENE

527

523

*PHENSODI

Codeine Phosphate (Antitussive) 60 mL

Codeine Phosphate (Antitussive) 60 mL

XN3

XN3

*BROWN MIXTURE GPO

Camphorated Opium Tinct


0.6 mL/5 mL x 450 mL
N3

520

*COFCODYL COUGH

528

524

Codeine Phosphate (Antitussive) 60 mL

*PHENSODI

Codeine Phosphate (Antitussive) 120 mL


XN3

Opium Tinct 5 mL/100 mL x 1000 mL

XN3

N3

521

525

*COFCODYL COUGH

*PHENSODI

Codeine Phosphate (Antitussive) 100 mL

*CAMPHORATED OPIUM
TINCTURE BP 1980

529

Codeine Phosphate (Antitussive) 1000 mL


XN3

XN3

*COUGH SYRUP GPO

Camphorated Opium Tinct


0.6 mL/5 mL x 60 mL
XN3

522

526

Indicates brands that contain more than 1 ingredient

530

PN DEX 2010

PRODUCT IDENTIFICATION CHART 29

*MIST. SCILL AMMON. GPO

*MASADYL COUGH

Camphorated Opium Tinct


0.6 mL/5 mL x 180 mL

*NEO COUGH

Codeine Phosphate (Antitussive) 100 mL

Codeine Phosphate (Antitussive) 240 mL

XN3

XN3

N3

531

535

*TERADYL SYRUP

539

*MASADYL COUGH

Codeine Phosphate (Antitussive) 240 mL


XN3

Codeine Phosphate (Antitussive) 60 mL

*CODYL COUGH
Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL

N3

XN3

540

532

536

*TERADYL SYRUP

*NEO COUGH

Codeine Phosphate (Antitussive) 60 mL


XN3

Codeine Phosphate (Antitussive) 1000 mL

*CODYL COUGH
Codeine Phosphate (Antitussive)
9 mg/5 mL x 100 mL

N3

XN3

537

533

*MASADYL COUGH

541

*NEO COUGH

Codeine Phosphate (Antitussive) 60 mL

Codeine Phosphate (Antitussive) 100 mL

XN3

XN3

*CODYL COUGH
Codeine Phosphate (Antitussive)
9 mg/5 mL x 1000 mL

XN3

534

538

542

*Shown smaller than actual size

30

PN DEX 2010

PRODUCT IDENTIFICATION CHART

*CODYL COUGH
Codeine Phosphate (Antitussive)
9 mg/5 mL x 4500 mL
XN3

Pseudoephedrine HCl 30 mg/5 mL x 60 mL

*BENADRYL CD

Codeine Phosphate (Antitussive) 1000 mL


XN3

P2

543

*MENOBARB ELIXIR

*PSEUDOEPHEDRINE SYRUP
MILANO

551

547

Phenobarbital Na 15 mg/5 mL x 60 mL
XP4

*POLY-COF SYRUP

Codeine Phosphate (Antitussive)


9 mg/5 mL x 60 mL

*BENYLIN CD

Codeine Phosphate (Antitussive) 60 mL


XN3

N3

544

*MENOBARB-20 ELIXIR

552

548

Phenobarbital Na 20 mg/5 mL x 60 mL
XP4

*POLY-COF SYRUP

*PHENSEDYL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 100 mL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 100 mL

N3

N3

545

549

*MILA-CONO

*BENADRYL CD

553

Codeine Phosphate (Antitussive) 60 mL

Codeine Phosphate (Antitussive) 60 mL

XN3

XN3

*BROWN MIXTURE
OSOTH INTERLAB
Camphorated Opium Tinct
0.6 mL/5 mL x 180 mL

N3

546

550

Indicates brands that contain more than 1 ingredient

554

PN DEX 2010

*HISEDYL

PRODUCT IDENTIFICATION CHART 31

*P-CODYL

Codeine Phosphate (Antitussive) 60 mL


XN3

555

*HISEDYL

XN3

N3

563

*PHENOBARB ELIXIR

*PONDNADYL

XN3

Phenobarbital Na 20 mg/5 mL x 60 mL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 100 mL

XP4

N3

556

560

*MIXTURE SCILLAE AMMON

*BONADINE CD

564

Codeine Phosphate (Antitussive) 60 mL


XN3

Camphorated Opium Tinct


2 mL/15 mL x 180 mL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 60 mL

559

Codeine Phosphate (Antitussive) 120 mL

*PONDNADYL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 120 mL

*PONDNADYL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 1000 mL
XN3

XN3

557

561

*P-CODYL

*PERCIDYL COUGH

Codeine Phosphate (Antitussive)


9 mg/5 mL x 60 mL

Codeine Phosphate (Antitussive) 100 mL


XN3

XN3

558

565

*NORDYL LINCTUS

Codeine Phosphate (Antitussive)


9 mg/5 mL x 100 mL
N3

562

566

*Shown smaller than actual size

32

PN DEX 2010

PRODUCT IDENTIFICATION CHART

*NORDYL LINCTUS

Codeine Phosphate (Antitussive)


9 mg/5 mL x 500 mL

*PHENOSIL ELIXIR

Phenobarbital Na 20 mg/5 mL x 450 mL

XP4

XN3

Camphorated Opium Tinct


0.45 mL/5 mL x 60 mL
N3

571

567

*NORTUSS LINCTUS

Codeine Phosphate (Antitussive) 100 mL


XN3

568

*NORTUSS LINCTUS

*MIXTURE TUSSIS

*DECOS

575

*MIXTURE TUSSIS

Codeine Phosphate (Antitussive)


9 mg/5 mL x 100 mL

Camphorated Opium Tinct


0.45 mL/5 mL x 120 mL

N3

N3

572

576

*ELIXIR PHENOBARB

Codeine Phosphate (Antitussive) 500 mL

Phenobarbital Na 60 mL

XN3

XP4

*MIXTURE TUSSIS

Camphorated Opium Tinct


0.45 mL/5 mL x 240 mL
N3

569

573

*PHENOSIL ELIXIR

*MIXTURE TUSSIS

Phenobarbital Na 20 mg/5 mL x 60 mL

XP4

570

577

*MIXTURE TUSSIS

Camphorated Opium Tinct


0.45 mL/5 mL x 30 mL

Camphorated Opium Tinct


0.45 mL/5 mL x 450 mL

N3

N3

574

578

Indicates brands that contain more than 1 ingredient

PN DEX 2010
*MIXTURE TUSSIS

PRODUCT IDENTIFICATION CHART 33

*CONADYL

Camphorated Opium Tinct


0.45 mL/5 mL x 1800 mL

Codeine Phosphate (Antitussive) 60 mL


XN3

XN3

*PHENCODIN

Codeine Phosphate (Antitussive)


9 mg/5 mL x 500 mL
XN3

579

583

*MIXTURE TUSSIS

587

*PHENOCO ELIXIR

Camphorated Opium Tinct


0.45 mL/5 mL x 3600 mL

Phenobarbital Na 20 mg/5 mL x 450 mL


P4

XN3

*PHENCODIN

Codeine Phosphate (Antitussive)


9 mg/5 mL x 1000 mL
XN3

580

584

*MANTADYL COUGH

588

*PHENOCO ELIXIR

Codeine Phosphate (Antitussive) 60 mL

Phenobarbital Na 20 mg/5 mL x 3800 mL

XN3

XP4

*TUSSIDYL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 60 mL
N3

581

585

*COSEDYL COUGH LINCTUS

*PHENCODIN

589

*MIST TUSSIS

Codeine Phosphate (Antitussive) 60 mL

Codeine Phosphate (Antitussive)


9 mg/5 mL x 60 mL

Camphorated Opium Tinct


0.6 mL/5 mL x 450 mL

XN3

N3

N3

586

590

582

*Shown smaller than actual size

34

PN DEX 2010

PRODUCT IDENTIFICATION CHART

*SQUILL AND AMMONIA MIXTURE *ORAMORPH

Morphine Sulfate 20 mg/mL x 30 mL

*FENTANYL ANTIGEN
Fentanyl Citrate 0.05 mg/mL x 10 mL

N2

N2

591

595

599

*DIMETANE EXPECTORANT DC

*METHADONE GPO

*DIAPINE

Camphorated Opium Tinct


1.3 mL/10 mL x 450 mL
N3

Codeine Phosphate (Antitussive) 2.5 L


XN3

Methadone HCl 10 mg/mL x 1000 mL

Diazepam 5 mg/mL x 1 mL
P4

N2

592

*CODIPRONT

Codeine Resinate 60 mL
XN3

596

600

*PENTAZOCINE ALL PLANTS

*DIAPINE

Pentazocine 30 mg/mL x 1 mL

Diazepam 10 mg/2 mL x 2 mL
P4

XP3

593

597

601

*ORAMORPH

*FENTANYL ANTIGEN

*PETHIDINE BIOLAB

Morphine Sulfate 10 mg/5 mL x 250 mL

Fentanyl Citrate 0.05 mg/mL x 2 mL

Pethidine HCl 100 mg/2 mL x 2 mL

N2

N2

N2

594

598

602

Indicates brands that contain more than 1 ingredient

PN DEX 2010
*DIAZEPAM GPO

PRODUCT IDENTIFICATION CHART 35


*PANGON

Diazepam 10 mg/2 mL x 2 mL

Pentazocine 30 mg/mL x 1 mL

P4

P3

*PETHIDINE
M & H MANUFACTURING

Pethidine HCl 50 mg/mL x 1 mL


N2

603

607

*EPHEDRINE GPO

*ROPAM

611

Ephedrine HCl 30 mg/mL x 1 mL

Diazepam 10 mg/2 mL x 2 mL

P2

P4

*PETHIDINE
M & H MANUFACTURING

Pethidine HCl 100 mg/2 mL x 2 mL


N2

604

608

612

*FENTANYL JANSSEN-CILAG

*MORPHINE SULFATE INJ BLUE

*MANOLIUM

Diazepam 10 mg/2 mL x 2 mL

P4

Fentanyl Citrate 0.05 mg/mL x 2 mL

Morphine Sulfate 10 mg/mL x 1 mL

N2

N2

605

609

613

*FENTANYL JANSSEN-CILAG

*MORPHINE SULFATE INJ PURPLE

*ZEPAM

Fentanyl Citrate 0.05 mg/mL x 10 mL

Morphine Sulfate 10 mg/mL x 1 mL

N2

N2

606

610

Diazepam 10 mg/2 mL x 2 mL
XP4

614

*Shown smaller than actual size

36

PN DEX 2010

PRODUCT IDENTIFICATION CHART

*TRANOLAN

Diazepam 10 mg/2 mL x 2 mL

P4

*TEMGESIC

Buprenorphine HCl 0.3 mg/mL x 1 mL


P2

*FENTANYL SANDOZ

Fentanyl Citrate 0.05 mg/mL x 2 mL


N2

615

*V DAY ZEPAM

619

623

Diazepam 10 mg/2 mL x 2 mL

Diazepam 10 mg/2 mL x 2 mL

P4

XP4

616

*V DAY ZEPAM NL

Diazepam 10 mg/2 mL x 2 mL

*SOSEGON

Pentazocine 30 mg/mL x 1 mL

P3

620

624

*DORMICUM

*DIAZA

Midazolam 5 mg/mL x 1 mL

Diazepam 10 mg/2 mL x 2 mL

P4

P2

617

621

625

*FORTWIN

*DORMICUM

*SIPAM

Pentazocine 30 mg/mL x 1 mL

XP3

618

*VALIUM

XP4

Midazolam 15 mg/3 mL x 3 mL

Diazepam 10 mg/2 mL x 2 mL

P2

P4

622

626

Indicates brands that contain more than 1 ingredient

PN DEX 2010
*DIAZEPAM T P DRUG

PRODUCT IDENTIFICATION CHART 37

*PETHIDINE T.P. DRUG

Diazepam 10 mg/2 mL x 2 mL

Pethidine HCl 50 mg/mL x 1 mL

P4

N2

627

631

*MORPHINE T.P. DRUG

635

*MONOZIDE-10

Morphine Sulfate 10 mg/mL x 1 mL

Diazepam 10 mg/2 mL x 2 mL
P4

*TAZCINE

*VESCOPAM
Diazepam 10 mg/2 mL x 2 mL

P4

632

*MORPHINE T.P. DRUG

Diazepam 10 mg/2 mL x 2 mL

XP4

N2

628

*LAYLIUM-10

636

*RIVOTRIL

Morphine Sulfate 10 mg/mL x 1 mL

Pentazocine 30 mg/mL x 1 mL

Clonazepam 1 mg/mL x 1 mL

N2

XP3

XP4

629

633

*MORPHINE T.P. DRUG

*ZEPAXID

637

*GARDENAL

Morphine Sulfate 10 mg/mL x 1 mL

Diazepam 10 mg/2 mL x 2 mL

N2

P4

P4

634

638

630

Phenobarbital Na 200 mg/4 mL

*Shown smaller than actual size

38

PN DEX 2010

PRODUCT IDENTIFICATION CHART

*NEMBUTAL

Pentobarbital Na 50 mg/mL x 20 mL
P3

*KETALAR
Ketamine HCl 50 mg/mL x 10 mL
P2

*FENTANYL SANDOZ

Fentanyl Citrate 0.05 mg/mL x 10 mL


N2

639

*AMYTAL

643

Amobarbital Na 0.5 g
XP3

645

Ketamine HCl 50 mg/mL x 10 mL

*FENTANYL GPO
Fentanyl 25 mcg/hr

P2

N2

641

646

*KETA-HAMELN

*FENTANYL GPO

Ketamine HCl 50 mg/mL x 10 mL

Fentanyl 12 mcg/hr

N2

640

*CALYPSOL

644

*FENTANYL GPO

Fentanyl 50 mcg/hr

P2

N2

642

647

Indicates brands that contain more than 1 ingredient

PN DEX 2010
*FENTANYL HEXAL
Fentanyl 12 mcg/hr

PRODUCT IDENTIFICATION CHART 39


*DUROGESIC
Fentanyl 50 mcg/hr x 5 mg

N2

N2

648

652

*FENTANYL HEXAL

*DUROGESIC

Fentanyl 25 mcg/hr

Fentanyl 100 mcg/hr x 10 mg

N2

N2

649

653

*FENTANYL HEXAL
Fentanyl 50 mcg/hr

N2

650

*DUROGESIC
Fentanyl 25 mcg/hr x 2.5 mg

N2

651

*Shown smaller than actual size

CLASSIFICATION OF PSYCHOTROPICS & NARCOTICS


1. AMFEPRAMONE
(DIETHYLPROPION)
2. AMINEPTINE
3. AMINOREX
4. BROTIZOLAM
5. BUPRENORPHINE
6. BUTORPHANOL
7. CATHINE
(D-NORPSEUDOEPHEDRINE)
8. EPHEDRINE
9. ESTAZOLAM
10. FENCAMFAMIN
11. FENETHYLLINE
12. FLUNITRAZEPAM
13. FLURAZEPAM
14. HALOXAZOLAM
15. KETAMINE
16. LOPRAZOLAM
17. LORMETAZEPAM
18. MAZINDOL
19. MESOCARB

20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.

METHYLPHENIDATE
MIDAZOLAM
N-ETHYLAMPHETAMINE
NIMETAZEPAM
NITRAZEPAM
PEMOLINE
PHENCYCLIDINE
PHENDIMETRAZINE
PHENMETRAZINE
PHENTERMINE
PHENYLPROPANOLAMINE
PIPRADROL
PSEUDOEPHEDRINE
QUAZEPAM
SECOBARBITAL
TEMAZEPAM
TRIAZOLAM
ZALEPLON
ZIPEPROL
ZOLPIDEM
ZOPICLONE


1.
2.
3.
4.

AMOBARBITAL
BUTALBITAL
CYCLOBARBITAL
GLUTETHIMIDE

Pink Pages_2010_Tip.pmd

5. MEPROBAMATE
6. PENTAZOCINE
7. PENTOBARBITAL

40

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.

ALLOBARBITAL
ALPRAZOLAM
BARBITAL
BENZPHETAMINE
BROMAZEPAM
BUTOBARBITAL
CAMAZEPAM
CHLORAL HYDRATE AND
ITS ADDUCTS
CHLORDIAZEPOXIDE
CHLORPHENTERMINE
CLOBAZAM
CLONAZEPAM
CLORAZEPATE
CLORTERMINE
CLOTIAZEPAM
CLOXAZOLAM
DIAZEPAM
DELORAZEPAM
ETHCHLORVYNOL
ETHINAMATE
ETHYL LOFLAZEPATE
FENPROPORAX
FLUDIAZEPAM
HALAZEPAM
INORGANIC BROMIDES
KETAZOLAM

27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.

7/4/2553, 09:28

LORAZEPAM
MEDAZEPAM
MEFENOREX
METHYPHENOBARBITAL
METHYPRYLON
NORDAZEPAM
OXAZEPAM
OXAZOLAM
PERLAPINE
PHENOBARBITAL
PINAZEPAM
PRAZEPAM
PROPYLHEXEDRINE
PYROVALERONE
SECBUTABARBITAL
SPA
TETRAZEPAM
TOFISOPAM
VINYLBITAL

PN DEX 2010

41



1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.

52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.

ACETYLDIHYDROCODEINE
ACETYLMETHADOL
ALFENTANIL
ALLYLPRODINE
ALPHACETYLMETHADOL
ALPHAMEPRODINE
ALPHAMETHADOL
ALPHAPRODINE
ANILERIDINE
BENZETHIDINE
BENZYLMORPHINE
BETACETYLMETHADOL
BETAMEPRODINE
BETAMETHADOL
BETAPRODINE
BEZITRAMIDE
CLONITAZENE
COCA BUSH
COCAINE
CODEINE
CODOXIME
CONCENTRATE OF POPPY STRAW
DEXTROMORAMIDE
DEXTROPROPOXYPHENE
DIAMPROMIDE
DIETHYLTHIAMBUTENE
DIFENOXIN
DIHYDROCODEINE
DIHYDROMORPHINE
DIMENOXADOL
DIMEPHEPTANOL
DIMETHYLTHIAMBUTENE
DIOXAPHETYLBUTYRATE
DIPHENOXYLATE
DIPIPANONE
DROTEBANOL
ECGONINE
ETHYLMETHYLTHIAMBUTENE
ETHYLMORPHINE
ETONITAZENE
ETOXERIDINE
FENTANYL
FURETHIDINE
HYDROCODONE
HYDROMORPHINOL
HYDROMORPHONE
HYDROXYPETHIDINE
ISOMETHADONE
LEVOMETHORPHAN
LEVOMORAMIDE
LEVOPHENACYLMORPHAN

Pink Pages_2010_Tip.pmd

41

LEVORPHANOL
MEDICINAL OPIUM
METAZOCINE
METHADONE
METHADONE INTERMEDIATE
METHYLDESORPHINE
METHYLDIHYDROMORPHINE
METOPON
MORAMIDE-INTERMEDIATE
MORPHERIDINE
MORPHINE
MORPHINE METHOBROMIDE
MORPHINE N-OXIDE
MYROPHINE
NICOCODINE
NICODICODINE
NICOMORPHINE
NORACYMETHADOL
NORCODEINE
NORLEVORPHANOL
NORMETHADONE
NORMORPHINE
NORPIPANONE
OPIUM
OXYCODONE
OXYMORPHONE
PETHIDINE
PETHIDINE-INTERMEDIATE-A
PETHIDINE-INTERMEDIATE-B
PETHIDINE-INTERMEDIATE-C
PHENADOXONE
PHENAMPROMIDE
PHENAZOCINE
PHENOMORPHAN
PHENOPERIDINE
PHOLCODINE
PIMINODINE
PIRITRAMIDE
PROHEPTAZINE
PROPERIDINE
PROPIRAM
RACEMETHORPHAN
RACEMORAMIDE
RACEMORPHAN
REMIFENTANIL
SUFENTANIL
THEBACON
THEBAINE
TILIDINE
TRIMEPRIDINE


1. CODEINE
2. DIPHENOXYLATE
3. OPIUM TINCTURE/CAMPORATED
OPIUM TINCTURE

7/4/2553, 09:28

NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM)

Pink Pages_2010_Tip.pmd

42

7/4/2553, 09:28

PN DEX 2010

43

Pink Pages_2010_Tip.pmd

43

7/4/2553, 09:28

PN DEX 2010

44

Pink Pages_2010_Tip.pmd

44

7/4/2553, 09:28

PN DEX 2010

45

(Generic Name)

Alprazolam

P4

tab

4.1. Hypnotics and


anxiolytics

Buprenorphine
hydrochloride

P2

sublingual tab,
sterile sol

4.7.1. Opioid
analgesics

Chloral hydrate

P4

oral sol (hosp)

4.1. Hypnotics
and anxiolytics

Chlordiazepoxide P4

cap, tab

4.1. Hypnotics
and anxiolytics

Clonazepam

tab

4.1. Hypnotics and


anxiolytics

P4

4.8.1. Drugs used


in the control of
epilepsy
4.9. Drugs used in
movement disorders
Codeine
phosphate

N2

tab

3.6.1. Cough
suppressants
4.7.1. Opioid
analgesics

Diazepam

P4

cap, tab, sterile sol

4.1. Hypnotics
and anxiolytics

Dipotassium
clorazepate

P4

cap, tab

4.1. Hypnotics
and anxiolytics

Ephedrine
hydrochloride

P2

nasal drop (hosp)


( 0.5-3%)

12.2.2. Topical nasal


decongestants

sterile sol

2.7.2. Vasoconstrictor
sympathomimetics


Pink Pages_2010_Tip.pmd

45

7/4/2553, 09:28

PN DEX 2010

46

Fentanyl

N2

transdermal
therapeutic system
(as base)

4.7.1. Opioid
analgesics

Fentanyl citrate

N2

sterile sol

15.1.4. Sedative
and analgesic
peri-operative drugs

Ketamine
hydrochloride

P2

sterile sol

15.1.1. Intravenous
anaesthetics

Lorazepam

P4

tab

4.1. Hypnotics
and anxiolytics

Methadone

N2

oral sol


(Generic Name)

hydrochloride

4.10. Drugs used

in substance

dependence
tab, oral sol

4.7.1. Opioid
analgesics

Methylphenidate

P2

tab (10 mg)

4.4. Central
nervous system
stimulants

AttentionDeficit Hyperactivity
Disorder (ADHD)

Midazolam
hydrochloride

P2

sterile sol

15.1.4. Sedative
and analgesic
peri-operative
drugs

4.8.2. Drugs used in


epilepticus status

15.1.4. Sedative
and analgesic
peri-operative
drugs

Midazolam
maleate

P2

tab

refractory
status epilepticus

(premedication)


Pink Pages_2010_Tip.pmd

46

7/4/2553, 09:28

PN DEX 2010

47

(Generic Name)

Morphine
sulfate

Nitrazepam

N2

P2

cap, tab, SR cap,


SR tab, sterile sol

4.7.1. Opioid
analgesics

sterile sol

15.1.4. Sedative
and analgesic
peri-operative drugs

tab

4.8.1. Drugs used


in the control of
epilepsy


infantile
spasms

Opium and
Glycyrrhiza
Mixture
Compound
(Mist. Tussis;
Brown Mixture)

N2

mixt (hosp)

3.6.1. Cough
suppressants

Pethidine
hydrochloride

N2

sterile sol

15.1.4. Sedative
and analgesic
peri-operative drugs
4.7.1. Opioid
analgesics

Phenobarbital

P4

tab (as base or


sodium)

4.8.1. Drugs used


in the control of
epilepsy

Phenobarbital
sodium

P4

sterile pwdr

4.8.2. Drugs used in


status epilepticus

16. Antidotes

(Phenobarbitone
sodium)

Pseudoephedrine P2
hydrochloride

tab, syr

3.7. Systemic nasal


decongestants

Squill and
Ammonia Mixture

mixt (hosp)

3.6.1. Cough
suppressants

N3


Pink Pages_2010_Tip.pmd

47

7/4/2553, 09:28

IMPORTANT DRUG NOTES


Provides useful information on significant contraindications, precautions, adverse reactions and
interactions of drugs, presented according to the Psychotropic & Narcotic Drugs List of Thailand.
Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions;
DI: Drug Interactions.

P2 - Psychotropic Substance
Schedule 2
AMFEPRAMONE
(DIETHYLPROPION)


I: Obesity.
CI: Advanced arteriosclerosis. Hyperthyroidism.
Hypersensitivity. Glaucoma. Agitated states.
History of drug abuse. Pulmonary HTN or severe
hypertension. Heart murmur or valvular disorders.
Emotional instability. History of psychiatric illness.
Concomitant use w/ other anorectic agents. MAOI
therapy or w/in 2 wk of discontinuation. Pregnancy
& lactation. Child & elderly.
SP: Increased risk of developing primary pulmonary
HTN (PPH). HTN & severe CV disease. Prolonged
use may induce dependence w/ withdrawal
symptoms on cessation of therapy; do not use for
more than 3 months. May increase convulsions in
some epileptic patients. Toxic psychosis. Peptic
ulceration. Prostatic hyperplasia.
AR: CV & CNS disturbances; GI effects; allergic
reactions; impotence; changes in libido,
gynecomastia, menstrual upset; hematopoietic
effects; dyspnea, hair loss, muscle pain, dysuria,
increased sweating, polyuria.
DI: Hypertensive risk w/ MAOIs. b-blockers,
guanethidine, tricyclic antidepressants, urinary
alkalinisers or acidifiers. Alters antidiabetic drug
requirements.

BUPRENORPHINE

I: As a perioperative analgesic supplement.


Moderate to severe pain. Premedication before
anaesthesia.

CI: Acute alcoholism; convulsive disorders; head


injuries; increased intracranial pressure; comatose
patients; resp depression & obstructive airway
disease; patients on established opioid agonists.
SP: Hepatic or renal disease; pregnancy, lactation;
hypothyroidism; adrenocortical insufficiency;
asthma; prostatic hyperplasia; shock; hypotension;
inflammatory or obstructive bowel disorders;
myasthaenia gravis; infants/neonates. Reduce dose
in elderly & debilitated patients. May precipitate
withdrawal symptoms in narcotic addicts.
AR: Sedation, nausea, dizziness, vertigo,
hypotension, miosis, headache, hypoventilation,
resp or CNS depression; tachycardia, bradycardia,
urinary retention, coma, vomiting, drowsiness,
sweating, confusion, dry mouth, diaphoresis,
withdrawal syndrome.
DI: Plasma-buprenorphine concentrations may be
affected when co-administered w/ drugs that
induce or inhibit cytochrome P450 isoenzyme
CYP3A4. Enhanced depressant effects w/ other
CNS depressants e.g. alcohol, anaesthetics,
anxiolytics, hypnotics, TCAs & antipsychotics.
Diazepam may produce resp & cardiac collapse.

CATHINE
(D-NORPSEUDOEPHEDRINE)

I: Obesity.
CI: Patients treated w/ MAOI or stopped MAOI w/in
the last 2 wk; moderate or severe hypertension;
pulmonary hypertension; structural cardiac
abnormalities or advanced arteriosclerosis; adrenal
tumour; hyperthyroidism or hyperexcitability; coronary
thrombosis; closed-angle glaucoma; pregnancy.
SP: Heart disease, mild hypertension, CHF or angina
of effort; prostate hyperplasia; patients w/ history
of drug or alcohol abuse; DM; psychotic patients; renal
disease. Growth retardation may occur in children.
AR: Headache, tachycardia, precordial pain,

Registration expired

Pink Pages_2010_Tip.pmd

48

7/4/2553, 09:28

PN DEX 2010

IMPORTANT DRUG NOTES 49

giddiness, restlessness or insomnia; dry mouth &


thrist, nausea, vomiting, sweating; difficulty in
micturition; muscular weakness & tremors;
tolerance & /or dependence may occur.
DI: Reduced effect of guanethidine. Increased risk
of arrhythmia in patients treated w/ digitalis due to
its sympathomimetic effects. Increased risk of
arrhythmia w/ chloroform, cyclopropane, halothane
or other halogenated anesthetics. The effect of
cathine may be reduced/enhanced by tricyclic antidepressants. Cathine should not be used in patients
treated w/ a MAOI or w/in 14 days of stopping MAOI
as hypertensive crisis may occur if used.

EPHEDRINE


I: Relief of moderate to severe acute asthma, relief
of broncoconstiction.
CI: Hypersensitivity. Hypertension, thyrotoxicosis,
BPH. Lactation.
SP: Ischaemic heart disease, hyperthyroidism,
diabetes mellitus, hypertension, angle-closure
glaucoma, renal impairment; prostatic
enlargement; pregnancy, elderly.
AR: Anxiety, tachycardia, tremor, dry mouth,
hypertension, cardiac arrhythmias, impaired
circulation to the extremities, nervousness, insomnia,
palpitations. Difficulty in micturition in patients w/
prostatic enlargement. Nasal drops: Local irritation,
rebound nasal congestion & drug-induced rhinitis on
prolonged use. Delusions, hallucinations. Seen w/
hypersensitivity & overdosage. Acute CNS & CVS
stimulation presenting as vomiting, fever,
hypertension, psychosis. Cardiac arrhythmias.
DI: Reduces antihypertensive effect of bethanidine
& guanethidine. May increase clearance of
dexamethasone. Increased incidence of adverse
effects when used w/ theophylline. Severe HTN when
combined w/ MAOIs or within 2 wk of discontinuance
of MAOI treatment. Increased risk of arrhythmias w/
cardiac glycosides, quinidine or tricyclic
antidepressants. Increased vaso-constriction or
pressor effects w/ ergot alkaloids or oxytocin.

FLUNITRAZEPAM

I: Induction of anaesthesia. Premedication in


surgery. Short-term management of insomnia.

CI: Preexisting CNS depression or coma, resp


depression, acute pulmonary insufficiency or sleep
apnoea; severe hepatic impairment; chronic
psychosis, phobic or obsessional states; may
precipitate suicide or aggressive behavior; not to
be used alone to treat depression or anxiety
associated w/ depression; glaucoma. Pregnancy,
lactation. Neonates.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; personality disorders
or organic brain changes; history of alcohol or drug
addiction; resp depression & hypotension w/
parenteral admin; this route should only be used
when facilities for reversing resp depression are
available.
AR: Drowsiness & lightheadedness, sedation,
muscle weakness & ataxia; less frequently vertigo,
headache, confusion, depression, slurred
speech, changes in libido, tremor, visual
disturbances, urinary retention, GI disturbances,
changes in salivation & amnesia.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
general anaesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Alcohol. Calciumchannel blockers; clonidine; diaxozide; disulfiram;
clozapine; diuretics; moxonidine; nabitone; nitrates;
cimetidine, esomeprazole & omeprazole; muscle
relaxants; dopaminergics; lofexidine; hydralazine,
minoxidil & nitroprusside; antifungals; angiotensin
II receptor antagonist; antiepileptics; -blockers;
antibacterials. Drugs which alter the hepatic
microsomal enzymes.

FLURAZEPAM

I: Short-term management of insomnia.


CI: Hypersensitivity; porphyria. Pregnancy (3 rd
trimester); neonates.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; personality disorders
or organic brain changes; history of alcohol or drug
addiction. Respiratory depression & hypotension
w/ parenteral admin. Dependence; lactation. Safety
& efficacy are not proven in child <15 yr.

Pink Pages_2010_Tip.pmd

49

7/4/2553, 09:28

Registration expired

50

KETAMINE


I: Induction of anaesthesia.
CI: Hypertension, history of cerebrovascular
accident. Eye injury, raised ocular & intracranial
pressure. Psychotic disorders.
SP: Minimise verbal & tactile stimulation during
recovery period. Chronic alcoholic & alcoholintoxicated patients. Preanaesthetic elevated
CSF pressure. Dependence & tolerance may
develop. May impair ability to drive or operate
machinery. Monitor cardiac function in patients
w/ HTN or cardiac decompensation. Pregnancy
& lactation.
AR: Emergence reactions e.g. vivid dreams,
hallucinations, confusion, irrational behaviour.
Increased muscle tone sometimes resembling
seizures. Temporary HTN & tachycardia.
Hypotension, bradycardia, arrhythmias.
Respiratory depression, apnoea, laryngospasm,
diplopia, nystagmus, nausea, vomiting,
lachrymation, hypersalivation, raised intraocular
& CSF pressure, skin rash & pain at inj site.
DI: May increase effects of nondepolarising
muscle relaxants. May reduce hypnotic effect of
thiopental. Prolonged recovery time w/
barbiturates/narcotics. Reduced cardiac output,
BP & pulse rate w/ halothane. Increased risk of
HTN & tachycardia w/ thyroid hormones.
Seizures & tachycardia may occur when used
w/ theophyllines.

PN DEX 2010

IMPORTANT DRUG NOTES

AR: Drowsiness & lightheadedness, sedation,


muscle weakness & ataxia; less frequently vertigo,
headache, confusion, depression, slurred
speech, changes in libido, tremor, visual
disturbances, urinary retention, GI disturbances,
changes in salivation & amnesia.
DI: Antidepressants, antihistamines, antipsychotics, general anesthetics, other hypnotics
or sedatives, opioid analgesics & cisapride.
Increased toxicity by amprenavir, cimetidine,
ciprofloxacin, clarithromycin, clozapine, CNS
depressants, diltiazem, disulfiram, digoxin,
erythromycin, ethanol, levodopa, loxapine,
metoprolol, metronidazole, miconazole,
nefazodone, nelfinavir, omeprazole, phenytoin,
rifabutin, rifampicin, ritonavir, troleandromycin,
valproic acid & verapamil. Effect is decreased by
carbamazepine, rifampicin & rifabutin. Alcohol.

LORMETAZEPAM


I: Short-term management of insomnia.
CI: CNS depression; resp depression, acute
pulmonary insufficiency or sleep apnoea; severe
hepatic impairment; chronic psychosis, phobic or
obsessional states; not to be used alone to treat
depression or associated anxiety; unstable
myasthenia gravis; glaucoma. Pregnancy &
lactation, children
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; personality disorders or
organic brain changes; history of alcohol or drug
addiction.
AR: Drowsiness & lightheadedness, muscle
weakness & ataxia, vertigo, headache, confusion,
depression, slurred speech, changes in libido,
tremor, visual disturbances, urinary retention, GI
disturbances, changes in salivation & amnesia.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
general anaesthetics, other hypnotics or
sedatives, opioid analgesics & alcohol.

METHYLPHENIDATE


I: Hyperactivity disorders. Narcolepsy.
CI: Marked anxiety, tension, agitation; glaucoma;
Tourettes syndrome or tics. Known severe
structural cardiac abnormalities, cardiomyopathy,
serious heart rhythm abnormalities, or other
serious cardiac disorders that could increase the
risk of sudden death. Extended-release form:
Severe hypertension, heart failure, arrhythmia,
hyperthyroidism, recent MI or angina.
SP: Pregnancy & lactation. History of alcohol or
drug abuse. Hypertension & other CV disorders
that might be exacerbated by increases in BP or
heart rate. Pre-existing psychosis or bipolar
disorder; monitor for symptoms of aggression or
hostility. History of seizure disorder. Children <6
yr (growth suppression); monitor growth during
therapy. May impair ability to drive or operate
machinery. Transdermal: Avoid exposure of
application site to any direct external heat source.
AR: Angina, arrhythmia, cerebral arteritis, cerebral

Registration expired

Pink Pages_2010_Tip.pmd

50

7/4/2553, 09:28

PN DEX 2010

IMPORTANT DRUG NOTES 51

occlusion, changes in BP, MI, necrotising vasculitis,


palpitation, pulse changes, tachycardia;
depression, dizziness, drowsiness, fever,
headache, insomnia, nervousness, neuroleptic
malignant syndrome (NMS), Tourettes syndrome,
toxic psychosis; erythema multiforme, exfoliative
dermatitis, hair loss, rash, urticaria; growth
retardation; abdominal pain, anorexia, diarrhoea,
nausea, vomiting, wt loss; anaemia, leukopenia,
thrombocytopenic purpura, thrombocytopenia;
abnormal LFTs, hepatic coma, increased
transaminases; arthralgia, dyskinesia; blurred
vision, visual accommodation disturbance; cough,
pharyngitis, sinusitis, upper resp tract infection;
accidental injury, hypersensitivity. Transdermal:
Insomnia, decreased appetite; nausea; tic,
emotional instability; vomiting, anorexia; nasal
congestion, nasopharyngitis; wt loss.
DI: May reduce effects of antihypertensive agents.
Reduced serum level w/ carbamazepine. Increased
serum levels or effects w/ CYP2D6 inhibitors e.g.
chlorpromazine, delavirdine, fluoxetine,
miconazole, paroxetine, pergolide, quinidine,
quinine, ritonavir, ropinirole. May increase serum
levels of phenytoin, TCAs. Possible severe HTN &
tachycardia w/ sibutramine. CNS depression w/
alcohol. Severe toxic reactions w/ clonidine.
Increased risk of hypertensive crisis w/ MAOIs.

respiration rate; apnoea; headache; hiccup;


nausea, increased appetite, vomiting; cough;
oversedation; seizure-like activity (paediatrics);
paradoxical reactions; kernicterus; nystagmus;
skin rash, pruritus; reduced alertness, confusion,
euphoria, hallucinations, fatigue, dizziness, ataxia,
post-op sedation, anterograde amnesia; jaundice;
cardiac arrest, heart rate changes, thrombosis;
anaphylaxis; laryngospasm, bronchospasm. Resp
depression, resp arrest; hypotension.
DI: Increased CNS depression w/ alcohol, opioids,
barbiturates, other sedatives & anaesthetics.
Increased resp depression w/ opiates,
phenobarbital, other benzodiazepines. Plasma
concentrations increased by CYP3A4 inhibitors
e.g. cimetidine, erythromycin, clarithromycin,
diltiazem, verapamil, ketoconazole & itraconazole,
antiretroviral agents, quinupristin w/ dalfopristin.
Midazolam conc decreased by phenytoin,
carbamazepine, phenobarbital, rifampicin.
Halothane, thiopental requirements may be
reduced during concurrent use.

NITRAZEPAM


MIDAZOLAM


I: Induction of anaesthesia. Premedication in
surgery. Sedation for dental & minor surgical
procedures. Sedation in critical care. Short-term
management of insomnia.
CI: Acute narrow-angle glaucoma; coma or patients
in shock; acute alcohol intoxication; intrathecal &
epidural admin. Acute pulmonary insufficiency or
marked neuromuscular resp weakness including
unstable myasthenia gravis; severe resp
depression.
SP: Paediatric patients w/ CV instability; chronic
renal failure; open-angle glaucoma; cardiac
disease; resp disease; myasthenia gravis;
neonates; history of drug or alcohol abuse; elderly
& debilitated (reduce dose); avoid prolonged use
or abrupt withdrawal; hepatic impairment; severe
fluid or electrolyte disturbances. May impair ability
to drive or operate machinery; titrate dose carefully;
monitor for early signs of hypoventilation, airway
obstruction, or apnea. Pregnancy, lactation.
AR: Physical & psychological dependence w/
withdrawal symptoms; decreased tidal vol &

I: Infantile spasms. Short-term management of


insomnia.
CI: Myasthenia gravis, narrow-angle glaucoma,
severe resp insufficiency, sleep apnoea
syndrome, severe hepatic impairment, porphyria.
SP: May induce anterograde amnesia; caution
patients to have uninterrupted sleep of 7-8 hr
after ingestion of dose. May impair ability to drive
or operate machinery. Depression, esp if suicidal
risk may be present. History of drug abuse or
acute alcoholism. Hepatic & renal impairment.
Respiratory disease. Debilitated patients. Patients
who are at risk of falls. Children, elderly. Pregnancy
& lactation.
AR: Hypotension, palpitation; agitation,
aggressiveness, amnesia, ataxia, confusion,
delusions, disorientation, dizziness, fatigue,
hallucination, hangover, headache, irritability,
nightmares, psychoses, rage, restlessness,
sedation; rash; changes in libido; constipation,
diarrhoea, excessive salivation, heartburn,
nausea, vomiting; granulocytopenia, leukopenia;
falling, muscle weakness; blurred or double vision;
tinnitus (associated w/ withdrawal); aspiration,
increased bronchial secretion, dyspnoea.
DI: CNS depressant effect increased w/ alcohol,
barbiturates, TCAs, phenothiazines, morphine

Pink Pages_2010_Tip.pmd

51

7/4/2553, 09:28

Registration expired

52

PHENTERMINE

I: Anorectic in short-term treatment of moderate


to severe obesity.
CI: Pulmonary hypertension, advanced
arteriosclerosis, moderate to severe hypertension,
hyperthyroidism, CV disease, glaucoma, history
of alcohol/drug abuse, agitated states, use during
or w/in 14 days following MAOI therapy. Lactation.
SP: Hypertension, DM, seizure disorder, Tourette
s syndrome, patients who have used other
anorexigens w/in the past year, children. May
impair ability to drive & operate machinery. Potential
for drug dependency. Discontinue if results are
not satisfactory w/in 4 wk or tolerance develops.
History of epilepsy. Renal or hepatic disease.
Pregnancy.
AR: Urticaria, GI upsets, palpitations, tachycardia,
elevated blood pressure, overstimulation,
restlessness, insomnia, tremor, headache, dry
mouth, dizziness, dysphoria, euphoria, psychosis,
changes in libido & impotence. Primary pulmonary
HTN & valvular heart disease.
DI: Decreased excretion by antacids, carbonic
anhydrase inhibitors (e.g. acetazolamide,
dichlorphenamide, methazolamide). Excretion is
increased by urinary acidifiers. Increased risk of
adverse effects w/ other sympathomimetic agents.
There is a risk of arrhythmias when used w/ TCA.
May reduce serum concentrations of phenytoin,
phenobarbital and ethosuximide. Severe
hypertensive episodes w/ MAOI. Primary
pulmonary HTN or valvular heart disease may
occur when phentermine is used concurrently w/
fenfluramine or dexfenfluramine. Avoid concurrent
use w/ sibutramine.

PSEUDOEPHEDRINE

I: Nasal congestion.
CI: Severe hypertension, phaeochromocytoma.
SP: Hyperthyroidism; ischaemic heart disease,
arrhythmia or tachycardia; occlusive vascular

PN DEX 2010

IMPORTANT DRUG NOTES

derivatives. Effects may be antagonised by


theophylline. Increased levels/effects w/
probenecid. Reduced levels/effects w/ rifampicin.
May reduce effects of levodopa.

disorders e.g. arteriosclerosis, HTN or aneurysms;


DM & closed-angle glaucoma; renal impairment,
prostatic enlargement. Pregnancy; lactation.
AR: Anginal pain; rebound congestion &
rhinorrhoea; fear, anxiety, restlessness, tremor,
insomnia, confusion, irritability & psychotic states;
reduced appetite, nausea, vomiting; gangrene;
cerebral haemorrhage & pulmonary oedema; reflex
bradycardia, tachycardia & cardiac arrhythmias,
palpitations & cardiac arrest, hypotension &
dizziness, fainting & flushing. Tissue necrosis &
sloughing; myocardial & arterial necrosis.
DI: Increased risk of HTN & arrhythmias if given
w/ cardiac glycosides, quinidine or TCAs.
Increased risk of vasoconstrictor effects if given
w/ ergot alkaloids or oxytocin. Co-admin w/ MAOIs
may cause hypertensive crisis. Anaesthetics e.g.
cyclopropane, halothane & other halogenated
anaesthestics; antihypertensive agents.

TEMAZEPAM

I: Short-term management of insomnia.


CI: Severe hepatic impairment. Pregnancy.
SP: Chronic pulmonary insufficiency, elderly or
debilitated patients, impaired liver or kidney
function, personality disorders or organic brain
changes, history of alcohol or drug addiction,
lactation.
AR: Confusion, dizziness, drowsiness, fatigue,
headache, lethargy, hangover, euphoria, difficulty
w/ coordination, ataxia, anorexia, tremor, vomiting
& backache.
DI: Enhanced sedation, resp & CV depression w/
drugs w/ CNS depressant properties.

TRIAZOLAM

I: Short-term management of insomnia.


CI: Preexisting CNS depression or coma; resp
depression; acute pulmonary insufficiency or sleep
apnoea; myasthenia gravis; chronic psychosis,
phobic or obsessional states; may precipitate
suicide or aggressive behaviour so it should not
to be used alone to treat depression or anxiety
associated w/ depression. Porphyria. Pregnancy
& lactation. Child.

Registration expired

Pink Pages_2010_Tip.pmd

52

7/4/2553, 09:28

PN DEX 2010

IMPORTANT DRUG NOTES 53

SP: Chronic pulmonary insufficiency; elderly or


debilitated patients; sleep apnoea; muscle
weakness; impaired liver or kidney function;
drowsiness may affect skilled tasks; personality
disorders or organic brain changes; history of
alcohol or drug addiction.
AR: Drowsiness, lightheadedness, dizziness,
sedation, agitation, hallucinations, abnormal
behaviour, muscle weakness, ataxia, confusion,
slurred speech, changes in libido, urinary retention,
anterograde amnesia.
DI: Increased plasma triazolam concentrations w/
oral contraceptives, ergotamine, ciclosporin,
isoniazid, ranitidine & CYP3A inhibitors e. g. some
macrolide antibiotics, cimetidine, isoniazid,
fluvoxamine, sertraline, paroxetine, diltiazem,
verapamil, amiodarone. Additive CNS depression
w/ other CNS depressants eg, antipsychotics,
other hypnotics or sedatives, opioid analgesics &
alcohol. Increased risk of prolonged sedation w/
potent CYP3A inhibitors e.g. azole antifungal
agents, nefazodone, HIV protease inhibitors, nonnucleoside reverse transcriptase inhibitors.

ZOLPIDEM

I: Short-term management of insomnia.


CI: Severe hepatic insufficiency.
SP: Obstructive sleep apnoea, myasthenia gravis,
compromised resp function, hepatic impairment.
Caution in patients exhibiting symptoms of
depression. Patients should be warned from doing
any work involving mental alertness or motor
coordination after ingestion of the drug. Pregnancy
& lactation. Re-evaulate if insomnia fail to remit
after 7-10 days. Max duration of treatment: 4 wk
including tapering.
AR: Amnesia, drowsiness, dizziness, diarrhoea,
nausea, vomiting, abnormal thinking &
behaviour, drugged feelings, back pain, ataxia,
hiccups, confusion, euphoria, insomnia, vertigo,
diplopia, abnormal vision. Hepatitis, anaphylactic
reactions, sleep-driving (driving while not fully
awake after drug ingestion, w/ no recollection
of the event).
DI: Increased sedation & incoordination w/ TCA.
Increased sedation w/ haloperidol & alcohol. Small
increase in zolpidem conc w/ ketoconazole.
Reduced effect of hypnotic effects w/ rifampicin.
Increased risk of prolonged sedation & resp
depression w/ ritonavir.

P3 - Psychotropic substance
Schedule 3
AMOBARBITAL

I: Severe intractable insomnia.


CI: Depression; pulmonary insufficiency; sleep
apnoea; preexisting CNS depression or coma;
severe hepatic impairment. Porphyria. Pregnancy
& lactation. Elderly & debilitated patients; young
adults & child.
SP: Renal insufficiency; given to patients in pain
may provoke a paradoxical excitatory reaction,
unless an analgesic is given concomitantly; may
impair ability to drive or operate machinery.
AR: Dependence; drowsiness, sedation, ataxia;
resp depression; headache; GI disturbances; skin
reactions; confusion & memory defects;
paradoxical excitement, irritability; hypersensitivity
reactions; haematologic disorders.
DI: Sedation or resp depression may be enhanced
by drugs w/ CNS depressants; MAOIs may prolong
the CNS depressant effects & also reduce the
convulsive threshold, thereby antagonise the
anitconvulsant action of barbiturates. Others:
Fenoprofen, methadone, pethidine & opioid
analgesics; disopyramide, lidocaine & quinidine;
chloramphenicol, doxycycline; warfarin & coumarin;
antidepressants eg, bupropion, fluoxetine, lithium
& mianserin; valproate & progabide; vigabatrin,
oxcarbazepine, carbamazepine, clonazepam,
ethosuximide, lamotrigine, tiagabine & zonisamide,
griseofulvin; teniposide; metronidazole;
chlorpromazine; HIV-protease inhibitors; blockers; calcium-channel blockers eg, nifedipine
& verapamil; digitoxin; ciclosporin; corticosteroids;
furosemide; montelukast; oral contraceptives;
theophylline; levothyroxine; flu vaccination &
vitamins. Alcohol. St. Johns wort.

PENTAZOCINE

I: Moderate to severe pain.


CI: Head injury; narcotic dependence; resp
depression; raised intracranial pressure; MI; heart
failure; arterial or pulmonary hypertension;
porphyria; pregnancy (prolonged use or high doses
at term).

Pink Pages_2010_Tip.pmd

53

7/4/2553, 09:28

Registration expired

54

IMPORTANT DRUG NOTES

SP: May precipitate withdrawal in narcotic addicts.


Impaired respiratory, renal & hepatic function;
morbidly obese patients; thyroid dysfunction;
prostatic hyperplasia or urinary stricture; biliary
tract impairment; adrenal insufficiency (including
Addisons disease); abdominal conditions. Elderly
or debilitated patients; seizure-prone patients; child
& infants (safety & efficacy not established in <1
yr); lactation. May impair ability to drive or operate
machinery. Administer IM rather than SC (when
frequent inj are needed) & inj sites should be
varied.
AR: Physical dependence; sedation, dizziness,
euphoria, lightheadedness, alterations of mood;
resp depression; visual hallucinations,
disorientation, confusion; hypertension,
tachycardia, circulatory depression; shock;
hypotension; nausea, vomiting, constipation;
seizures, diaphoresis; rash; blood dyscrasias;
local tissue damages (SC), muscle fibrosis (IM).
Respiratory depression, hypotension, circulatory
failure, deepening coma, convulsions.
DI: Depressant affects potentiated by alcohol, CNS
depressants; concurrent use w/ fluoxetine may
lead to diaphoresis, ataxia flushing & tremor
associated w/ serotonin syndrome.

P4 - Psychotropic Substance
Schedule 4
ALPRAZOLAM


I: Panic attacks. Short-term management of anxiety.
CI: Acute narrow-angle glaucoma, preexisting
CNS depression or coma, resp depression, acute
pulmonary insufficiency or sleep apnoea; severe
hepatic impairment; pregnancy, lactation.
SP: Dosage reduction or gradual withdrawal.
Dependence. Geriatric or debilitated patients.
Muscle weakness, impaired hepatic or renal
function; arteriosclerosis; obesity; depression
particularly suicidal tendency; chronic pulmonary
insufficiency. May impair ability to drive or operate
machinery. Children <18 yr.
AR: Psychological & physical dependence,
withdrawal syndrome; drowsiness, sedation, vertigo,
headache, visual disturbances, GI disturbances,
jaundice; fatigue, muscle weakness, ataxia,
dizziness, confusion & depression. Blood dyscrasias.

PN DEX 2010
DI: Potentiates action of alcohol & CNS
depressants. Reduced conc w/ cigarette smoking
by 50%. Cimetidine & fluoxetine reduce the
clearance of alprazolam. Alprazolam enhances
activity of imipramine & desipramine.

BROMAZEPAM

I: Anxiety.
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency or sleep
apnea; severe hepatic impairment; not indicated
for chronic psychosis, phobic or obsessional
states; may precipitate suicide or aggressive
behavior, not used alone to treat depression or
anxiety associated w/ depression; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; patients w/
personality disorders or organic brain changes;
pregnancy & lactation; history of alcohol or drug
addiction due to risk of dependence; resp
depression & hypotension w/ parenteral
administration, therefore this route should only be
used when facilities for reversing resp depression
are available.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
in libido, tremor, visual disturbances, urinary
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
hypersensitivity reactions; pain & thrombophlebitis;
raised liver enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
general anesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Alcohol. Drugs which
alter the hepatic microsomal enzymes.

CHLORDIAZEPOXIDE

I: Acute anxiety. Acute symptoms of alcohol


withdrawal. Anxiety. Insomnia. Muscle spasms.
Premedication before anaesthesia. Severe

Registration expired

Pink Pages_2010_Tip.pmd

54

7/4/2553, 09:28

PN DEX 2010

IMPORTANT DRUG NOTES 55

symptoms of alcohol withdrawal.


CI: Acute pulmonary insufficiency, resp depression,
patients w/ marked neuromuscular resp weakness;
hypersensitivity to benzodiazepines; chronic
psychosis; porphyria; pregnancy & lactation.
SP: Alcohol; sedation, dependence. Elderly &
debilitated patients. Liver or kidney dysfunction.
Avoid prolonged usage.
AR: Physical & psychological dependence;
withdrawal syndrome; impairs psychomotor
performance, aggression (in predisposed individuals
esp in combination w/ alcohol); sedation; blood
dyscrasias, jaundice, hepatic dysfunction. May rarely
cause hypoplastic or haemolytic anaemia.
DI: Cimetidine increases serum conc of
chlordiazepoxide. Potentiates action of major
neuroleptics. Alcohol potentiates CNS-depressant
effect of chlordiazepoxide.

CLOBAZAM


I: Adjunct in epilepsy. Short-term management of
anxiety.
CI: Hypersensitivity; history of drug dependence;
myasthaenia gravis; pregnancy (1 st trimester),
lactation; serious liver damage; sleep apnoea
syndrome; impaired resp function.
SP: May impair ability to perform skilled tasks &
hazardous activities; elderly; renal or hepatic
impairment; alcoholics; obesity; withdrawal should
be gradual.
AR: Constipation, anorexia, nausea; dizziness,
fine tremors; worsening of resp symptoms in
predisposed individuals; ataxia, drowsiness,
headache, confusion; loss of libido, motor
dysfunction; dependence; visual disturbances &
wt gain. Respiratory depression.
DI: Increased hepatic clearance of clobazam
when administered w/ phenytoin, phenobarbital
or carbamazepine. Cimetidine may increase levels
of clobazam. Concurrent alcohol, hypnotics &
sedative antidepressants can potentiate CNS side
effects of clobazam.

CLONAZEPAM


I: Emergency management of status epilepticus.

Epilepsy. Panic disorder.


CI: Hypersensitivity to benzodiazepines, acute
pulmonary insufficiency, acute narrow angle
glaucoma.
SP: Neonates, chronic pulmonary insufficiency,
hepatic/renal dysfunction, porphyria, elderly;
pregnancy & lactation.
AR: Drowsiness, fatigue, muscular hypotonia,
coordination disturbances, dizziness, vertigo,
anorexia, visual disturbances, libido changes.
Salivary or bronchial hypersecretion leading to resp
problems (children). May produce diminished
reflexes or coma. Rarely, blood dyscrasias.
DI: Carbamazepine, phenobarbitone or phenytoin
may accelerate clonazepam metabolism.
Increased sedative effect w/ alcohol, general
anaesthetics & TCAs.

CLORAZEPATE

I: Alcohol withdrawal syndrome. Anxiety. Epilepsy.


CI: Hypersensitivity (cross-sensitivity w/ other
benzodiazepines may occur); narrow-angle
glaucoma. Patients w/ depressive or psychotic
disorders. child <9 yr. Pregnancy; lactation.
SP: Elderly, debilitated patients; hepatic disease,
alcoholics; renal impairment; resp disease;
impaired gag reflex; patients experiencing apnoea
during sleep; operating machines or driving;
patients on CNS depressant or psychoactive drug
therapy; depression, esp those w/ suicidal
tendencies; history of drug-dependence.
AR: Jaundice, hepatic necrosis; extrapyramidal
disorders; acute attacks of porphyria in porphyric
patients, hypotension; drowsiness, fatigue, ataxia,
lightheadedness, memory impairment, insomnia,
anxiety, headache, depression, slurred speech,
confusion, nervousness, dizziness, irritability; rash;
decreased libido; xerostomia, constipation,
diarrhoea, decreased salivation, nausea, vomiting,
increased or decreased appetite; dysarthria,
tremor; blurred vision, diplopia.
DI: Potentiates CNS effects of narcotic analgesics,
barbiturates,
phenothiazines,
ethanol,
antihistamines, MAO Inhibitors, sedativehypnotics, cyclic antidepressants. CYP3A4
inhibitors eg, amprenavir, cimetidine, ciprofloxacin,
clarithromycin may increase serum conc & toxicity
of clorazepate. Carbamazepine, rifampin & rifabutin
may decrease clorazepate therapeutic effects by
enhancement of clorazepate metabolism.

Pink Pages_2010_Tip.pmd

55

7/4/2553, 09:28

Registration expired

56

PN DEX 2010

IMPORTANT DRUG NOTES

DIAZEPAM

ETHYL LOFLAZEPATE

I: Adjunct in the management of seizures. Alcohol


withdrawal syndrome. Insomnia associated w/
anxiety. Muscle spasms. Premedication before
anaesthesia. Sedation in minor surgical & medical
procedures. Severe anxiety.
CI: Hypersensitivity; myasthenia gravis,
preexisting CNS depression or coma, resp
depression; acute pulmonary insufficiency or sleep
apnoea syndrome; severe hepatic impairment;
acute narrow angle glaucoma; child <6 mth (oral);
pregnancy & lactation.

I: Short-term management of anxiety.

SP: Impaired renal & hepatic function, resp


disease, organic cerebral changes, elderly,
psychotic patients, epileptics, history of alcohol
or drug addiction, impaired gag reflex, obese
patients. May cause CNS depression. Discontinue
treatment if patient develops psychiatric &
paradoxical reactions. Caution when used in
patients w/ depression or anxiety associated w/
depression, esp if patient has suicidal risk. May
increase risk of falls. Safety & efficacy of the inj
have not been established in child <1 mth of age.
Safety & efficacy of oral use have not been
established in child <6 mth of age. Safety &
efficacy of rectal gel have not been established
in child <2 yr of age. Abrupt withdrawal or large
dose reduction may cause rebound or withdrawal
symptoms.
AR: Psychological & physical dependence w/
withdrawal syndrome, fatigue, drowsiness,
sedation, ataxia, vertigo, confusion, depression,
GI disturbances, changes in salivation, amnesia,
jaundice, paradoxical excitation, elevated liver
enzyme values; muscle weakness, visual
disturbances, headache, slurring of speech &
dysarthria, mental changes, incontinence,
constipation, hypotension, tachycardia, changes
in libido, pain & thrombophlebitis at inj site (IV).
Respiratory & CNS depression, coma.
DI: Increased clearance of diazepam when used
w/ phenytoin, carbamazepine & phenobarbital.
Reversible deterioration of parkinsonism may occur
when given together w/ levodopa. Combination
w/ lithium may produce hypothermia. May need to
reduce dose of narcotics when used concurrently.
Phenothiazines, barbiturates, MAOIs potentiate
action of diazepam. Additive CNS depressant
effects w/ alcohol & CNS depressants or
psychoactive medications. Mutual potentiation of
action w/ analgesics, anaesthetics & some
anticonvulsants.

CI: Preexisting CNS depression or coma, resp


depression, acute pulmonary insufficiency or sleep
apnoea; severe hepatic impairment; not indicated
for chronic psychosis, phobic or obsessional states;
may precipitate suicide or aggressive behaviour,
not used alone to treat depression or anxiety
associated w/ depression; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; patients w/
personality disorders or organic brain changes;
pregnancy, lactation; history of alcohol or drug
addiction due to risk of dependence. Resp
depression & hypotension may occur w/ parenteral
admin.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
in libido, tremor, visual disturbances, urinary
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
hypersensitivity reactions; pain & thrombophlebitis;
raised liver enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression
w/ drugs that have CNS depressant properties e.g.
antidepressants, antihistamines, antipsychotics,
general anesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Drugs which alter
the hepatic microsomal enzymes.

LORAZEPAM

I: Acute anxiety. Anxiety. Insomnia associated w/


anxiety. Premedication in surgery. Prophylaxis of
nausea & vomiting associated w/ cytotoxic therapy.
Sedation in critical care. Status epilepticus.
CI: Severe hepatic impairment; resp depression;
acute narrow-angle glaucoma; pregnancy & lactation.
SP: Hepatic & renal dysfunction; pulmonary
insufficiency; myasthenia gravis; may impair ability
to drive or operate machinery; elderly or debilitated
patients.

Registration expired

Pink Pages_2010_Tip.pmd

56

7/4/2553, 09:28

PN DEX 2010

IMPORTANT DRUG NOTES 57

AR: Drowsiness, headache, dizziness, confusion;


blurred vision; nausea; weakness; unsteadiness.
Resp depression.
DI: Potentiation of CNS depression produced by
alcohol; general anaesthetics; narcotic analgesics;
TCAs; MAOIs; phenothiazines; antipsychotics;
barbiturates; scopolamine.

MEDAZEPAM

I: Short-term management of anxiety.


CI: Glaucoma.
SP: Severe hepatic impairment. Elderly or
debilitated patients; muscle weakness or
myasthenia gravis; impaired liver or kidney function;
predisposition to seizures; depression; severe resp
dysfunction; sleep apnoea; movement disorders;
drowsiness may affect skilled tasks; history of
alcohol or drug addiction. Treatment withdrawal
should be gradual. Avoid long-term use. Pregnancy
& lactation.
AR: Fatigue, drowsiness, dizziness, prolonged
reaction time, headache, coordination disorders
(ataxia), confusion, anterograde amnesia. Rarely,
GI symptoms, laryngeal spasm, chest pain,
hypotension, bradycardia, depression, decreased
libido, increased appetite, dry mouth, muscle
weakness, resp failure.
DI: Additive CNS depression or sedative effects
w/ drugs that have CNS depressant properties e.g.
alcohol, antidepressants, sedating antihistamines,
antipsychotics, general anaesthetics, other
hypnotics or sedatives, opioid analgesics,
cisapride. Increased risk of toxicity w/ hepatic
microsomal enzyme inhibitors.

function. Patients w/ acute pain & depressive


disorders. May impair ability to drive or operate
machinery. Lactation.
AR: Bradycardia, hypotension, syncope;
drowsiness, lethargy, CNS excitation or
depression, impaired judgment, hangover effect,
confusion, somnolence, agitation, hyperkinesia,
ataxia, nervousness, headache, insomnia,
nightmares, hallucinations, anxiety, dizziness;
rash, exfoliative dermatitis; nausea, vomiting,
constipation; agranulocytosis, thrombocytopenia,
megaloblastic anaemia; pain at inj site,
thrombophlebitis (IV); oliguria: laryngospasm, resp
depression, apnoea (especially w/ rapid IV admin),
hypoventilation. Stevens-Johnson syndrome.
DI: May enhance the hepatotoxic potential of
paracetemaol overdoses. May decrease levels/
effects of various CYP isoenzyme substrates e.g.
teniposide, methotrexate, antipsychotics,
b-blockers, calcium-channel blockers, other
anticonvulsants, chloramphenicol, cimetidine,
corticosteroids, ciclosporin, doxycycline,
oestrogens, felbamate, griseofulvin, tacrolimus,
furosemide, methadone, oral contraceptives,
theophylline, TCAs, warfarin. May reduce effects
of guanfacine. Reduced metabolism & or increased
toxicity w/ chloramphenicol, felbamate, MAOIs,
valproic acid. May enhance the nephrotoxic effects
of methoxyflurane. Additive sedation and/or resp
depression w/ ethanol, sedatives, antidepressants,
opioid analgesics, benzodiazepines & other CNS
depressants. May decrease levels/effects of
antiarrhythmic drugs e.g. disopyramide,
propafenone, quinidine.

PINAZEPAM


PHENOBARBITAL



I: Emergency management of acute seizures.
Generalised tonic-clonic seizures. Hypnotic. Partial
seizures. Preoperative sedation. Sedation. Status
epilepticus.
CI: Severe renal & hepatic disorders. Severe resp
depression, dyspnoea or airway obstruction;
porphyria. Pregnancy.
SP: Elderly or debilitated patients, children.
Withdraw gradually. Impaired renal, hepatic & resp

I: Insomnia associated w/ anxiety. Short-term


management of anxiety.
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency,
myasthenia gravis, sleep apnoea, severe hepatic
impairment; not indicated for chronic psychosis,
phobic or obsessional states; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; patients w/
personality disorders or organic brain changes;
pregnancy, lactation; history of alcohol or drug
addiction, hypotension & apnoea w/ IV admin,
therefore this route should only be used when

Pink Pages_2010_Tip.pmd

57

7/4/2553, 09:28

Registration expired

58

IMPORTANT DRUG NOTES

facilities for reversing resp depression are available.


Monitor for signs of suicidal tendency or aggressive
behavior; not to be used alone to treat depression
or anxiety associated w/ depression.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
in libido, tremor, visual disturbances, urinary
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
hypersensitivity
reactions;
pain
&
thrombophloebitis; raised liver enzyme values;
paradoxical excitation.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties e.g.
alcohol, antidepressants, antihistamines,
antipsychotics, general anaesthetics, other
hypnotics or sedatives, opioid analgesics &
cisapride.

PN DEX 2010
general anaesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Decreased serum
levels when used w/ phenytoin. May increase the
plasma levels of bupivacaine. Serum levels may be
increased by valproate & modafinil.

TOFISOPAM

I: Alcohol withdrawal syndrome. Short-term


management of anxiety.
CI: Aggressive-impulsive psychopathy. Pregnancy.
SP: Discontinue if sleep disturbances occur. Avoid
sleep disturbances by taking last dose earlier (e.g.
before 5 pm).
AR: Nausea, rash, epigastric pain, itching, extreme
liveliness, hyperactivity, aggressiveness.

PRAZEPAM

N2 - Narcotic Drug Schedule 2

I: Short-term management of anxiety.


CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency or sleep
apnoea; severe hepatic impairment; chronic
psychosis, phobic or obsessional states; glaucoma;
porphyria. Myasthenia gravis.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired liver
or kidney function; drowsiness may affect skilled
tasks; monitor cardio-respiratory function when used
for deep sedation; patients w/ personality disorders
or organic brain changes; pregnancy & lactation;
history of alcohol or drug addiction due to risk of
depression. resp depression & hypotension w/
parenteral admin, therefore this route should only
be used when facilities for reversing resp depression
are available. May precipitate suicide or aggressive
behavior, not used alone to treat depression or
anxiety associated w/ depression.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache, confusion,
depression, slurred speech, changes in libido,
tremor, visual disturbances, urinary retention, GI
disturbances, changes in salivation & amnesia;
rarely, jaundice, blood disorders & hypersensitivity
reactions; pain & thrombophloebitis; raised liver
enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression w/
alcohol, drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,

CODEINE (ANALGESIC)

I: Mild to moderate pain.


CI: Resp depression, obstructive airway disease,
asthma. Acute alcoholism, convulsive disorders,
head injuries, comatose patients, raised
intracranial pressure. Pregnancy (prolonged use
or high doses at term).
SP: Hypothyroidism, adrenocortical insufficiency;
asthma, impaired hepatic or renal function,
prostatic hyperplasia, hypotension, shock,
inflammatory or obstructive bowel disorders,
myasthenia gravis. Infants, neonates; Reduce dose
in elderly or debilitated patients. May impair ability
to drive or operate machinery. Lactation.
AR: Dependence, withdrawal symptoms; nausea,
vomiting, constipation; drowsiness, confusion;
difficulty in micturition, ureteric or biliary spasms,
urinary retention; dry mouth, dizziness, sweating,
facial flushing, headache, vertigo, bradycardia,
tachycardia, palpitations, orthostatic hypotension,
hypothermia, restlessness, mood changes,
decreased libido or potency, hallucination, miosis;
raised intracranial pressure, muscle rigidity. Resp
depression & hypotension, w/ circulatory failure
& deepening coma (larger doses). Convulsions
(especially in child & infants). Rhabdomyolysis.

Registration expired

Pink Pages_2010_Tip.pmd

58

7/4/2553, 09:28

PN DEX 2010

IMPORTANT DRUG NOTES 59

DI: Enhanced depressant effects w/ alcohol,


anaesthetics, anxiolytics, hypnotics, TCAs,
antipsychotics. Possible CNS depression or
excitation w/ MAOIs. May alter effects of other
compounds e.g. cyclizine, mexiletine, cisapride,
metoclopramide & domperidone.

METHADONE



I: Analgesia. Intractable cough associated w/ lung
cancer. Neonatal abstinence syndrome. Opioid
dependence.

FENTANYL



I: Adjunct to general anaesthesia. Breakthrough
cancer pain. Intractable chronic pain. Premedication
before anaesthesia.
CI: Hypersensitivity.
SP: Myasthaenia gravis. Head injury; increased
intracranial pressure; intracranial lesions; renal or
hepatic impairment; neonates; opioid-nontolerant
patients. Increased risk of resp depression in
elderly, debilitated patients, patient w/ hypoxia or
hypercapnia.
Hypothyroidism,
prostatic
hyperplasia, inflammatory bowel disorders,
bradycardia or bradyarrhythmias. Rapid IV infusion
may cause skeletal muscle & chest wall rigidity,
impaired ventilation or resp distress/arrest.
Prolonged use may cause tolerance, psychological
& physical dependence. Abrupt withdrawal after
prolonged admin may lead to withdrawal
symptoms. Lactation. Pregnancy (avoid high doses
or prolonged usage).
AR: Nausea, vomiting; bradycardia, oedema, CNS
depression, confusion, dizziness,drowsiness,
headache, sedation, transient hypotension,
peripheral vasodilation; increased intracranial
pressure. High IV dose may cause chest wall
rigidity. Transdermal: Rash, erythema & itching.
Respiratory depression, trunk rigidity,
laryngospasm, bronchoconstriction.
DI: Depressant effects may be enhanced by other
CNS depressants e.g. alcohol, anaesthetics,
anxiolytics, hypnotics, TCAs & antipsychotics.
Ammonium Cl may increase excretion of fentanyl.
Phenothiazines may increase hypotensive effect
of opioid analgesics. Serum levels may be
increased by CYP3A4 inhibitors (e.g. azole
antifungals, clarithromycin, diclofenac, doxycycline,
erythromycin, imatinib, isoniazid, nefazodone,
nicardipine, propofol, protease inhibitors, quinidine,
telithromycin & verapamil). May reduce the efficacy
of pegvisomant. Serum levels may be reduced by
rifamycin derivatives. May increase serotonergic
effect of SSRIs & sibutramine.

CI: Acute resp depression; acute bronchial asthma;


acute alcoholism; risk of paralytic ileus; raised
intracranial pressure or head injury.
SP: Dose should be individualised. Prolonged QT
interval; CV disease; hepatic impairment;
electrolyte abnormalities; concommitant use of QT
prolonging drug; resp disease; elderly. May impair
ability to drive or operate machinery.
AR: Nausea; vomiting; constipation; anorexia;
abdominal pain; drowsiness; resp depression;
hypotension; bradycardia; euphoria; headache;
dysphoria; urinary retention; miosis; visual
disturbances; impotence; dizziness; sweating;
pruritis; asthenia; arrythmias; QT prolongation.
Cardiac arrest; resp arrest; shock.
DI: Withdrawal symptoms may be experienced w/
naloxone, naltrexone, pentazocine, nalbuphine,
butorphanol, & buprenorphine. Increased
clearance & possible reduced efficacy w/ some
antiretrovirals (abacavir, amprenavir, efavirenz,
nelfinavir, nevirapine, ritonavir, lopinavir); rifampin;
phenytoin; phenobarbital; carbamazepine.
Decreased clearance & possibly increased toxicity
w/ CYP3A4 inhibitors (e.g. ketoconazole,
voriconazole, sertraline, fluvoxamine). Increased
chance of cardiac toxicity w/ other QT prolonging
drugs. Increased CNS depression w/ alcohol, other
opioids or CNS depressants. Methadone may
increase plasma levels of desipramine, zidovudine.

MORPHINE

I: Acute pain. Acute pulmonary oedema. Analgesia


during labour. Chronic pain. Intractable cough
associated w/ lung cancer. Moderate to severe
pain. Pain associated w/ myocardial infarction. Pain
relief. Premedication in surgery. Unstable angina
not responsive to anti-ischaemic therapy.
CI: Respiratory depression, acute or severe
asthma; paralytic ileus; obstructive airway disease;
acute liver disease; comatose patients; increased
intracranial pressure; acute alcoholism. Pulmonary

Pink Pages_2010_Tip.pmd

59

7/4/2553, 09:28

Registration expired

60

IMPORTANT DRUG NOTES

PN DEX 2010

oedema resulting from a chemical resp irritant.


SP: Elderly; hypothyroidism; renal & liver disease;
head injury, intracranial lesions; hypotension,
circulatory shock; adrenocortical insufficiency;
asthma; prostatic hyperplasia; inflammatory or
obstructive bowel disease; myasthaenia gravis;
infants <3 mth; pregnancy, lactation; hypovolaemia,
biliary tract disorders.
AR: Convulsions; nausea, vomiting, dry mouth,
constipation; urinary retention; headache, vertigo;
palpitations; hypothermia; pruritus, urticaria;
tachycardia, bradycardia; blurred vision; miosis;
dependency; drowsiness; lightheadedness;
dizziness; sweating; dysphoria; euphoria.
Respiratory depression; circulatory failure;
hypotension; deepening coma; anaphylactic
reactions.
DI: May potentiate effects of TCAs; increased risk
of serotonin syndrome w/ serotonergic drugs; risk
of cardiac arrythmias w/ QT prolonging drugs;
sedative effects may be increased by
metoclopramide; antagonises efficacy of diuretics;
morphine levels decreased by rifampicin.
Increased CNS depression w/ other CNS
depressants (e.g. other opioids, general
anaesthetics, benzodiazepines, barbiturates),
alcohol. Risk of severe hypotension w/ MAOIs.

nausea, vomiting, constipation, anorexia, stomach


cramps, xerostomia, biliary spasm, paralytic ileus,
sphincter of Oddi spasm; ureteral spasms,
decreased urination; pain at inj site; weakness;
dyspnoea; histamine release, physical &
psychological dependence.
DI: Increased pethidine metabolite levels w/
aciclovir, cimetidine, ritonavir. Reduced analgesic
effects w/ phenytoin, barbiturates. Additive sedative
and/or resp depressive effects w/ alcohol,
barbiturates, benzodiazepines, phenothiazines,
TCAs, other CNS depressants. Increased risk of
serotonin syndrome w/ MAOIs (not be given
concurrently or w/in 14 days of their
discontinuation), serotonin agonists, serotonin
reuptake inhibitors, sibutramine, TCAs.

PETHIDINE

I: Cough suppressant. Mild to moderate pain.


CI: Resp depression, obstructive airway disease,
asthma. Acute alcoholism, convulsive disorders,
head injuries, comatose patients, raised
intracranial pressure. Pregnancy (prolonged use
or high doses at term).
SP: Hypothyroidism, adrenocortical insufficiency;
asthma, impaired hepatic or renal function,
prostatic hyperplasia, hypotension, shock,
inflammatory or obstructive bowel disorders,
myasthenia gravis. Infants, neonates; Reduce dose
in elderly or debilitated patients. May impair ability
to drive or operate machinery. Lactation.
AR: Dependence, withdrawal symptoms; nausea,
vomiting, constipation; drowsiness, confusion;
difficulty in micturition, ureteric or biliary spasms,
urinary retention; dry mouth, dizziness, sweating,
facial flushing, headache, vertigo, bradycardia,
tachycardia, palpitations, orthostatic hypotension,
hypothermia, restlessness, mood changes,
decreased libido or potency, hallucination, miosis;
raised intracranial pressure, muscle rigidity. Resp
depression & hypotension, w/ circulatory failure &
deepening coma (larger doses). Convulsions
(especially in child & infants). Rhabdomyolysis.
DI: Enhanced depressant effects w/ alcohol,
anaesthetics, anxiolytics, hypnotics, TCAs,

I: Adjunct to anaesthesia. Moderate to severe acute


pain. Obstetric analgesia. Postoperative pain.
Preoperative medication.
SP: May impair ability to drive or operate
machinery. Hypovolaemia, CV disease; adrenal
insufficiency; biliary tract disorder; CNS depression
or coma; history of drug abuse or acute alcoholism;
head injury, intracranial lesions, elevated
intracranial pressure; hepatic or renal impairment;
morbidly obese; prostatic hyperplasia; toxic
psychoses; pre-existing resp compromise (hypoxia
and/or hypercapnia), COPD or other obstructive
airway disease; sickle-cell disease; supraventricular
tachycardia; thyroid dysfunction. Elderly & debilitated
patients. Withdraw gradually. Pregnancy (avoid
prolonged use or high doses at term) & lactation.
AR: Hypotension; fatigue, drowsiness, dizziness,
nervousness, headache, restlessness, malaise,
confusion, depression, hallucinations, tremors,
muscle twitches, increased intracranial pressure,
seizure, serotonin syndrome; rash, urticaria;

N3 - Narcotic Drug Schedule 3


CODEINE
(ANTITUSSIVE/ANALGESIC)

Registration expired

Pink Pages_2010_Tip.pmd

60

7/4/2553, 09:28

PN DEX 2010

IMPORTANT DRUG NOTES 61

antipsychotics. Possible CNS depression or


excitation w/ MAOIs. May alter effects of other
compounds e.g. cyclizine, mexiletine, cisapride,
metoclopramide & domperidone.

DEXTROPROPOXYPHENE

I: Mild to moderate pain.


CI: Hypersensitivity, chronic resp diseases,
porphyria, pregnancy. Patients on MAOI treatment
or w/in 2 wk of stopping treatment.
SP: Suicidal patients, hepatic or renal disease;
lactation, elderly.
AR: Dizziness, sedation, weakness; nausea,
vomiting, constipation; rash, urticaria; visual
disturbances; physiological dependence.
Convulsions in long-term therapy. Cardiac
conduction abnormalities & arrhythmias; liver
impairment.
DI: Inhibits hepatic metabolism of benzodiazepines, b-blockers, carbamazepine, phenytoin
& warfarin. Increased risk of toxicity when coadministered w/ ritonavir. Potentiation of
depressant effects when used w/ alcohol or CNS
depressants. Accidental or intentional overdosage
fatal (especially if combined w/ alcohol, &
analgesics e.g. paracetamol & aspirin).

OPIUM TINCTURE /
CAMPORATED OPIUM TINCTURE

I: Cough suppressant.
CI: Severe hepatic & renal diseases; raised
intracranial pressure; acute resp depression or
obstructive airways disease; comatose patients;
prolonged use or high dosages near term.
SP: Hepatic or renal diseases; head injury, CNS
depression, history of opioid agonist dependence;
biliary tract or acute abdominal disorders; Addison
s disease; obesity; urinary difficulties; resp
disease; thyroid disease; infants<3 mths,
debilitated patients & elderly; pregnancy.
AR: CNS depression, hypotension, drowsiness &
palpitation, bradycardia; sweating, flushing,
pruritis; malaise; urinary tract spasm & reduction
in urination; constipation; miosis. Severe resp
depression; increased intracranial pressure.
DI: Increased CNS depression w/ alcohol, other
opiate agonists, general anesthetics, tranquillizers,
sedatives & hypnotics. However, some
tranquillizers e.g. phenothiazines may antagonize
the effect of opiate analgesia; opium prep may
increase the effect of TCA & MAOIs. Reduced
effectiveness of diuretics in patients w/ CHF.
Should not be given to patients bitten by
Centruroides sculpturatus, Ewing & C. gertschi
Stahnke scorpions as opiate agonist may potentiate
the effect of the venoms. May cause serotonin
syndrome if used w/ MAOIs.

DIPHENOXYLATE


I: Acute diarrhoea. Chronic diarrhoea.
CI: Infants & child <4 yr. Jaundice, intestinal
obstruction.
Diarrhoea
associated
w/
pseudomembranous colitis or enterotoxinproducing bacteria.
SP: Hepatic dysfunction, inflammatory bowel
disease. Pregnancy, lactation; young children.
AR: GI effects; headache, drowsiness, dizziness,
restlessness, euphoria, depression, numbness of
the extremities; hypersensitivity reactions,
swelling of the gums.
DI: Potentiates effects of other CNS depressants
(alcohol, barbiturates) & some anxiolytics.
Theoretical hypertensive crisis w/ MAOIs.

Pink Pages_2010_Tip.pmd

61

7/4/2553, 13:01

Registration expired

Color profile: Disabled


Composite 150 lpi at 45 degrees

CONTROLLED SUBSTANCE CLASS

/
Ketamine HCl

P2

Calypsol 50 mg/mL x 10 mL
Keta-Hameln
50 mg/mL x 10 mL
Ketalar 50 mg/mL x 10 mL

Buprenorphine HCl
002
007

Buprine 0.2 mg
Temgesic 0.2 mg
Temgesic
0.3 mg/mL x 1 mL

619

D-Norpseudoephedrine
HCl

Lormetazepam
Loramet 1 mg

Methylphenidate HCl

Concerta 18 mg
504 Concerta 36 mg
Methylphenidate
Hexal 10 mg
Ritalin 10 mg
D-Norpseudoephedrine Rubifen 10 mg
Mirapront N 20 mg

Resinate
D-Norpseudoephedrine SR
Osmopharm 20 mg

Diethylpropion HCl
Dietil Retard 75 mg
Prefamone 75 mg
Regenon Retard 75 mg
Regenon Retard 75 mg

505

Atractil 75 mg

Dormicum
5 mg/mL x 1 mL
Dormicum 15 mg
084 Dormicum
15 mg/3 mL x 3 mL
174
115
486

Alodorm 5 mg
Resinate Mogadon 5 mg
497 Nitrados 5 mg

Ephedrine GPO
30 mg/mL x 1 mL

Panbesy 15 mg
604 Panbesy 30 mg
Phentermine
Osmopharm 15 mg

Flunitrazepam
Rohypnol 1 mg

Flurazepam
Dalmadorm 15 mg

621 Temazepam
351 Euhypnos 20 20 mg

394

047
135
184
136
045

518

523
547

398

622

Triazolam
Halcion 0.25 mg
078 Trialam 0.25 mg
081 Trycam 0.25 mg
062

350
168
348

Zolpidem Tartrate

Phentermine HCl

Ephedrine HCl

143

Midazolam

Nitrazepam
Diethylpropion

Pseudoephedrine HCl
641 Pseudoephedrine
Asian Pharm 30 mg
642 Pseudoephedrine
Asian Pharm 60 mg
643
Pseudoephedrine
BJ Benjaosoth 60 mg
Pseudoephedrine
Medicine Products 60 mg
102 Pseudoephedrine
Milano 30 mg
Pseudoephedrine
Milano 60 mg
Pseudoephedrine Syrup
169
Asian Pharm
114
30 mg/5 mL x 60 mL
Pseudoephedrine Syrup
117
BJ Benjaosoth
041
30 mg/5 mL x 60 mL
038 Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL

425
461

110

Stilnox 10 mg

451

P3
Phentermine Resinate

Duromine 15 mg
Duromine 30 mg
Phentermine Trenker 15 mg
478 Phentermine Trenker 30 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM

499
488
466 Amobarbital
424 Ama 50 mg

144

Color profile: Disabled


Composite 150 lpi at 45 degrees

PN DEX 2010
Pangon
30 mg/mL x 1 mL
Sosegon
30 mg/mL x 1 mL

Pentobarbital Na
Nembutal
50 mg/mL x 20 mL

P4

Prazol 0.5 mg
Siampraxol 0.25 mg
607 Siampraxol 0.5 mg
Xanacine 0.25 mg
624 Xanacine 0.5 mg
Xanacine 1 mg
Xanax 0.25 mg
Xanax 0.5 mg
Xanax 1 mg
Xanax XR 0.5 mg
639 Xanax XR 1 mg
Xanax XR 2 mg
Xiemed 0.25 mg
Xiemed 0.5 mg
Xiemed 1 mg
Zolam 0.25 mg
Zolam 0.5 mg
Zolam 1 mg

Alprazolam
Alcelam 0.25 mg
Alcelam 0.5 mg
Alcelam 1 mg
Allam 0.25 mg
Allam 0.5 mg
Allam 1 mg
Alpralan 0.25 mg
Alpralan 0.5 mg
Alpramed 0.25 mg
Alpramed 0.5 mg
Alpramed 1 mg
Alprax 0.25 mg
Alprazolam Frx 0.5 mg
Anax 0.25 mg
Anax 0.5 mg
Anpress 0.25 mg
Anpress 0.5 mg
Anpress 1 mg
Dizolam 0.25 mg
Dizolam 0.5 mg
Dizolam 1 mg
Inzolam 0.25 mg
Inzolam 0.5 mg
Inzolam 1 mg
Manex 0.25 mg
Manex 0.5 mg
Manex 1 mg
Marzolam 0.25 mg
Marzolam 0.5 mg
Marzolam 1 mg
Mitranax 0.25 mg
Mitranax 0.5 mg
Mitranax 1 mg
Moxinax 0.25 mg
Moxinax 0.5 mg
Pharnax 0.25 mg
Pharnax 0.5 mg
Pharnax 1 mg

097
241
288
103
250
293
042
214
252
105
393
156
256
085
230
088
248
282
089
233
297
104
251
294
099
244
291
090
235
283
106
253
295
094
238
101
247
292

Bromazepam
Lexotan 1.5 mg
Lexotan 3 mg

Chlordiazepoxide HCl
Benpine 5 mg
Benpine 10 mg
Benpine 25 mg
Cebarax 5 mg
Chlordiazepoxide
March Pharma 25 mg
Chlordiazepoxide
T Man 10 mg
Chlordixide 5 mg
Chlordixide 10 mg
Comoben 5 mg
Comoben 10 mg
Cozep 10 mg
Cozep 25 mg
Dirax 5 mg
Kenspa 5 mg

Librax 5 mg
Metaxide 10 mg
Minoxide 10 mg
Modurax 5 mg
Pondnebium 5 mg
Tumax 5 mg
Zepoxide 10 mg

234
098
243
091
236
284
096
240
287
344
069
353
108
249
296
093
237
285

Frisium 5 mg

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM

Clonaril 1 mg
Povanil 0.5 mg
Povanil 2 mg
Prenarpil 0.5 mg
Prenarpil 1 mg
Prenarpil 2 mg
Rivotril 0.5 mg
Rivotril 2 mg

412
498
194
380
467
373
358
195
362
491
138
181
385
223
381
481
477
377
371
400
279

043

342
186
067
407
337
054
408
055

Clorazepate
Dipotassium

Cloraxene 5 5 mg
Cloraze 5 mg
Deda 5 mg
Deda 10 mg
Dipot 5 mg
Polizep 5 mg
Pomadom 10 mg
Tenmed 5 mg
070 Tenmed 10 mg
228 Trancap 5 mg
Trancon 5 mg
Tranmed 5 mg
Tranpate 5 mg
Tranxene 5 mg

Clobazam

Clonazepam

436
433
437
265
432
444
423
440
269
470
456
428
416
438

Diazepam
A-Zerax 2 mg
A-Zerax 5 mg
Diamed 2 mg
Diamed 5 mg
Diano 2 mg
Diano 5 mg
Diapam 2 mg
Diapam 5 mg
Diapine 2 mg
Diapine 2 mg
Diapine 5 mg
Diapine 5 mg
Diapine
5 mg/mL x 1 mL
Diapine 10 mg
Diapine
10 mg/2 mL x 2 mL
Diazepam
BJ Benjaosoth 2 mg
Diazepam
BJ Benjaosoth 5 mg
Diazepam
BJ Benjaosoth 10 mg
Diazepam
General Drugs House 2 mg

453
463
503
482
015
140
369
329
010
473
166
484
600
386
601
050
374
222
318

Frame Numbers in Bold Italics

CONTROLLED SUBSTANCE CLASS

Pentazocine

CONTROLLED SUBSTANCE CLASS 63

Color profile: Disabled


Composite 150 lpi at 45 degrees

CONTROLLED SUBSTANCE CLASS

64

Diazepam
General Drugs House 5 mg
Diazepam GPO 2 mg
Diazepam GPO 5 mg
Diazepam GPO 10 mg
Diazepam GPO
10 mg/2 mL x 2 mL
Diazepam
H K Pharm 2 mg
Diazepam
H K Pharm 5 mg
Diazepam
H K Pharm 10 mg
Diazepam
Lerd Singh 2 mg
Diazepam
Lerd Singh 5 mg
Diazepam
Ponds Chemical 2 mg
Diazepam
Ponds Chemical 5 mg
Diazepam T Man 2 mg
Diazepam T Man 5 mg
Diazepam T P Drug
10 mg/2 mL x 2 mL
Diazepam Vesco 2 mg
Diazepam Vesco 5 mg
Ditran 2 mg
Ditran 5 mg
Divopan 2 mg
Divopan 5 mg
Dizep 2 mg
Dizep 5 mg
Dizepam 2 mg
Dizepam 5 mg
Manodiazo 2 mg
Manodiazo 5 mg
Manodiazo 10 mg
Manolium
10 mg/2 mL x 2 mL
Monozide-10
10 mg/2 mL x 2 mL
Ropam
10 mg/2 mL x 2 mL
Sipam 2 mg
Sipam 5 mg
Sipam 10 mg
Sipam
10 mg/2 mL x 2 mL
Tranolan 2 mg
Tranolan 5 mg
Tranolan
10 mg/2 mL x 2 mL
V Day Zepam 2 mg
V Day Zepam 5 mg
V Day Zepam
10 mg/2 mL x 2 mL

PN DEX 2010

CONTROLLED SUBSTANCE CLASS


V Day Zepam NL
148
10 mg/2 mL x 2 mL
052 Vason 2 mg
149 Vescopam
334
10 mg/2 mL x 2 mL
Vispam 10 mg
603 Vorapam 2 mg
Vorapam 5 mg
218 Zepaxid 2 mg
Zepaxid 5 mg
160 Zepaxid
10 mg/2 mL x 2 mL
343 Zopam 2 mg
Zopam 5 mg
066 Zopam 10 mg

Phenobarbital Na
617 Gardenal
396
200 mg/4 mL

Neuramizone
20 mg
636
323 Phenobarbital
Atlantic 32.5 mg
064
159 Phenobarbital
Atlantic 65 mg
506
462 Phenobarbital
Atlantic 100 mg
634 Phenoco Elixir
20 mg/5 mL x 450 mL
048
Phenotal Elixir
145
20 mg/5 mL x 60 mL
331

638
403
011
012
277
584
517

161
367

Pinazepam

216 Anta 0.5 mg


364 Anta 1 mg
211 Anta 2 mg
Anxira 0.5 mg
627 Anxira 1 mg
325 Hawkcopax 0.5 mg
134 Kemora 0.5 mg
418 Kemora 1 mg
476 Lonza 0.5 mg
049 Lonza 1 mg
146 Lora 0.5 mg
171 Lora 1 mg
Lora 2 mg
190
Loramed 2 mg
224
Loravan 0.5 mg
151
Loravan 1 mg
469
Lorazep 0.5 mg
502
Lorazep 1 mg
335
Lorazep 2 mg
Lorazin 0.5 mg
613
Lorazin 1 mg
Lorazin 2 mg
632
Ora 0.5 mg
Ora 1 mg
608
Tranavan 0.5 mg
056
Tranavan 1 mg
154
Zeda 0.5 mg
339
Zeda 1 mg
Zora 0.5 mg
626 Zora 2 mg
130
177
615
475 Medazepam
465 Celium 5 mg
Medazine 5 mg
616 Medazine 10 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM

464

Domar 5 mg

Lorazepam
304
020
125
300
022
321
411
024
313
019
368
036
217
210
302
027
309
003
357
324
044
227
310
030
307
034
014
360
328
179

Prazepam
Pozapam 5 mg
Pozapam 10 mg

459
175

Tofisopam
Grandaxin 50 mg

051

N2
Codeine Phosphate
(Analgesic)
Codeine GPO 15 mg
Codeine GPO 30 mg

004
018

Fentanyl

Durogesic
25 mcg/hr x 2.5 mg
Durogesic
50 mcg/hr x 5 mg
Durogesic
100 mcg/hr x 10 mg
Fentanyl GPO
12 mcg/hr
Fentanyl GPO
397
25 mcg/hr
487 Fentanyl GPO
50 mcg/hr
483

651
652
653
645
646
647

Color profile: Disabled


Composite 150 lpi at 45 degrees

PN DEX 2010

Pethidine M & H Manufacturing


50 mg/mL x 1 mL
Pethidine M & H Manufacturing
649
100 mg/2 mL x 2 mL
Pethidine T.P. Drug
650
50 mg/mL x 1 mL

648

611

612
631

Fentanyl Citrate
Fentanyl Antigen
0.05 mg/mL x 2 mL
Fentanyl Antigen
0.05 mg/mL x 10 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL
Fentanyl Sandoz
0.05 mg/mL x 2 mL
Fentanyl Sandoz
0.05 mg/mL x 10 mL

Methadone HCl
Methadone GPO 5 mg
Methadone GPO
10 mg/mL x 1000 mL

Morphine Sulfate
Kapanol 20 mg
Kapanol 50 mg
Kapanol 100 mg
Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
MST Continus 10 mg
MST Continus 30 mg
MST Continus 60 mg
Oramorph
10 mg/5 mL x 250 mL
Oramorph
20 mg/mL x 30 mL

Pethidine HCl
Pethidine Biolab
100 mg/2 mL x 2 mL

N3

598
599
605

Camphorated Opium
Tinct

606 Brown Mixture GPO


0.6 mL/5 mL x 180 mL
623 Brown Mixture GPO
0.6 mL/5 mL x 450 mL
644 Brown Mixture Osoth Interlab
0.6 mL/5 mL x 180 mL

Mist Tussis
0.6 mL/5 mL x 450 mL

Mist. Scill Ammon. GPO


126
0.6 mL/5 mL x 180 mL

Mixture Tussis
596
0.45 mL/5 mL x 30 mL
Mixture Tussis
0.45 mL/5 mL x 60 mL
Mixture Tussis
0.45 mL/5 mL x 120 mL
119
Mixture Tussis
120
0.45 mL/5 mL x 240 mL
121
Mixture Tussis
0.45 mL/5 mL x 450 mL
609
Squill and Ammonia Mixture
1.3 mL/10 mL x 450 mL
610

527
528
554
590
531
574
575
576
577
578
591

628
629

Codeine Phosphate
(Analgesic)

630
406
278
183

Codicet 15 mg
Codicet Blue 15 mg

Codigesic 15 mg

Masapara With Codeine


15 mg

594 Nasa With Codeine


15 mg
595 Para-Co 15 mg
Paradeine 15 mg
Parcono 8 mg
Tylenol With Codeine
15 mg
Tylenol With Codeine
30 mg
602

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM

Codeine Phosphate
(Antitussive)
Bluco 10 mg

Bronpect 10 mg

Centrodine CD 10 mg
Clinopront 10 mg
Co-Cof 10 mg

Codee-C 10 mg

Codepect 10 mg

Codesia 10 mg

Codesia
10 mg/5 mL x 60 mL
Codyl Cough
9 mg/5 mL x 60 mL

Codyl Cough
9 mg/5 mL x 100 mL
Decos 9 mg/5 mL x 100 mL

Mila-Tercon 8 mg
Neopect 10 mg

Nordyl Linctus
9 mg/5 mL x 100 mL

Phencodin
9 mg/5 mL x 60 mL
Phensedyl
9 mg/5 mL x 100 mL
Poly-Cof Syrup
9 mg/5 mL x 60 mL
Poly-Cof Syrup
9 mg/5 mL x 100 mL
Pondnadyl
9 mg/5 mL x 60 mL
Pondnadyl
9 mg/5 mL x 100 mL

Rolar 10 mg
Ropect 10 mg
Rotuss 10 mg

Seco 10 mg

Terco-C 10 mg
Tussidyl
9 mg/5 mL x 60 mL

355
298
225
378
165
388
202
391
516
540
541
572
167
199
566
586
553
548
549
563
564
203
201
204
389
387
589

Codeine Resinate

414 Codipront 30 mg
352
112
410

494

Diphenoxylate HCl

Lomotil 2.5 mg
080 Spasil 2.5 mg
347
074
079

006
009

Opium Tinct
075 Camphorated Opium Tincture

BP 1980
5 mL/100 mL x 1000 mL
076

529

Frame Numbers in Bold Italics

CONTROLLED SUBSTANCE CLASS

Fentanyl Hexal
12 mcg/hr
Fentanyl Hexal
25 mcg/hr
Fentanyl Hexal
50 mcg/hr

CONTROLLED SUBSTANCE CLASS 65

Color profile: Disabled


Composite 150 lpi at 45 degrees

MANUFACTURER'S INDEX

2M (MED-MAKER)

2 (-)
Anpress 0.25 mg
Anpress 1 mg
Xiemed 0.5 mg

Dipot 5 mg
Lorazep 0.5 mg
Lorazep 1 mg
088
Lorazep 2 mg
282
Phenotal Elixir
249
20 mg/5 mL x 60 mL

3 /.

A N H PRODUCTS


Comoben 5 mg
Comoben 10 mg
Divopan 2 mg
Divopan 5 mg

517

BARD/FDA

3M PHARMA/FDA
Duromine 15 mg
Duromine 30 mg

432 BANGKOK LAB & COSMETIC


309
003

Clinopront 10 mg
378
357

Codigesic 15 mg
112

/.

ASIAN PHARM/FDA

/.

499
488 Pseudoephedrine
Asian Pharm 30 mg
Pseudoephedrine
Asian Pharm 60 mg
Pseudoephedrine Syrup
Asian Pharm
30 mg/5 mL x 60 mL
362
491
049
146

MST Continus 10 mg
MST Continus 30 mg
143 MST Continus 60 mg

406
278
183

047

BIOLAB/FDA
518

/.

Pethidine Biolab
100 mg/2 mL x 2 mL

602

ATLANTIC LAB

ALPHAPHARM/FDA

/.

Alodorm 5 mg
Trialam 0.25 mg

078
168

ALZA CORP/FDA

/.
Concerta 18 mg
Concerta 36 mg

169
114

ANTIGEN/FDA

/.

Fentanyl Antigen
0.05 mg/mL x 2 mL
Fentanyl Antigen
0.05 mg/mL x 10 mL

ASIAN PHARM

598
599

Ama 50 mg
Benpine 5 mg
Benpine 10 mg
Benpine 25 mg
Diapine 2 mg
Diapine 2 mg
Diapine 5 mg
Diapine 5 mg
Diapine 5 mg/mL x 1 mL
Diapine 10 mg
Diapine 10 mg/2 mL x 2 mL
Dizolam 0.25 mg
Dizolam 0.5 mg
Dizolam 1 mg
Lora 0.5 mg
Lora 1 mg
Lora 2 mg
Phenobarbital Atlantic
32.5 mg
Phenobarbital Atlantic
65 mg
Phenobarbital Atlantic
100 mg

A-Zerax 2 mg
A-Zerax 5 mg
Codesia 10 mg
Codesia
10 mg/5 mL x 60 mL

453 B L HUA
463
391
Codicet 15 mg
516 Terco-C 10 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM

144
412
498
194
010
473
166
484
600
386
601
089
233
297
368
036
217

BJ BENJAOSOTH

()

Diazepam BJ Benjaosoth
2 mg
Diazepam BJ Benjaosoth
5 mg
Diazepam BJ Benjaosoth
10 mg
Minoxide 10 mg

374
222
477

BJ BENJAOSOTH/FDA

()/.

Pseudoephedrine
BJ Benjaosoth 60 mg
Pseudoephedrine Syrup
BJ Benjaosoth
011
30 mg/5 mL x 60 mL
012

277

050

135

523

BOEHRINGER
INGELHEIM/FDA

/.
Oramorph
10 mg/5 mL x 250 mL
414 Oramorph
20 mg/mL x 30 mL
387

594
595

Color profile: Disabled


Composite 150 lpi at 45 degrees

PN DEX 2010

MANUFACTURER'S INDEX

BRITISH DISPENSARY

GLAXOSMITHKLINE/FDA

( )

/.

/.
014 Kapanol 20 mg
360 Kapanol 50 mg
Kapanol 100 mg

119 Keta-Hameln
50 mg/mL x 10 mL
120
121

CARDINAL HEALTH
AUSTRALIA

HEXAL AG/FDA


Ropect 10 mg

Rotuss 10 mg

CEVA ANIMAL HEALTH


Nembutal
50 mg/mL x 20 mL

CHAROEN BHAESAJ

Paradeine

15 mg

201
204 Brown Mixture GPO
0.6 mL/5 mL x 180 mL

Brown Mixture GPO


0.6 mL/5 mL x 450 mL
Camphorated Opium Tincture

BP 1980
5 mL/100 mL x 1000 mL
639
Diazepam GPO 2 mg
Diazepam GPO 5 mg
Diazepam GPO 10 mg
Diazepam GPO
10 mg/2 mL x 2 mL
Mist. Scill Ammon. GPO
074
0.6 mL/5 mL x 180 mL

/.

DOUGLAS/FDA

/.

Nitrados 5 mg
Trycam 0.25 mg

/.

GPO

DEXO/FDA
Prefamone 75 mg

642

GPO/FDA
174

/.

Codeine GPO 15 mg
Codeine GPO 30 mg
Ephedrine GPO
30 mg/mL x 1 mL
062 Methadone GPO 5 mg
Methadone GPO
348
10 mg/mL x 1000 mL

Fentanyl GPO
Fentanyl GPO
Fentanyl GPO
527
Fentanyl Hexal
Fentanyl Hexal
528
Fentanyl Hexal

12 mcg/hr
25 mcg/hr
50 mcg/hr
12 mcg/hr
25 mcg/hr
50 mcg/hr

645
646
647
648
649
650

529
052
149 INPAC PHARMA
334

Inzolam
603 Inzolam
Inzolam
531 Lorazin
Lorazin
Lorazin
Tenmed
Tenmed

0.25 mg
0.5 mg
1 mg
0.5 mg
1 mg
2 mg
5 mg
10 mg

104
251
294
324
044
227
440
269

004
018 INTERTHAI

604
126 Tranxene 5 mg

438

596

JANSSEN-CILAG/FDA

-/.

EGIS

GREATER PHARMA

Grandaxin 50 mg

051

Diapam 2 mg
Diapam 5 mg

GEDEON RICHTER/FDA

/.

Calypsol 50 mg/mL x 10 mL

641

H K PHARM

GENERAL DRUGS HOUSE

Diazepam
General Drugs House 2 mg
Diazepam
General Drugs House 5 mg
Zora 0.5 mg
Zora 2 mg

318
148
328
179

Allam 0.25 mg
Allam 0.5 mg
Allam 1 mg
Deda 5 mg
Deda 10 mg
Diazepam H K Pharm 2 mg
Diazepam H K Pharm 5 mg
Diazepam H K Pharm 10 mg

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM

Durogesic
25 mcg/hr x 2.5 mg
Durogesic
369
50 mcg/hr x 5 mg
329
Durogesic
100 mcg/hr x 10 mg
Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL

103
250
293
437
265
218
160
343

651
652
653
605
606

KENYAKU

Bronpect 10 mg
Kenspa 5 mg
Prazol 0.5 mg

298
223
234

Frame Numbers in Bold Italics

MANUFACTURER'S INDEX

Zeda 0.5 mg
Zeda 1 mg

67

HAMELN/FDA

Color profile: Disabled


Composite 150 lpi at 45 degrees

68

PN DEX 2010

MANUFACTURER'S INDEX

LBS

Marzolam 0.5 mg
Marzolam 1 mg


Hawkcopax 0.5 mg
Pangon 30 mg/mL x 1 mL
Ropam 10 mg/2 mL x 2 mL

LERD SINGH
Alpramed 0.25 mg
Alpramed 0.5 mg
Alpramed 1 mg
Chlordixide 5 mg
Chlordixide 10 mg
Diazepam Lerd Singh 2 mg
Diazepam Lerd Singh 5 mg

252
105
393
358
195
066
161

Rubifen 10 mg

MANUFACTURER'S INDEX

M & H MANUFACTURING

Bluco 10 mg

Codicet Blue 15 mg

Diano 2 mg
Diano 5 mg

Mila-Tercon 8 mg

Parcono 8 mg

/.

321
607
608 MASA LAB
Cebarax 5 mg
Dizepam 2 mg
Dizepam 5 mg

Masapara With Codeine


038
15 mg

Neopect 10 mg
Ora 0.5 mg
Ora 1 mg

LAB RUBIO/FDA

235 MILANO
283

MEDICINE PRODUCTS

380
224
151

MILANO/FDA

/.

410
199 Pseudoephedrine
310
Milano 30 mg
030 Pseudoephedrine
Milano 60 mg
Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL

313
019 MILLIMED
091
236
284 Anax 0.25 mg
Anax 0.5 mg
Co-Cof 10 mg
Nasa With Codeine 15 mg
MEDICINE PRODUCTS/FDA
Poly-Cof Syrup
355
9 mg/5 mL x 60 mL
352
Poly-Cof Syrup
Pseudoephedrine
9 mg/5 mL x 100 mL
Medicine Products 60 mg
184
Vason 2 mg
Lonza 0.5 mg
Lonza 1 mg
Xanacine 0.25 mg
Xanacine 0.5 mg
Xanacine 1 mg

M & H MANUFACTURING/FDA
Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
Pethidine M & H Manufacturing
50 mg/mL x 1 mL
Pethidine M & H Manufacturing
100 mg/2 mL x 2 mL

609
610
611
612

MACK/FDA

/.

Mirapront N 20 mg

MARCH PHARMA

Chlordiazepoxide
March Pharma 25 mg
Manodiazo 2 mg
Manodiazo 5 mg
Manodiazo 10 mg
Manolium
10 mg/2 mL x 2 mL
Marzolam 0.25 mg

504

136
045
547

/.

/.

015
140
167
079

085
230
165
080
548
549
396

MEDICPHARMA

Codee-C 10 mg

Codyl Cough
9 mg/5 mL x 60 mL

Codyl Cough
9 mg/5 mL x 100 mL
Diamed 2 mg
Diamed 5 mg
Dirax 5 mg
Medazine 5 mg
Medazine 10 mg
Para-Co 15 mg
Prenarpil 0.5 mg
Prenarpil 1 mg
Prenarpil 2 mg
Tranmed 5 mg
Zolam 0.25 mg
Zolam 0.5 mg
Zolam 1 mg

467
469
502 MEGA LIFESCIENCES
335

613 Codepect 10 mg
090 Rolar 10 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM

MODERN MANU
388

Cloraze 5 mg
Moxinax 0.25 mg
541 Moxinax 0.5 mg
503
482
385
487 NOVARTIS/FDA
483
347 Ritalin 10 mg
407
337
054
428 OLAN-KEMED
093
237
285 Alpralan 0.25 mg
Alpralan 0.5 mg
Kemora 0.5 mg
Kemora 1 mg
Loramed 2 mg
Tranolan 2 mg
202 Tranolan 5 mg
203 Tranolan 10 mg/2 mL x 2 mL

540

433
094
238

/.

041

042
214
411
024
210
130
177
615

Color profile: Disabled


Composite 150 lpi at 45 degrees

PN DEX 2010

MANUFACTURER'S INDEX
PHARMASANT LAB

Alprazolam Frx 0.5 mg

Codipront 30 mg
Librax 5 mg

Lomotil 2.5 mg

Phensedyl
9 mg/5 mL x 100 mL

Tylenol With Codeine 15 mg

Tylenol With Codeine 30 mg

256
494
381
006
553
075
076

OSMOPHARM/FDA

/.

D-Norpseudoephedrine SR
Osmopharm 20 mg
Panbesy 15 mg
Panbesy 30 mg
Phentermine
Osmopharm 15 mg

505
425
461

Alcelam 0.25 mg
Alcelam 0.5 mg
Alcelam 1 mg
Anta 0.5 mg
Anta 1 mg
Anta 2 mg

Centrodine CD 10 mg
Cozep 10 mg
Cozep 25 mg
Pomadom 10 mg
Povanil 0.5 mg
Povanil 2 mg
Pozapam 5 mg
Pozapam 10 mg
Zopam 2 mg
Zopam 5 mg
Zopam 10 mg

097
241
288
304
020
125
225
138
181
423
186
067
459
175
048
145
331

451

Brown Mixture Osoth Interlab


0.6 mL/5 mL x 180 mL

P P LAB


V Day Zepam 2 mg
V Day Zepam 5 mg
V Day Zepam
10 mg/2 mL x 2 mL
V Day Zepam NL
10 mg/2 mL x 2 mL

PARKE-DAVIS/FDA

/.

Ketalar 50 mg/mL x 10 mL

Domar 5 mg
Mitranax 0.25 mg
554 Mitranax 0.5 mg
Mitranax 1 mg
Polizep 5 mg
Tranavan 0.5 mg
Tranavan 1 mg

/.

Dalmadorm 15 mg
Dormicum 5 mg/mL x 1 mL
Dormicum 15 mg
Dormicum 15 mg/3 mL x 3 mL
Mogadon 5 mg
Rohypnol 1 mg

478
621
351
622
081
394

464
106
253
295 SALUTAS PHARMA/FDA
444
307
Methylphenidate Hexal 10 mg
034

617 Diazepam
Ponds Chemical 2 mg
Diazepam
Ponds Chemical 5 mg

Pondnadyl
9 mg/5 mL x 60 mL
643 Pondnadyl
9 mg/5 mL x 100 mL
Pondnebium 5 mg

/.
Fentanyl Sandoz
0.05 mg/mL x 2 mL
367 Fentanyl Sandoz
0.05 mg/mL x 10 mL
216

623
644

563

SANOFI-AVENTIS
564
371

Frisium 5 mg
Gardenal 200 mg/4 mL

096 R P SCHERER/FDA
240
287
344 Euhypnos 20 20 mg
069
353

117

SANDOZ CANADA/FDA

PONDS CHEMICAL

566

/.

PFIZER
Xanax 0.25 mg
Xanax 0.5 mg
Xanax 1 mg
Xanax XR 0.5 mg
Xanax XR 1 mg
Xanax XR 2 mg

070
228
408
055

ROCHE/FDA

Nordyl Linctus
9 mg/5 mL x 100 mL

475
465
616

1.5 mg
3 mg
0.5 mg
2 mg

Lexotan
Lexotan
Rivotril
Rivotril

ROSEMONT PHARM
POLIPHARM

OSOTH INTERLAB

69

ROCHE

/.

043
638

SANOFI-SYNTHELABO
398

Sosegon 30 mg/mL x 1 mL

624

RECKITT BENCKISER/FDA

/.

PHARMACIA/FDA

/.

Halcion 0.25 mg

Temgesic 0.2 mg
350 Temgesic 0.3 mg/mL x 1 mL

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM

SANOFI-WINTHROP/FDA

-/.

007
619 Stilnox 10 mg

110

Frame Numbers in Bold Italics

MANUFACTURER'S INDEX

OLIC

Color profile: Disabled


Composite 150 lpi at 45 degrees

70

Phenoco Elixir
20 mg/5 mL x 450 mL

Siampraxol 0.25 mg
Siampraxol 0.5 mg
Sipam 2 mg
Sipam 5 mg
Sipam 10 mg
Sipam 10 mg/2 mL x 2 mL

SIAM BHEASACH/FDA

098
243
056 T P DRUG
154
339
626 Diazepam T P Drug
10 mg/2 mL x 2 mL
Trancap 5 mg
Zepoxide 10 mg

Buprine 0.2 mg

002

T P DRUG/FDA

/.
SRIPRASIT PHARMA

Decos 9 mg/5 mL x 100 mL

Neuramizone 20 mg

Seco 10 mg

Spasil 2.5 mg
Tumax 5 mg

UDOMPHON (PHIHALAB)
584

572
403
389
009
400

Morphine T.P. Drug


10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Pethidine T.P. Drug
50 mg/mL x 1 mL

()
Metaxide
Zepaxid
Zepaxid
Zepaxid

/.

MANUFACTURER'S INDEX

PN DEX 2010

MANUFACTURER'S INDEX

SIAM BHEASACH

10 mg
2 mg
5 mg
10 mg/2 mL x 2 mL

481
506
462
634

627
470 UTOPIAN
279

Anpress 0.5 mg
Anxira 0.5 mg
Anxira 1 mg
Celium 5 mg
Clonaril 1 mg

628 Modurax 5 mg
Trancon 5 mg
629 Vispam 10 mg
Xiemed 0.25 mg
630 Xiemed 1 mg

248
300
022
397
342
377
456
323
108
296

631

V S PHARMA
SUPHONG BHAESAJ

Dizep 2 mg
Dizep 5 mg
Loravan 0.5 mg
Loravan 1 mg
Mixture Tussis
0.45 mL/5 mL x 30 mL
Mixture Tussis
0.45 mL/5 mL x 60 mL
Mixture Tussis
0.45 mL/5 mL x 120 mL

Mixture Tussis
0.45 mL/5 mL x 240 mL

Mixture Tussis
0.45 mL/5 mL x 450 mL

T MAN PHARMA

Chlordiazepoxide
T Man 10 mg
Diazepam T Man 2 mg
Diazepam T Man 5 mg
Manex 0.25 mg
Manex 0.5 mg
Manex 1 mg
Tranpate 5 mg

T O CHEMICALS

Cloraxene 5 5 mg

TEMMLER/FDA

/.

575

Pharnax 0.25 mg
Pharnax 0.5 mg
115 Pharnax 1 mg
486 Phencodin
9 mg/5 mL x 60 mL
Tussidyl
9 mg/5 mL x 60 mL
Vorapam 2 mg
Vorapam 5 mg

576

Monozide-10
10 mg/2 mL x 2 mL

632

171
Regenon Retard 75 mg
190
Regenon Retard 75 mg
302
027
574 THAI P D CHEMICALS

586
589
064
159

VESCO PHARM

577
578

101
247
292

THAIPHARMED 1942

1942
Ditran 2 mg
Ditran 5 mg

373 TORRENT
364
211
099 Alprax 0.25 mg
244
291
416 TRENKER/FDA

Diazepam Vesco 2 mg
325
Diazepam Vesco 5 mg
134
418 Vescopam 10 mg/2 mL x 2 mL 636
476

VIDHYASOM

156 Mist Tussis


0.6 mL/5 mL x 450 mL
Squill and Ammonia Mixture
1.3 mL/10 mL x 450 mL

590
591

/.

Atractil 75 mg
Dietil Retard 75 mg
Phentermine Trenker 15 mg
436 Phentermine Trenker 30 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM

497 WYETH-AYERST/FDA
084
466
424 Loramet 1 mg

-/.

102

Color profile: Disabled


Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX

Registration No. Frame No.

A
Alcelam 0.25 mg
Alcelam 0.5 mg
Alcelam 1 mg
Allam 0.25 mg
Allam 0.5 mg
Allam 1 mg
Alnax 0.25 mg
Alnax 0.5 mg
Alnax 1 mg
Alodorm 5 mg
Alpazam 0.25 mg
Alpazam 0.5 mg
Alpazam 1 mg
Alpralan 0.25 mg
Alpralan 0.5 mg
Alpramed 0.25 mg
Alpramed 0.5 mg
Alpramed 1 mg
Alprax 0.25 mg
Alprax 0.5 mg
Alprax 1 mg
Alprazolam:
- Alcelam 0.25 mg
- Alcelam 0.5 mg
- Alcelam 1 mg
- Allam 0.25 mg
- Allam 0.5 mg
- Allam 1 mg
- Alnax 0.25 mg
- Alnax 0.5 mg
- Alnax 1 mg
- Alpazam 0.25 mg
- Alpazam 0.5 mg
- Alpazam 1 mg
- Alpralan 0.25 mg
- Alpralan 0.5 mg
- Alpramed 0.25 mg
- Alpramed 0.5 mg
- Alpramed 1 mg
- Alprax 0.25 mg
- Alprax 0.5 mg
- Alprax 1 mg
- Alprazolam Frx
0.25 mg

P1A 1/52
P1A 23/49
P1A 24/49
P1A 1/48
P1A 2/48
P1A 3/48
P1A 51/50
P1A 52/50
P1A 47/50
P1A 48/50
P1A 7/48
P1C 1/46
-

097
241
288
103
250
293
087
232
281
078
100
245
246
042
214
252
105
393
156
409
057

P1A 1/52
P1A 23/49
P1A 24/49
P1A 1/48
P1A 2/48
P1A 3/48
P1A 51/50
P1A 52/50
P1A 47/50
P1A 48/50
P1A 7/48
P1C 1/46
-

097
241
288
103
250
293
087
232
281
100
245
246
042
214
252
105
393
156
409
057

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM

109

Registration No. Frame No.

- Alprazolam Frx
0.5 mg
- Anax 0.25 mg
- Anax 0.5 mg
- Anpress 0.25 mg
- Anpress 0.5 mg
- Anpress 1 mg
- Anzion 0.25 mg
- Anzion 0.5 mg
- Anzion 1 mg
- Dizolam 0.25 mg
- Dizolam 0.5 mg
- Dizolam 1 mg
- Farzolam 0.25 mg
- Farzolam 0.5 mg
- Farzolam 1 mg
- Inzolam 0.25 mg
- Inzolam 0.5 mg
- Inzolam 1 mg
- Manex 0.25 mg
- Manex 0.5 mg
- Manex 1 mg
- Marzolam 0.25 mg
- Marzolam 0.5 mg
- Marzolam 1 mg
- Mitranax 0.25 mg
- Mitranax 0.5 mg
- Mitranax 1 mg
- Moxinax 0.25 mg
- Moxinax 0.5 mg
- Pharnax 0.25 mg
- Pharnax 0.5 mg
- Pharnax 1 mg
- Prazol 0.5 mg
- Siampraxol 0.25 mg
- Siampraxol 0.5 mg
- Siampraxol 1 mg
- Sunax 0.25 mg
- Sunax 0.5 mg
- Xalam 0.25 mg
- Xalam 0.5 mg
- Xalam 1 mg
- Xanacine 0.25 mg
- Xanacine 0.5 mg
- Xanacine 1 mg
- Xanax 0.25 mg

P1A 10/51
P1A 9/46
P1A 10/46
P1A 33/50
P1A 4/48
P1A 35/50
P1A 5/48
P1A 15/50
P1A 6/48
P1A 58/50
P1A 59/50
P1A 60/50
P1A 36/51
P1A 21/46
P1A 8/47
P1A 5/47
P1A 42/52
P1A 43/52
P1A 36/50
P1A 37/50
P1A 38/50
P1A 19/49
P1A 20/49
P1A 28/51
P1A 29/51
P1A 30/51
P1A 3/51
P1A 6/52
P1A 7/52
P1A 13/48
P1A 14/48
P1A 15/48
P1C 20/52

256
085
230
088
248
282
086
231
280
089
233
297
092
242
289
104
251
294
099
244
291
090
235
283
106
253
295
094
238
101
247
292
234
098
243
290
107
254
095
239
286
091
236
284
096

Frame Numbers in Bold Italics

Color profile: Disabled


Composite 150 lpi at 45 degrees

72

PN DEX 2010

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

GENERIC & BRAND NAME INDEX

- Xanax 0.5 mg
- Xanax 1 mg
- Xanax XR 0.5 mg
- Xanax XR 1 mg
- Xanax XR 2 mg
- Xiemed 0.25 mg
- Xiemed 0.5 mg
- Xiemed 1 mg
- Zolam 0.25 mg
- Zolam 0.5 mg
- Zolam 1 mg
Alprazolam Frx
0.25 mg
Alprazolam Frx
0.5 mg

Ama 50 mg
Amobarbital:
- Ama 50 mg
Amobarbital Na:
- Amytal 0.5 g
Amytal 0.5 g
Anax 0.25 mg
Anax 0.5 mg
Anpress 0.25 mg
Anpress 0.5 mg
Anpress 1 mg
Anta 0.5 mg
Anta 1 mg
Anta 2 mg
Anxene 5 mg
Anxene 10 mg
Anxielax 5 mg
Anxira 0.5 mg
Anxira 1 mg
Anzion 0.25 mg
Anzion 0.5 mg
Anzion 1 mg
Ativan 0.5 mg
Ativan 1 mg
Ativan 2 mg
Atractil 75 mg
Azepam 2 mg
Azepam 5 mg
A-Zerax 2 mg
A-Zerax 5 mg

P1C 21/52
P1C 22/52
P1C 17/50
P1C 18/50
P1C 19/50
P1A 27/49
P1A 34/50
P1A 28/49
P1A 44/50
P1A 45/50
P1A 46/50

240
287
344
069
353
108
249
296
093
237
285

109

P1A 10/51
P2A 60/43

256
144

P2A 60/43

144

P1A 9/46
P1A 10/46
P1A 33/50
P1A 4/48
P1A 35/50
P1A 29/50
P1A 28/50
P1A 29/52
P1A 24/52
P1A 25/52
P1A 37/52
P1A 38/52

640
640
085
230
088
248
282
304
020
125
430
262
460
300
022
086
231
280
308
028
129
497
219
299
453
463

B
Belladonna Alkaloids With
Phenobarbital 16.2 mg
Bellergal 20 mg
Belloid 30 mg
Benadryl CD 60 mL
Benadryl CD 1000 mL
Benera 20 mg

221
207
124
550
551
404

Registration No. Frame No.


Benpine 5 mg
Benpine 10 mg
Benpine 25 mg

Benylin CD 60 mL

Bluco 10 mg

Blucon 10 mg

Bonadine CD 60 mL
Bromazepam:
- Lexotan 1.5 mg
- Lexotan 3 mg

Bromtussia DC 60 mL

Bronpect 10 mg
Brown Mixture GPO
0.6 mL/5 mL x 180 mL

Brown Mixture GPO


0.6 mL/5 mL x 450 mL
Brown Mixture
Osoth Interlab
0.6 mL/5 mL x 180 mL
Buprenorphine HCl:
- Buprine 0.2 mg
- Temgesic 0.2 mg
- Temgesic
0.3 mg/mL x 1 mL
Buprine 0.2 mg

412
498
194
552
355
332
561

P1C 5/49
P1C 6/49
N2A 1/51

070
228
515
298

N2A 15/45

527

N2A 15/45

528

N2A 7/43

554

002
007

619
002

124

361
276
641

Butobarbital:
- Belloid 30 mg

C
Calmipam 2 mg
Calmipam 5 mg
Calypsol 50 mg/mL x 10 mL

Camphorated Opium Tinct:


- Brown Mixture GPO
0.6 mL/5 mL x 180 mL N2A 15/45
- Brown Mixture GPO
0.6 mL/5 mL x 450 mL N2A 15/45
- Brown Mixture
Osoth Interlab
0.6 mL/5 mL x 180 mL N2A 7/43
- Cough Syrup GPO
0.6 mL/5 mL x 60 mL
- Mist. Scill Ammon. GPO
0.6 mL/5 mL x 180 mL N2A 13/46
- Mist Tussis
0.6 mL/5 mL x 450 mL N2A 14/45
- Mixture Scillae Ammon
2 mL/15 mL x 180 mL
- Mixture Tussis
0.45 mL/5 mL x 30 mL N2A 11/46
- Mixture Tussis
0.45 mL/5 mL x 60 mL N2A 11/46
- Mixture Tussis
0.45 mL/5 mL x 120 mL N2A 11/46
- Mixture Tussis
0.45 mL/5 mL x 240 mL N2A 11/46
- Mixture Tussis
0.45 mL/5 mL x 450 mL N2A 11/46

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM

P1A 8/49
P1A 3/49
P1A 1/49
N2A 12/47
-

527
528
554
530
531
590
557
574
575
576
577
578

Color profile: Disabled


Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

- Mixture Tussis
0.45 mL/5 mL x 1800 mL
- Mixture Tussis
0.45 mL/5 mL x 3600 mL
- Squill and Ammonia Mixture
1.33 mL/10 mL x 450 mL N2A 9/47
Camphorated Opium Tincture
BP 1980
5 mL/100 mL x 1000 mL
N2A 9/45

Cebarax 5 mg
P2A 22/51
Celium 5 mg
P1A 24/51

Cemol Codeine 15 mg
Centrodine CD 10 mg
N2A 11/47
Cexene 5 mg
Cexene 10 mg
Chlordiazepoxide
Acdhon 10 mg
Chlordiazepoxide
Charoen Bhaesaj 10 mg
Chlordiazepoxide HCl:
- Benpine 5 mg
P1A 8/49
- Benpine 10 mg
P1A 3/49
- Benpine 25 mg
P1A 1/49
- Cebarax 5 mg
P2A 22/51
- Chlordiazepoxide
Acdhon 10 mg
- Chlordiazepoxide
Charoen Bhaesaj 10 mg
- Chlordiazepoxide
March Pharma 25 mg P1A 13/44
- Chlordiazepoxide
T Man 10 mg
P1A 4/51
- Chlordibrax 5 mg
- Chlordixide 5 mg
P1A 9/51
- Chlordixide 10 mg
P1A 26/51
- Chlorzep 5 mg
- Comoben 5 mg
P1A 30/49
- Comoben 10 mg
P1A 31/49
- Cozep 10 mg
P1A 3/50
- Cozep 25 mg
P1A 4/50
- Dirax 5 mg
P2A 4/46
- Epoxide 10 mg
- Epoxide 25 mg
- Kenspa 5 mg
P2A 36/52
- Librax 5 mg
P2A 85/43
- Licon 5 mg
- Med-Zepoxide 5 mg
- Med-Zepoxide 10 mg
- Metaxide 10 mg
P1A 7/51
- Minoxide 10 mg
P1A 47/44
- Modurax 5 mg
P2A 46/44
- Pobrax 5 mg
- Pondnebium 5 mg
P1A 13/49
- Pondnebium 10 mg
- Radibrax 5 mg
- Tumax 5 mg
P2A 25/51
- Utorax 5 mg
-

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM

Registration No. Frame No.

579
580
591

529
380
397
072
225
450
273
501
500
412
498
194
380
501
500
467
373
382
358
195
359
362
491
138
181
385
187
193
223
381
379
468
053
481
477
377
376
371
192
392
400
383

73

- Zepobrax 5 mg
- Zepoxide 5 mg
- Zepoxide 10 mg
- Zepoxin 5 mg
- Zepoxin 10 mg
Chlordiazepoxide
March Pharma 25 mg
Chlordiazepoxide
T Man 10 mg

Chlordibrax 5 mg
Chlordixide 5 mg
Chlordixide 10 mg
Chlorzep 5 mg

Clinepect 10 mg

Clinopect 10 mg

Clinopront 10 mg
Clobazam:
- Frisium 5 mg

- Frisium 10 mg
Clonaril 1 mg

P1A 3/44
-

384
413
279
205
118

P1A 13/44

467

P1A 4/51
P1A 9/51
P1A 26/51
N2A 1/50

373
382
358
195
359
495
196
378

P1C 25/49,
P1B 26/49
P1A 15/51

043
037
342

Clonazepam:
- Clonaril 1 mg
- Povanil 0.5 mg
- Povanil 2 mg
- Prenarpil 0.5 mg
- Prenarpil 1 mg
- Prenarpil 2 mg
- Rivotril 0.5 mg
- Rivotril
1 mg/mL x 1 mL
- Rivotril 2 mg
Cloramed 5 mg
Cloramed 10 mg
Cloraxene 5 5 mg
Cloraze 5 mg
Cloraze 10 mg

P1A 15/51
P1A 33/52
P1A 34/52
P1A 30/52
P1A 31/52
P1A 32/52
P1C 7/49

342
186
067
407
337
054
408

P1C 17/48
P1A 4/49
P1A 32/51
-

637
055
429
264
436
433
266

Clorazepate Dipotassium:
- Anxene 5 mg
- Anxene 10 mg
- Anxielax 5 mg
- Cexene 5 mg
- Cexene 10 mg
- Cloramed 5 mg
- Cloramed 10 mg
- Cloraxene 5 5 mg
- Cloraze 5 mg
- Cloraze 10 mg
- Clozene 5 mg
- Clozene 10 mg
- Clozepate 5 mg
- Conzep 5 mg
- Conzep 10 mg
- Deda 5 mg
- Deda 10 mg

P1A 4/49
P1A 32/51
P1A 14/46
P1A 15/46

430
262
460
450
273
429
264
436
433
266
421
452
442
454
420
437
265

Frame Numbers in Bold Italics

GENERIC & BRAND NAME INDEX

PN DEX 2010

Color profile: Disabled


Composite 150 lpi at 45 degrees

74

PN DEX 2010

GENERIC & BRAND NAME INDEX

GENERIC & BRAND NAME INDEX

Registration No. Frame No.

- Diposef 5 mg
- Diposef 10 mg
- Dipot 5 mg
- Dopam 5 mg
- Exan 5 mg
- Exan 10 mg
- Flulium 5 mg
- Flulium 10 mg
- Frexene 5 mg
- Frexene 10 mg
- Gaxene 5 mg
- Manotran 5 mg
- Manotran 10 mg
- Polizep 5 mg
- Polizep 10 mg
- Pomadom 5 mg
- Pomadom 10 mg
- Posene 5 mg
- Posene 10 mg
- Sanor 5 mg
- Sanor 10 mg
- Serene
Masa Lab 10 mg
- Serene
V S Pharma 5 mg
- Tamylab-S 5 mg
- Tenmed 5 mg
- Tenmed 10 mg
- T-Five 5 mg
- Tranadon-S 5 mg
- Trancap 5 mg
- Trancap 10 mg
- Tranclor 5 mg
- Tranclor 10 mg
- Trancon 5 mg
- Trancon 10 mg
- Tranmed 5 mg
- Tranmed 10 mg
- Tranpate 5 mg
- Tranpon 5 mg
- Transpon Forte
10 mg
- Tranxene 5 mg
- Tranxene 10 mg
- Tranzep 5 mg
- Uptran 10 mg
- Upzene 5 mg
- Zetran 5 mg
Clozene 5 mg
Clozene 10 mg
Clozepate 5 mg

Cocet 15 mg

Co-Cof 10 mg

Codee-C 10 mg
Codeine GPO 15 mg

P1A 40/52
P1A 23/50
P1A 2/46
-

427
260
432
133
489
492
443
274
415
419
448
435
263
444
268
455
423
172
402
426
258

259

P1A 54/42
P1A 55/42
P1A 27/42
P1A 4/44
P1A 39/52
P1A 61/43
-

431
445
440
269
446
447
470
173
439
272
456
422
428
261
416
441
257

P1A 16/46
N2A 6/51
N2A 5/45
-

438
271
434
267
490
449
421
452
442
071
165
388
004

Registration No. Frame No.


Codeine GPO 30 mg
Codeine Phosphate (Analgesic):
- Cemol Codeine 15 mg
- Cocet 15 mg
- Codeine GPO 15 mg
- Codeine GPO 30 mg
N1A 1/52
- Codicet 15 mg
N2A 10/51
- Codicet Blue 15 mg
- Codicet Pink 15 mg
N2A 3/50
- Codigesic 15 mg
- Cotenol 15 mg
- Masapara With Codeine
15 mg
N2A 5/50
- Nasa With Codeine
15 mg
N2A 4/51
- Pacogesic 8 mg
N2A 7/42
- Para-Co 15 mg
N2A 2/50
- Paradeine 15 mg
- Paradyl 8 mg
- Paragen Co 15 mg
- Paramed-Co 15 mg
- Parcod 15 mg
N2A 4/50
- Parcono 8 mg
- Tylenol With Codeine
15 mg
N2A 6/43
- Tylenol With Codeine
30 mg
N2A 11/43
Codeine Phosphate (Antitussive):
- Benadryl CD 60 mL
- Benadryl CD 1000 mL
- Benylin CD 60 mL
N2A 12/47
- Bluco 10 mg
- Blucon 10 mg
- Bonadine CD 60 mL
- Bromtussia DC 60 mL
N2A 1/51
- Bronpect 10 mg
- Centrodine CD 10 mg N2A 11/47
- Clinepect 10 mg
- Clinopect 10 mg
N2A 1/50
- Clinopront 10 mg
N2A 6/51
- Co-Cof 10 mg
N2A 5/45
- Codee-C 10 mg
N2A 4/52
- Codepect 10 mg
N2A 4/47
- Codesia 10 mg
- Codesia
10 mg/5 mL x 60 mL
N2A 3/47
- Codyl Cough
9 mg/5 mL x 60 mL
N2A 6/50
- Codyl Cough
9 mg/5 mL x 100 mL
N2A 6/50
- Codyl Cough
9 mg/5 mL x 1000 mL
- Codyl Cough
9 mg/5 mL x 4500 mL
- Cofcodyl Cough 60 mL
- Cofcodyl Cough 100 mL

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

018
072
071
004
018
414
352
255
112
073
410
080
189
347
074
083
113
395
077
079
075
076
550
551
552
355
332
561
515
298
225
495
196
378
165
388
202
391
516
540
541
542
543
521
522

Color profile: Disabled


Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

- Comodine Cough 60 mL
- Conadyl 60 mL
- Corynil 10 mg
- Cosedyl Cough Linctus
60 mL
- Decos
9 mg/5 mL x 100 mL
N2A 8/51
- Dimetane Expectorant DC
2.5 L
- Hisedyl 60 mL
- Hisedyl 120 mL
- Mantadyl Cough 60 mL
- Masadyl Cough 60 mL
- Masadyl Cough 100 mL
- Masadyl Cough 240 mL
- Mila-Cono 60 mL
N2A 7/47
- Mila-Tercon 8 mg
- Neo Cough 60 mL
- Neo Cough 100 mL
- Neo Cough 240 mL
- Neocod 10 mg
- Neo-Codein 10 mg
- Neocof 10 mg
- Neo-Cophen 10 mg
N2A 10/46
- Neopect 10 mg
- Nordyl Linctus
9 mg/5 mL x 100 mL
N2C 3/51
- Nordyl Linctus
9 mg/5 mL x 500 mL
- Nortuss Linctus
100 mL
- Nortuss Linctus
500 mL
- P-Codyl
9 mg/5 mL x 60 mL
- P-Codyl
9 mg/5 mL x 120 mL
- Percidyl Cough 100 mL
- Phencodin
9 mg/5 mL x 60 mL
N2A 10/43
- Phencodin
9 mg/5 mL x 500 mL
- Phencodin
9 mg/5 mL x 1000 mL
- Phensedyl
9 mg/5 mL x 100 mL
N2A 8/43
- Phensodi 60 mL
- Phensodi 120 mL
- Phensodi 1000 mL
- Poly-Cof Syrup
9 mg/5 mL x 60 mL
N2A 5/51
- Poly-Cof Syrup
9 mg/5 mL x 100 mL
N2A 5/51
- Polydine CD 10 mg
- Pondnadyl
9 mg/5 mL x 60 mL
N2A 3/48
- Pondnadyl
9 mg/5 mL x 100 mL
N2A 3/48

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

507
583
200
582
572
592
555
556
581
534
535
536
546
167
537
538
539
345
346
188
198
199
566
567
568
569
558
559
562
586
587
588
553
524
525
526
548
549
270
563
564

75

Registration No. Frame No.

- Pondnadyl
9 mg/5 mL x 1000 mL
- Rolar 10 mg
- Ropect 10 mg
- Rotuss 10 mg
- Seco 10 mg
- Tenadrin-C 60 mL
- Teradene 60 mL
- Teradyl Syrup 60 mL
- Teradyl Syrup 1000 mL
- Terco-C 10 mg
- Tocodyl 10 mg
- Tussidyl
9 mg/5 mL x 60 mL
- Zorituss 10 mg
Codeine Resinate:
- Codipront 30 mg
- Codipront 30 mg
- Codipront 60 mL
Codepect 10 mg
Codesia 10 mg
Codesia
10 mg/5 mL x 60 mL
Codicet 15 mg
Codicet Blue 15 mg
Codicet Pink 15 mg
Codigesic 15 mg
Codipront 30 mg
Codipront 30 mg
Codipront 60 mL
Codyl Cough
9 mg/5 mL x 60 mL
Codyl Cough
9 mg/5 mL x 100 mL

Codyl Cough
9 mg/5 mL x 1000 mL
Codyl Cough
9 mg/5 mL x 4500 mL
Cofcodyl Cough 60 mL

Cofcodyl Cough 100 mL


Comoben 5 mg
Comoben 10 mg
Comodine Cough 60 mL
Conadyl 60 mL
Concerta 18 mg
Concerta 36 mg
Conzep 5 mg
Conzep 10 mg
Corynil 10 mg
Cosedyl Cough Linctus
60 mL
Cotenol 15 mg
Cough Syrup GPO
0.6 mL/5 mL x 60 mL
Cozep 10 mg
Cozep 25 mg

N2A 3/52
N2C 12/46
N2C 9/46
N2A 2/47
N2A 1/49
-

565
203
201
204
389
519
520
532
533
387
390

N2A 6/45
-

589
197

N2A 9/51
N2A 4/52
N2A 4/47

493
494
593
202
391

N2A 3/47
N1A 1/52
N2A 10/51
N2A 3/50
N2A 9/51
-

516
414
352
255
112
493
494
593

N2A 6/50

540

N2A 6/50

541

542

P1A 30/49
P1A 31/49
-

543
521
522
362
491
507
583
169
114
454
420
200
582

P1A 3/50
P1A 4/50

073
530
138
181

Frame Numbers in Bold Italics

GENERIC & BRAND NAME INDEX

PN DEX 2010

Color profile: Disabled


Composite 150 lpi at 45 degrees

76

Registration No. Frame No.

D
Dalmadorm 15 mg
Davol 32.5 mg

Decos
9 mg/5 mL x 100 mL
Deda 5 mg
Deda 10 mg

N2A 8/51
P1A 14/46
P1A 15/46

GENERIC & BRAND NAME INDEX

Dextropropoxyphene HCl:
- Davol 32.5 mg
Dextropropoxyphene Napsylate:
- Pardex 32.5 mg
Diadon 5 mg
Diamed 2 mg
P1A 9/49
Diamed 5 mg
P1A 10/49
Diano 2 mg
P1A 9/48
Diano 5 mg
P1A 10/48
Diapam 2 mg
P1A 5/51
Diapam 5 mg
P1A 6/51
Diapine 2 mg
P1A 13/50
Diapine 2 mg
P1A 12/50
Diapine 5 mg
P1A 11/51
Diapine 5 mg
P1A 14/50
Diapine
5 mg/mL x 1 mL
P1A 21/51
Diapine 10 mg
P1A 18/49
Diapine
10 mg/2 mL x 2 mL
P1A 21/51
Diaz 2 mg
Diaz 5 mg
Diaz 10 mg
Diaza 2 mg
Diaza 5 mg
Diaza
10 mg/2 mL x 2 mL
Diazepam:
- Azepam 2 mg
- Azepam 5 mg
- A-Zerax 2 mg
- A-Zerax 5 mg
- Calmipam 2 mg
- Calmipam 5 mg
- Diadon 5 mg
- Diamed 2 mg
- Diamed 5 mg
- Diano 2 mg
- Diano 5 mg
- Diapam 2 mg
- Diapam 5 mg
- Diapine 2 mg
- Diapine 2 mg
- Diapine 5 mg
- Diapine 5 mg
- Diapine
5 mg/mL x 1 mL

PN DEX 2010

GENERIC & BRAND NAME INDEX

478
275
572
437
265
275
116
349
503
482
015
140
369
329
010
473
166
484
600
386
601
061
157
341
338
153
625

P1A 37/52
P1A 38/52
P1A 9/49
P1A 10/49
P1A 9/48
P1A 10/48
P1A 5/51
P1A 6/51
P1A 13/50
P1A 12/50
P1A 11/51
P1A 14/50

219
299
453
463
361
276
349
503
482
015
140
369
329
010
473
166
484

P1A 21/51

600

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

Registration No. Frame No.

- Diapine 10 mg
- Diapine
10 mg/2 mL x 2 mL
- Diaz 2 mg
- Diaz 5 mg
- Diaz 10 mg
- Diaza 2 mg
- Diaza 5 mg
- Diaza
10 mg/2 mL x 2 mL
- Diazepam Acdhon 2 mg
- Diazepam
BJ Benjaosoth 2 mg
- Diazepam
BJ Benjaosoth 5 mg
- Diazepam
BJ Benjaosoth 10 mg
- Diazepam
Charoen Bhaesaj 2 mg
- Diazepam
General Drugs House
2 mg
- Diazepam
General Drugs House
5 mg
- Diazepam GPO 2 mg
- Diazepam GPO 5 mg
- Diazepam GPO 10 mg
- Diazepam GPO
10 mg/2 mL x 2 mL
- Diazepam
H K Pharm 2 mg
- Diazepam
H K Pharm 5 mg
- Diazepam
H K Pharm 10 mg
- Diazepam
Lerd Singh 2 mg
- Diazepam
Lerd Singh 5 mg
- Diazepam
Ponds Chemical 2 mg
- Diazepam
Ponds Chemical 5 mg
- Diazepam
Ponds Chemical 5 mg
- Diazepam
Samakeephaesaj 2 mg
- Diazepam
Samakeephaesaj 5 mg
- Diazepam
Sommai Bhaesaj 5 mg
- Diazepam T Man 2 mg
- Diazepam T Man 5 mg
- Diazepam T Man 5 mg
- Diazepam T Man 10 mg
- Diazepam
T P Drug 2 mg
- Diazepam
T P Drug 5 mg

P1A 18/49

386

P1A 21/51
-

601
061
157
341
338
153

625
472

P1A 13/52

050

P1A 14/52

374

P1A 15/52

222

333

P1A 14/49

318

P1A 24/50
-

148
052
149
334

603

P1A 32/49

218

P1A 33/49

160

P1A 34/49

343

P1A 49/50

066

P1A 50/50

161

P1A 32/45

367

P1A 33/45

162
216

363

142

P1A 12/52
P1A 62/44
-

320
364
163
211
327

017

155

Color profile: Disabled


Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

- Diazepam T P Drug
10 mg
- Diazepam T P Drug
10 mg/2 mL x 2 mL
- Diazepam Vesco 2 mg
- Diazepam Vesco 5 mg
- Diazepion 2 mg
- Diazepion 5 mg
- Diazepion 10 mg
- Dilium 2 mg
- Dilium 5 mg
- Dimed 2 mg
- Dimed 5 mg
- Dipam 2 mg
- Dipam 5 mg
- Dipam 10 mg
- Ditran 2 mg
- Ditran 5 mg
- Divopan 2 mg
- Divopan 5 mg
- Dizan 2 mg
- Dizan 5 mg
- Dizep 2 mg
- Dizep 5 mg
- Dizepam 2 mg
- Dizepam 5 mg
- DZP2 2 mg
- Laylium-10
10 mg/2 mL x 2 mL
- Manodiazo 2 mg
- Manodiazo 5 mg
- Manodiazo 10 mg
- Manolium
10 mg/2 mL x 2 mL
- Med-Zepam 2 mg
- Med-Zepam 5 mg
- Monozide 2 mg
- Monozide-10
10 mg/2 mL x 2 mL
- Pam-5 5 mg
- Popam 2 mg
- Popam 5 mg
- Ropam 5 mg
- Ropam
10 mg/2 mL x 2 mL
- S.Co Zepam 5 mg
- Sipam 2 mg
- Sipam 5 mg
- Sipam 10 mg
- Sipam
10 mg/2 mL x 2 mL
- Stesolid 2 mg
- Stesolid 5 mg
- Stesolid 10 mg
- Tranolan 2 mg
- Tranolan 5 mg

340

P1A 27/51
P1A 53/50
P1A 54/50
P1A 8/50
P1A 61/50
P1A 11/48
P1A 12/48
P1A 5/50
P1A 6/50
P1A 21/49
P1A 22/49
-

627
325
134
480
474
191
178
326
068
164
040
137
330
418
476
049
146
457
417
171
190
224
151
471

P1A 83/43
P1A 84/43
P1A 23/51

635
469
502
335

P1A 12/49
-

613
039
336
496

P1A 37/49
-

632
206
111
170
158

P1A 13/45
P1A 15/49
P1A 16/49
P1A 17/49

608
220
056
154
339

P1A 39/50
P1A 42/50
P1A 43/50

626
401
485
479
130
177

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

77

Registration No. Frame No.

- Tranolan
10 mg/2 mL x 2 mL
- V Day Zepam 2 mg
- V Day Zepam 5 mg
- V Day Zepam
10 mg/2 mL x 2 mL
- V Day Zepam NL
10 mg/2 mL x 2 mL
- Valax 2 mg
- Valax 5 mg
- Valax 10 mg
- Valenium 2 mg
- Valenium 5 mg
- Valium 5 mg
- Valium
10 mg/2 mL x 2 mL
- Vason 2 mg
- Vescopam
10 mg/2 mL x 2 mL
- Vispam 2 mg
- Vispam 5 mg
- Vispam 10 mg
- Vomed 2 mg
- Vomed 5 mg
- Vorapam 2 mg
- Vorapam 5 mg
- Winopam 2 mg
- Winopam 5 mg
- Zepam 2 mg
- Zepam 5 mg
- Zepam
10 mg/2 mL x 2 mL
- Zepaxid 2 mg
- Zepaxid 5 mg
- Zepaxid
10 mg/2 mL x 2 mL
- Zopam 2 mg
- Zopam 5 mg
- Zopam 10 mg
Diazepam Acdhon 2 mg
Diazepam
BJ Benjaosoth 2 mg
Diazepam
BJ Benjaosoth 5 mg
Diazepam
BJ Benjaosoth 10 mg
Diazepam
Charoen Bhaesaj 2 mg
Diazepam
General Drugs House
2 mg
Diazepam
General Drugs House
5 mg
Diazepam GPO 2 mg
Diazepam GPO 5 mg
Diazepam GPO 10 mg

P1A 41/52
P1A 88/42
P1A 89/42

615
475
465

P2A 82/43

616

P1A 11/46
-

617
031
132
322
065
150
152

P1A 16/48

620
396

P1A 7/50
P1A 16/50
P1A 40/50
P1A 41/50
-

636
366
213
323
059
147
064
159
063
375
399
354

P1A 20/50
P1A 21/50

614
506
462

P1A 32/50
P1A 35/49
P1A 36/49
P1A 3/46
-

634
048
145
331
472

P1A 13/52

050

P1A 14/52

374

P1A 15/52

222

333

P1A 14/49

318

P1A 24/50
-

148
052
149
334

Frame Numbers in Bold Italics

GENERIC & BRAND NAME INDEX

PN DEX 2010

Color profile: Disabled


Composite 150 lpi at 45 degrees

78

PN DEX 2010

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

Diazepam GPO
10 mg/2 mL x 2 mL
Diazepam
H K Pharm 2 mg
Diazepam
H K Pharm 5 mg
Diazepam
H K Pharm 10 mg
Diazepam
Lerd Singh 2 mg
Diazepam
Lerd Singh 5 mg
Diazepam
Ponds Chemical 2 mg
Diazepam
Ponds Chemical 5 mg
Diazepam
Ponds Chemical 5 mg
Diazepam
Samakeephaesaj 2 mg
Diazepam
Samakeephaesaj 5 mg
Diazepam
Sommai Bhaesaj 5 mg
Diazepam T Man 2 mg
Diazepam T Man 5 mg
Diazepam T Man 5 mg
Diazepam T Man 10 mg
Diazepam T P Drug 2 mg
Diazepam T P Drug 5 mg
Diazepam T P Drug 10 mg
Diazepam T P Drug
10 mg/2 mL x 2 mL
Diazepam Vesco 2 mg
Diazepam Vesco 5 mg
Diazepion 2 mg
Diazepion 5 mg
Diazepion 10 mg

GENERIC & BRAND NAME INDEX

Diethylpropion HCl:
- Dietil Retard 75 mg

- Prefamone 75 mg
- Regenon Retard 75 mg
- Regenon Retard 75 mg
Diethylpropion Resinate:
- Atractil 75 mg
Dietil Retard 75 mg
Dilium 2 mg
Dilium 5 mg
Dilomil 2.5 mg
Dimed 2 mg
Dimed 5 mg

Dimetane Expectorant DC
2.5 L
Dipam 2 mg
Dipam 5 mg
Dipam 10 mg

603

P1A 32/49

218

P1A 33/49

160

P1A 34/49

343

P1A 49/50

066

P1A 50/50

161

P1A 32/45

367

162

P1A 33/45

216

363

142

P1A 12/52
P1A 62/44
-

320
364
163
211
327
017
155
340

P1A 27/51
P1A 53/50
P1A 54/50
-

627
325
134
480
474
191

084
174
115
486

497
084
178
326
001
068
164

592
040
137
330

Registration No. Frame No.


Diphenoxylate HCl:
- Dilomil 2.5 mg
- Ditropine 2.5 mg
- Lomotil 2.5 mg
- Spasil 2.5 mg
Diposef 5 mg
Diposef 10 mg
Dipot 5 mg

Dirax 5 mg
Ditran 2 mg
Ditran 5 mg
Ditropine 2.5 mg
Divopan 2 mg
Divopan 5 mg
Dizan 2 mg
Dizan 5 mg
Dizep 2 mg
Dizep 5 mg
Dizepam 2 mg
Dizepam 5 mg
Dizolam 0.25 mg
Dizolam 0.5 mg
Dizolam 1 mg

D-Norpseudoephedrine HCl:
- Mirapront N 20 mg
D-Norpseudoephedrine Resinate:
D-Norpseudoephedrine SR
Osmopharm 20 mg
D-Norpseudoephedrine SR
Osmopharm 20 mg
Domar 5 mg
P1A 5/52

Donnatal 16.2 mg
Dopam 5 mg
Dormicum
5 mg/mL x 1 mL
Dormicum 15 mg
Dormicum
15 mg/3 mL x 3 mL
Durogesic
25 mcg/hr x 2.5 mg
Durogesic
50 mcg/hr x 5 mg
Durogesic
100 mcg/hr x 10 mg
Duromine 15 mg
Duromine 30 mg
DZP2 2 mg
-

001
008
006
009
427
260
432
385
418
476
008
049
146
457
417
171
190
224
151
089
233
297
504

505
505
464
060
133
621
351
622
651
652
653
499
488
471

E
Elixir Phenobarb 60 mL
Ephedrine GPO
30 mg/mL x 1 mL
Ephedrine HCl:
- Ephedrine GPO
30 mg/mL x 1 mL
Epoxide 10 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

N2A 4/48
N2A 2/51
P1A 40/52
P2A 4/46
P1A 8/50
P1A 61/50
P1A 11/48
P1A 12/48
P1A 5/50
P1A 6/50
P1A 21/49
P1A 22/49
P1A 5/48
P1A 15/50
P1A 6/48

573

604

604
187

Color profile: Disabled


Composite 150 lpi at 45 degrees

PN DEX 2010

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

Epoxide 25 mg

193

Ethyl Loflazepate:
- Meilax 1 mg
- Meilax 2 mg
- Victan 2 mg
Euhypnos 20 20 mg
Exan 5 mg
Exan 10 mg

021
176
182
398
489
492

092
242
289

651

652

653
645
646
647
648
649
650

598

599

598

599

605

606

623

644
645
646
647
648
649
650

605

606

623

Fentanyl:
- Durogesic
25 mcg/hr x 2.5 mg
- Durogesic
50 mcg/hr x 5 mg
- Durogesic
100 mcg/hr x 10 mg
- Fentanyl GPO 12 mcg/hr
- Fentanyl GPO 25 mcg/hr
- Fentanyl GPO 50 mcg/hr
- Fentanyl Hexal 12 mcg/hr
- Fentanyl Hexal 25 mcg/hr
- Fentanyl Hexal 50 mcg/hr
Fentanyl Antigen
0.05 mg/mL x 2 mL
Fentanyl Antigen
0.05 mg/mL x 10 mL
Fentanyl Citrate:
- Fentanyl Antigen
0.05 mg/mL x 2 mL
- Fentanyl Antigen
0.05 mg/mL x 10 mL
- Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
- Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL
- Fentanyl Sandoz
0.05 mg/mL x 2 mL
- Fentanyl Sandoz
0.05 mg/mL x 10 mL
Fentanyl GPO 12 mcg/hr
Fentanyl GPO 25 mcg/hr
Fentanyl GPO 50 mcg/hr
Fentanyl Hexal 12 mcg/hr
Fentanyl Hexal 25 mcg/hr
Fentanyl Hexal 50 mcg/hr
Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL
Fentanyl Sandoz
0.05 mg/mL x 2 mL

Registration No. Frame No.


Fentanyl Sandoz
0.05 mg/mL x 10 mL
Flulium 5 mg
Flulium 10 mg

644
443
274

Flunitrazepam:
- Rohypnol 1 mg

394

Flurazepam:
- Dalmadorm 15 mg
Fortwin 30 mg/mL x 1 mL
Frexene 5 mg
Frexene 10 mg
Frisium 5 mg

P1C 25/49,
P1B 26/49
-

Frisium 10 mg

478
618
415
419
043
037

G
Gardenal 200 mg/4 mL
Gaxene 5 mg
Grandaxin 50 mg

P1C 1/50
P1C 27/50

638
448
051

H
Halcion 0.25 mg
Hawkcopax 0.5 mg
Hawkcopax 1 mg
Hisedyl 60 mL
Hisedyl 120 mL

P1A 8/51
-

350
321
365
555
556

P1A 58/50
P1A 59/50
P1A 60/50

104
251
294

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

Inzolam 0.25 mg
Inzolam 0.5 mg
Inzolam 1 mg

K
Kapanol 20 mg
Kapanol 50 mg
Kapanol 100 mg
Kemora 0.5 mg
P1A 18/47
Kemora 1 mg
P1A 21/47

Kenspa 5 mg
P2A 36/52
Keta-Hameln
50 mg/mL x 10 mL
Ketalar 50 mg/mL x 10 mL
Ketamine HCl:
- Calypsol
50 mg/mL x 10 mL

- Keta-Hameln
50 mg/mL x 10 mL
- Ketalar 50 mg/mL x 10 mL

119
120
121
411
024
223
642
643

641

642
643

Frame Numbers in Bold Italics

GENERIC & BRAND NAME INDEX

Farzolam 0.25 mg
Farzolam 0.5 mg
Farzolam 1 mg

79

Color profile: Disabled


Composite 150 lpi at 45 degrees

80

PN DEX 2010

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

GENERIC & BRAND NAME INDEX

L
Laylium-10
10 mg/2 mL x 2 mL
Lexotan 1.5 mg
Lexotan 3 mg

Librax 5 mg

Licon 5 mg
Lizavan 0.5 mg
Lizavan 1 mg
Lomotil 2.5 mg
Lonza 0.5 mg
Lonza 1 mg
Lora 0.5 mg
Lora 1 mg
Lora 2 mg
Lora-P 0.5 mg
Lora-P 1 mg
Lora-P 2 mg
Loramed 0.5 mg
Loramed 1 mg
Loramed 2 mg
Loramet 1 mg
Lorapam 0.5 mg
Lorapam 1 mg
Lorapam 2 mg
Lorapine 0.5 mg
Lorapine 1 mg
Loravan 0.5 mg
Loravan 1 mg
Lorazene 0.5 mg
Lorazene 1 mg
Lorazene 2 mg
Lorazep 0.5 mg
Lorazep 1 mg
Lorazep 2 mg

P1C 5/49
P1C 6/49
P2A 85/43
N2A 4/48
P1A 11/49
P1A 18/48
P1A 17/51
P1A 18/51
P1A 19/51
P1A 23/47
P1A 22/50
P1A 2/49
P1A 17/47
P1A 20/47
P1A 22/47

635
070
228
381
379
305
023
006
313
019
368
036
217
319
016
123
306
025
210
102
311
026
128
314
035
302
027
301
013
127
309
003
357

Lorazepam:
- Anta 0.5 mg
- Anta 1 mg
- Anta 2 mg
- Anxira 0.5 mg
- Anxira 1 mg
- Ativan 0.5 mg
- Ativan 1 mg
- Ativan 2 mg
- Hawkcopax 0.5 mg
- Hawkcopax 1 mg
- Kemora 0.5 mg
- Kemora 1 mg
- Lizavan 0.5 mg
- Lizavan 1 mg
- Lonza 0.5 mg
- Lonza 1 mg
- Lora 0.5 mg

P1A 29/50
P1A 28/50
P1A 29/52
P1A 24/52
P1A 25/52
P1A 8/51
P1A 18/47
P1A 21/47
P1A 11/49
P1A 18/48
P1A 17/51

304
020
125
300
022
308
028
129
321
365
411
024
305
023
313
019
368

Registration No. Frame No.

- Lora 1 mg
- Lora 2 mg
- Lora-P 0.5 mg
- Lora-P 1 mg
- Lora-P 2 mg
- Loramed 0.5 mg
- Loramed 1 mg
- Loramed 2 mg
- Lorapam 0.5 mg
- Lorapam 1 mg
- Lorapam 2 mg
- Lorapine 0.5 mg
- Lorapine 1 mg
- Loravan 0.5 mg
- Loravan 1 mg
- Lorazene 0.5 mg
- Lorazene 1 mg
- Lorazene 2 mg
- Lorazep 0.5 mg
- Lorazep 1 mg
- Lorazep 2 mg
- Lorazepam
Acdhon 0.5 mg
- Lorazepam
Acdhon 1 mg
- Lorazepam
Macrophar 1 mg
- Lorazin 0.5 mg
- Lorazin 1 mg
- Lorazin 2 mg
- Lozepam 0.5 mg
- Lozepam 1 mg
- Ora 0.5 mg
- Ora 1 mg
- Ora 2 mg
- Pora 0.5 mg
- Pora 1 mg
- Pora 2 mg
- Razepam 0.5 mg
- Razepam 1 mg
- Razepam 2 mg
- Tranavan 0.5 mg
- Tranavan 1 mg
- Vemed 0.5 mg
- Zeda 0.5 mg
- Zeda 1 mg
- Zora 0.5 mg
- Zora 2 mg
Lorazepam
Acdhon 0.5 mg
Lorazepam
Acdhon 1 mg
Lorazepam
Macrophar 1 mg
Lorazin 0.5 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

P1A 18/51
P1A 19/51
P1A 23/47
P1A 22/50
P1A 2/49
P1A 17/47
P1A 20/47
P1A 22/47

036
217
319
016
123
306
025
210
311
026
128
314
035
302
027
301
013
127
309
003
357

317

033

P1A 28/45
P1A 29/45
P1A 30/45
P1A 12/51
P1A 13/51
P1A 3/52
P1A 4/52
P1A 8/52
P1A 9/52
P1A 25/50
P1A 26/50

372
324
044
227
303
405
310
030
212
370
139
215
315
032
131
307
034
316
014
360
328
179

317

033

P1A 28/45

372
324

Color profile: Disabled


Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

Lorazin 1 mg
Lorazin 2 mg

P1A 29/45
P1A 30/45

044
227

102
303
405

Lormetazepam:
- Loramet 1 mg
Lozepam 0.5 mg
Lozepam 1 mg

M
Manex 0.25 mg
Manex 0.5 mg
Manex 1 mg
Manodiazo 2 mg
Manodiazo 5 mg
Manodiazo 10 mg
Manolium
10 mg/2 mL x 2 mL
Manotran 5 mg
Manotran 10 mg
Mantadyl Cough 60 mL
Marzolam 0.25 mg
Marzolam 0.5 mg
Marzolam 1 mg
Masadyl Cough 60 mL
Masadyl Cough 100 mL
Masadyl Cough 240 mL
Masapara With Codeine
15 mg
Medazepam:
- Celium 5 mg
- Medazine 5 mg
- Medazine 10 mg
Medazine 5 mg
Medazine 10 mg
Med-Zepam 2 mg
Med-Zepam 5 mg
Med-Zepoxide 5 mg
Med-Zepoxide 10 mg
Meilax 1 mg
Meilax 2 mg
Menobarb 60 mg
Menobarb Elixir
15 mg/5 mL x 60 mL
Menobarb-20 Elixir
20 mg/5 mL x 60 mL
Meprobamate:
- Reinbamate 400 mg
Metaxide 10 mg
Methadone GPO 5 mg
Methadone GPO
10 mg/mL x 1000 mL
Methadone HCl:
- Methadone GPO 5 mg
- Methadone GPO
10 mg/mL x 1000 mL

P1A 36/51
P1A 21/46
P1A 8/47
P1A 83/43
P1A 84/43
P1A 23/51

099
244
291
469
502
335

P1A 12/49
P1A 5/47
P1A 42/52
P1A 43/52
-

613
435
263
581
090
235
283
534
535
536

N2A 5/50

410

P1A 24/51
P1A 30/50
P1A 31/50
P1A 30/50
P1A 31/50
-

397
487
483
487
483
039
336
468
053
021
176
185

544

545

P1A 7/51
-

082
481
126

596

126

596

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

81

Registration No. Frame No.


Methylphenidate HCl:
- Concerta 18 mg
- Concerta 36 mg
- Methylphenidate
Hexal 10 mg
- Ritalin 10 mg
- Rubifen 10 mg
Methylphenidate
Hexal 10 mg
Midazolam:
- Dormicum
5 mg/mL x 1 mL
- Dormicum 15 mg
- Dormicum
15 mg/3 mL x 3 mL

Mila-Cono 60 mL
Mila-Tercon 8 mg
Minoxide 10 mg
Mirapront N 20 mg
Mist Tussis
0.6 mL/5 mL x 450 mL
Mist. Scill Ammon. GPO
0.6 mL/5 mL x 180 mL
Mitranax 0.25 mg
Mitranax 0.5 mg
Mitranax 1 mg

Mixture Scillae Ammon


2 mL/15 mL x 180 mL
Mixture Tussis
0.45 mL/5 mL x 30 mL
Mixture Tussis
0.45 mL/5 mL x 60 mL
Mixture Tussis
0.45 mL/5 mL x 120 mL

Mixture Tussis
0.45 mL/5 mL x 240 mL
Mixture Tussis
0.45 mL/5 mL x 450 mL
Mixture Tussis
0.45 mL/5 mL x 1800 mL
Mixture Tussis
0.45 mL/5 mL x 3600 mL

Modurax 5 mg
Mogadon 5 mg
Monozide 2 mg
Monozide-10
10 mg/2 mL x 2 mL

169
114

117
041
038

117

621
351

N2A 7/47
P1A 47/44
-

622
546
167
477
504

N2A 14/45

590

N2A 13/46
P1A 36/50
P1A 37/50
P1A 38/50

531
106
253
295

557

N2A 11/46

574

N2A 11/46

575

N2A 11/46

576

N2A 11/46

577

N2A 11/46

578

579

P2A 46/44
-

580
377
081
496

P1A 37/49

632

Morphine Sulfate:
- Kapanol 20 mg
- Kapanol 50 mg
- Kapanol 100 mg
- Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
- Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
- Morphine T.P. Drug
10 mg/mL x 1 mL
- Morphine T.P. Drug
10 mg/mL x 1 mL

119
120
121

609

610

628

629

Frame Numbers in Bold Italics

GENERIC & BRAND NAME INDEX

PN DEX 2010

Color profile: Disabled


Composite 150 lpi at 45 degrees

82

PN DEX 2010

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

- Morphine T.P. Drug


10 mg/mL x 1 mL
- MST Continus 10 mg
- MST Continus 30 mg
- MST Continus 60 mg
- Oramorph
10 mg/5 mL x 250 mL
- Oramorph
20 mg/mL x 30 mL
Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Moxinax 0.25 mg
Moxinax 0.5 mg
MST Continus 10 mg
MST Continus 30 mg
MST Continus 60 mg

630
406
278
183

594

595

609

610

628

629

P1A 19/49
P1A 20/49
-

630
094
238
406
278
183

GENERIC & BRAND NAME INDEX

Nasa With Codeine


15 mg
Nembutal
50 mg/mL x 20 mL
Neo Cough 60 mL
Neo Cough 100 mL
Neo Cough 240 mL
Neocod 10 mg
Neo-Codein 10 mg
Neocof 10 mg
Neo-Cophen 10 mg
Neopect 10 mg
Neuramizone 20 mg
Nitrados 5 mg
Nitrazepam:
- Alodorm 5 mg
- Mogadon 5 mg
- Nitrados 5 mg
Nordyl Linctus
9 mg/5 mL x 100 mL

Nordyl Linctus
9 mg/5 mL x 500 mL
Nortuss Linctus 100 mL
Nortuss Linctus 500 mL

N2A 4/51

080

P1F 2/50
N2A 10/46
P2A 5/45
-

639
537
538
539
345
346
188
198
199
403
062

078
081
062

N2C 3/51

566

567
568
569

O
Opium Tinct:
- Camphorated Opium Tincture
BP 1980
5 mL/100 mL x 1000 mL N2A 9/45

529

Registration No. Frame No.


Ora 0.5 mg
Ora 1 mg
Ora 2 mg
Oramorph
10 mg/5 mL x 250 mL
Oramorph
20 mg/mL x 30 mL

310
030
212

594

595

189
206
425
461

P1A 20/51
N2A 7/42
N2A 2/50
N2A 4/50
-

607
347
074
083
113
395
077
079
116

558

559

618

Pacogesic 8 mg
Pam-5 5 mg
Panbesy 15 mg
Panbesy 30 mg
Pangon
30 mg/mL x 1 mL
Para-Co 15 mg
Paradeine 15 mg
Paradyl 8 mg

Paragen Co 15 mg
Paramed-Co 15 mg

Parcod 15 mg
Parcono 8 mg
Pardex 32.5 mg
P-Codyl
9 mg/5 mL x 60 mL

P-Codyl
9 mg/5 mL x 120 mL
Pentazocine:
- Fortwin
30 mg/mL x 1 mL
- Pangon
30 mg/mL x 1 mL
- Pentazocine All Plants
30 mg/mL x 1 mL
- Sosegon
30 mg/mL x 1 mL
- Tazcine
30 mg/mL x 1 mL
Pentazocine All Plants
30 mg/mL x 1 mL
Pentazocine HCl:
- Tazcine 25 mg
- Tazcine 50 mg
Pentobarbital Na:
- Nembutal
50 mg/mL x 20 mL
Percidyl Cough 100 mL
Pethidine Biolab
100 mg/2 mL x 2 mL
Pethidine HCl:
- Pethidine Biolab
100 mg/2 mL x 2 mL
- Pethidine
M & H Manufacturing
50 mg/mL x 1 mL
- Pethidine
M & H Manufacturing
100 mg/2 mL x 2 mL

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

P1A 12/51
P1A 13/51
-

P1A 20/51
P1C 29/49

607
597
624

633

597

058
226

P1F 2/50
-

639
562

602

602

611

612

Color profile: Disabled


Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

- Pethidine T.P. Drug


50 mg/mL x 1 mL
Pethidine M & H Manufacturing
50 mg/mL x 1 mL
Pethidine M & H Manufacturing
100 mg/2 mL x 2 mL
Pethidine T.P. Drug
50 mg/mL x 1 mL
Pharnax 0.25 mg
P1A 28/51
Pharnax 0.5 mg
P1A 29/51
Pharnax 1 mg
P1A 30/51

Phencodin
9 mg/5 mL x 60 mL
N2A 10/43

Phencodin
9 mg/5 mL x 500 mL
Phencodin
9 mg/5 mL x 1000 mL
Phenobarb 30 mg
Phenobarb 60 mg
Phenobarb Elixir
20 mg/5 mL x 60 mL
Phenobarbital
Acdhon 15 mg
Phenobarbital
Acdhon 30 mg
Phenobarbital
Acdhon 60 mg
Phenobarbital
Atlantic 16.25 mg
Phenobarbital
Atlantic 32.5 mg
P1A 33/51
Phenobarbital
Atlantic 65 mg
P1A 34/51
Phenobarbital
Atlantic 100 mg
P1A 35/51
Phenobarbital
Chew Brothers 30 mg
Phenobarbital Elixir Acdhon
20 mg/5 mL x 30 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 60 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 120 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 240 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 450 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 500 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 1000 mL
Phenobarbital Na:
- Belladonna Alkaloids With
Phenobarbital 16.2 mg

631
611
612
631
101
247
292
586
587
588
209
046
560
356
122
029
208
011
012
277
312
508
509
510
511
512
513
514

221

- Bellergal 20 mg

207

- Benera 20 mg

404

- Donnatal 16.2 mg

060

- Elixir Phenobarb 60 mL

573

- Gardenal 200 mg/4 mL

P1C 1/50

638

185

- Menobarb 60 mg

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

83

Registration No. Frame No.

- Menobarb Elixir
15 mg/5 mL x 60 mL
- Menobarb-20 Elixir
20 mg/5 mL x 60 mL
P2A 5/45
- Neuramizone 20 mg
- Phenobarb 30 mg
- Phenobarb 60 mg
- Phenobarb Elixir
20 mg/5 mL x 60 mL
- Phenobarbital
Acdhon 15 mg
- Phenobarbital
Acdhon 30 mg
- Phenobarbital
Acdhon 60 mg
- Phenobarbital
Atlantic 16.25 mg
- Phenobarbital
P1A 33/51
Atlantic 32.5 mg
- Phenobarbital
P1A 34/51
Atlantic 65 mg
- Phenobarbital
Atlantic 100 mg
P1A 35/51
- Phenobarbital
Chew Brothers 30 mg
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 30 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 60 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 120 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 240 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 450 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 500 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 1000 mL
- Phenobarbitone
New Life Pharma 30 mg
- Phenobarbitone
New Life Pharma 60 mg
- Phenoco Elixir
20 mg/5 mL x 450 mL P1A 26/47
- Phenoco Elixir
20 mg/5 mL x 3800 mL
- Phenocon 60 mg
- Phenosil Elixir
20 mg/5 mL x 60 mL
- Phenosil Elixir
20 mg/5 mL x 450 mL
- Phenotal Elixir
P1A 16/52
20 mg/5 mL x 60 mL
Phenobarbitone
New Life Pharma 30 mg
Phenobarbitone
New Life Pharma 60 mg
-

544
545
403
209
046
560
356
122
029
208
011
012
277
312
508
509
510
511
512
513
514
005
180
584
585
229
570
571
517
005
180

Frame Numbers in Bold Italics

GENERIC & BRAND NAME INDEX

PN DEX 2010

Color profile: Disabled


Composite 150 lpi at 45 degrees

84

PN DEX 2010

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

Phenoco Elixir
20 mg/5 mL x 450 mL
Phenoco Elixir
20 mg/5 mL x 3800 mL
Phenocon 60 mg
Phenosil Elixir
20 mg/5 mL x 60 mL
Phenosil Elixir
20 mg/5 mL x 450 mL
Phenotal Elixir
20 mg/5 mL x 60 mL
Phensedyl
9 mg/5 mL x 100 mL

Phensodi 60 mL

Phensodi 120 mL
Phensodi 1000 mL
Phentermine HCl:
- Panbesy 15 mg

- Panbesy 30 mg
- Phentermine
Osmopharm 15 mg
Phentermine Osmopharm
15 mg
Phentermine Resinate:
- Duromine 15 mg

- Duromine 30 mg
- Phentermine
Trenker 15 mg
- Phentermine
Trenker 30 mg
Phentermine Trenker 15 mg
Phentermine Trenker 30 mg

GENERIC & BRAND NAME INDEX

Phenylpropanolamine HCl:
- Phenylpropanolamine
Pharmasant 25 mg
Phenylpropanolamine
Pharmasant 25 mg
Pinazepam:
- Domar 5 mg

Pobrax 5 mg
Polizep 5 mg
Polizep 10 mg

Poly-Cof Syrup
9 mg/5 mL x 60 mL
Poly-Cof Syrup
9 mg/5 mL x 100 mL

Polydine CD 10 mg
Pomadom 5 mg
Pomadom 10 mg

Pondnadyl
9 mg/5 mL x 60 mL
Pondnadyl
9 mg/5 mL x 100 mL

Pondnadyl
9 mg/5 mL x 1000 mL
Pondnebium 5 mg

P1A 26/47

584

585
229

570

571

P1A 16/52

517

N2A 8/43
-

553
524
525
526

425
461

451

451

499
488

466

424
466
424

141

141

P1A 5/52
P1A 23/50
-

Registration No. Frame No.


Pondnebium 10 mg
Popam 2 mg
Popam 5 mg
Pora 0.5 mg
Pora 1 mg
Pora 2 mg
Posene 5 mg
Posene 10 mg
Povanil 0.5 mg
Povanil 2 mg
Pozapam 5 mg
Pozapam 10 mg
Prasepine 5 mg

P1A 33/52
P1A 34/52
P1A 23/52
P1A 39/51
-

192
111
170
370
139
215
172
402
186
067
459
175
458

Prazepam:
- Pozapam 5 mg

P1A 23/52

459

P1A 39/51

175

P1A 3/51
P1A 30/52
P1A 31/52
P1A 32/52

458
234
174
407
337
054

143

047

- Pozapam 10 mg
- Prasepine 5 mg
Prazol 0.5 mg
Prefamone 75 mg
Prenarpil 0.5 mg
Prenarpil 1 mg
Prenarpil 2 mg
Pseudoephedrine
Asian Pharm 30 mg
Pseudoephedrine
Asian Pharm 60 mg
Pseudoephedrine
BJ Benjaosoth 60 mg

135

Pseudoephedrine HCl:
- Pseudoephedrine
Asian Pharm 30 mg

143

- Pseudoephedrine
Asian Pharm 60 mg

047

- Pseudoephedrine
BJ Benjaosoth 60 mg

135

- Pseudoephedrine
Medicine Products 60 mg

184

- Pseudoephedrine
Milano 30 mg

136

- Pseudoephedrine
Milano 60 mg

045

- Pseudoephedrine Syrup
Asian Pharm
30 mg/5 mL x 60 mL

518

- Pseudoephedrine Syrup
BJ Benjaosoth
30 mg/5 mL x 60 mL

523

547

184

136

045

464
376
444
268

N2A 5/51

548

N2A 5/51
P1A 2/46

549
270
455
423

N2A 3/48

563

N2A 3/48

564

P1A 13/49

565
371

- Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL
Pseudoephedrine
Medicine Products 60 mg
Pseudoephedrine
Milano 30 mg
Pseudoephedrine
Milano 60 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM

Color profile: Disabled


Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

Pseudoephedrine Syrup
Asian Pharm
30 mg/5 mL x 60 mL
Pseudoephedrine Syrup
BJ Benjaosoth
30 mg/5 mL x 60 mL
Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL

518

523

547

Radibrax 5 mg
Razepam 0.5 mg
Razepam 1 mg
Razepam 2 mg
Regenon Retard 75 mg
Regenon Retard 75 mg
Reinbamate 400 mg
Ritalin 10 mg
Rivotril 0.5 mg
Rivotril
1 mg/mL x 1 mL
Rivotril 2 mg
Rohypnol 1 mg
Rolar 10 mg
Ropam 5 mg
Ropam
10 mg/2 mL x 2 mL
Ropect 10 mg
Rotuss 10 mg
Rubifen 10 mg

P1C 7/49

392
315
032
131
115
486
082
041
408

P1C 17/48
N2A 3/52
-

637
055
394
203
158

P1A 13/45
N2C 12/46
N2C 9/46
-

608
201
204
038

S
S.Co Zepam 5 mg
Sanor 5 mg
Sanor 10 mg

Seco 10 mg
N2A 2/47
Serene
Masa Lab 10 mg
Serene
V S Pharma 5 mg
Siampraxol 0.25 mg
P1A 6/52
Siampraxol 0.5 mg
P1A 7/52
Siampraxol 1 mg
Sipam 2 mg
P1A 15/49
Sipam 5 mg
P1A 16/49
Sipam 10 mg
P1A 17/49
Sipam
10 mg/2 mL x 2 mL
P1A 39/50
Sosegon
30 mg/mL x 1 mL
P1C 29/49
Spasil 2.5 mg
N2A 2/51
Squill And Ammonia Mixture
1.3 mL/10 mL x 450 mL
N2A 9/47
Stesolid 2 mg
-

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:51 AM

220
426
258
389
259
431
098
243
290
056
154
339
626
624
009
591
401

85

Registration No. Frame No.


Stesolid 5 mg
Stesolid 10 mg
Stilnox 10 mg
Sunax 0.25 mg
Sunax 0.5 mg

485
479
110
107
254

445
058
633
226

T
Tamylab-S 5 mg
Tazcine 25 mg
Tazcine 30 mg/mL x 1 mL
Tazcine 50 mg

Temazepam:
- Euhypnos 20 20 mg
Temgesic 0.2 mg
Temgesic 0.3 mg/mL x 1 mL
Tenadrin-C 60 mL
Tenmed 5 mg
P1A 54/42
Tenmed 10 mg
P1A 55/42
Teradene 60 mL
Teradyl Syrup 60 mL

Teradyl Syrup 1000 mL


Terco-C 10 mg
N2A 1/49
T-Five 5 mg
Tocodyl 10 mg
Tofisopam:
- Grandaxin 50 mg
Tranadon-S 5 mg
Tranavan 0.5 mg
Tranavan 1 mg
Trancap 5 mg
Trancap 10 mg
Tranclor 5 mg
Tranclor 10 mg
Trancon 5 mg
Trancon 10 mg
Tranmed 5 mg
Tranmed 10 mg
Tranolan 2 mg
Tranolan 5 mg
Tranolan
10 mg/2 mL x 2 mL
Tranpate 5 mg
Tranpon 5 mg
Transpon Forte 10 mg
Tranxene 5 mg
Tranxene 10 mg
Tranzep 5 mg
Trialam 0.25 mg
Triazolam:
- Halcion 0.25 mg
- Trialam 0.25 mg
- Trycam 0.25 mg
Trycam 0.25 mg

398
007
619
519
440
269
520
532
533
387
446
390

P1C 27/50
P1A 3/52
P1A 4/52
P1A 27/42
P1A 4/44
P1A 39/52
P1A 42/50
P1A 43/50

051
447
307
034
470
173
439
272
456
422
428
261
130
177

P1A 41/52
P1A 61/43
P1A 16/46
-

615
416
441
257
438
271
434
168

350
168
348
348

Frame Numbers in Bold Italics

GENERIC & BRAND NAME INDEX

PN DEX 2010

Color profile: Disabled


Composite 150 lpi at 45 degrees

86

PN DEX 2010

GENERIC & BRAND NAME INDEX


Registration No. Frame No.

Tumax 5 mg

Tussidyl
9 mg/5 mL x 60 mL

Tylenol With Codeine


15 mg

Tylenol With Codeine


30 mg

P2A 25/51

400

N2A 6/45

589

N2A 6/43

075

N2A 11/43

076

U
Uptran 10 mg
Upzene 5 mg

Utorax 5 mg

267
490
383

GENERIC & BRAND NAME INDEX

V
V Day Zepam 2 mg
V Day Zepam 5 mg
V Day Zepam
10 mg/2 mL x 2 mL
V Day Zepam NL
10 mg/2 mL x 2 mL
Valax 2 mg
Valax 5 mg
Valax 10 mg
Valenium 2 mg
Valenium 5 mg
Valium 5 mg
Valium
10 mg/2 mL x 2 mL
Vason 2 mg
Vemed 0.5 mg
Vescopam
10 mg/2 mL x 2 mL
Victan 2 mg
Vispam 2 mg
Vispam 5 mg
Vispam 10 mg
Vomed 2 mg
Vomed 5 mg
Vorapam 2 mg
Vorapam 5 mg

P1A 88/42
P1A 89/42

475
465

P2A 82/43

616

P1A 11/46
-

617
031
132
322
065
150
152

P1A 16/48
-

620
396
316

P1A 7/50
P1A 16/50
P1A 40/50
P1A 41/50

636
182
366
213
323
059
147
064
159

Registration No. Frame No.


Xanax 0.25 mg
Xanax 0.5 mg
Xanax 1 mg
Xanax XR 0.5 mg
Xanax XR 1 mg
Xanax XR 2 mg
Xiemed 0.25 mg
Xiemed 0.5 mg
Xiemed 1 mg

P1C 20/52
P1C 21/52
P1C 22/52
P1C 17/50
P1C 18/50
P1C 19/50
P1A 27/49
P1A 34/50
P1A 28/49

096
240
287
344
069
353
108
249
296

Z
Zeda 0.5 mg
Zeda 1 mg
Zepam 2 mg
Zepam 5 mg
Zepam
10 mg/2 mL x 2 mL
Zepaxid 2 mg
Zepaxid 5 mg
Zepaxid
10 mg/2 mL x 2 mL

Zepobrax 5 mg
Zepoxide 5 mg
Zepoxide 10 mg
Zepoxin 5 mg
Zepoxin 10 mg
Zetran 5 mg
Zolam 0.25 mg
Zolam 0.5 mg
Zolam 1 mg
Zolpidem Tartrate:
- Stilnox 10 mg
Zopam 2 mg
Zopam 5 mg
Zopam 10 mg
Zora 0.5 mg
Zora 2 mg
Zorituss 10 mg

P1A 8/52
P1A 9/52
-

014
360
399
354

P1A 20/50
P1A 21/50

614
506
462

P1A 32/50
P1A 3/44
P1A 44/50
P1A 45/50
P1A 46/50

634
384
413
279
205
118
449
093
237
285

P1A 35/49
P1A 36/49
P1A 3/46
P1A 25/50
P1A 26/50
-

110
048
145
331
328
179
197

W
-

063
375

P1A 13/48
P1A 14/48
P1A 15/48

095
239
286
091
236
284

Winopam 2 mg
Winopam 5 mg

X
Xalam 0.25 mg
Xalam 0.5 mg
Xalam 1 mg
Xanacine 0.25 mg
Xanacine 0.5 mg
Xanacine 1 mg

Indicates brands that contain more than 1 ingredient

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:51 AM





1. PNdex







PNdex












2. /-

3.

4. (PNdex 2010)
/-

5.
6.


21-30

31-40

41-50

51-60

7.
8.


P87-88 Feed back.indd 1

5/4/2553 13:21:29

P87-88 Feed back.indd 2

. .
. 11000

2/4/2553 12:34:42